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Abstract 
Nanostructured drug delivery systems (DDS) have drawn great attention in 
these last years due to the improvement of the efficacy of therapeutic 
principle, by enhancing their biocompatibility, bioavailability and targeting. 
Particular interest was focused on the design and development of 
multifunctional architectures for the delivery of different therapeutics and 
diagnostic agents and their spatially and temporally controlled release. In this 
study we report the design, synthesis and characterization of two main 
categories of nanostructured functional materials for drug delivery: simple 
DDS based on inorganic and magnetic nanoparticles (MNPs) and more 
complex hybrid responsive platforms based on lipids and MNPs. Calcium 
Phosphate NPs decorated with oligonucleotide single and double strands as 
nanocarriers for gene delivery endowed of high biodegradability and 
biocompatibility, were synthesized and characterized by DLS and Atomic 
Force Microscopy. Moreover, magnetic core-shell hydrophobic and 
hydrophilic nanoparticles of magnetite (Au@Fe3O4) were prepared and 
characterized through DLS and SAXS. These MNPs, having suitable sizes to 
be incorporated in the lipid bilayers and in the aqueous core of liposomes 
(magnetoliposomes), were used as actuators for the magnetic triggered 
release of Carboxyfluorescein from the core of liposomes dispersed in 
biological fluids (serum 10% and 55% in protein concentration), in order to 
study the effects of the serum proteins on the release behavior. The design, 
preparation and characterization of another hybrid lipid/MNPs DDS, where 
hydrophobic Fe3O4 NPs are embedded in the bilayer of bicontinuous cubic 
lipid phase of Glyceryl Monooleate (GMO), either in bulk phase and in 
dispersed cubic lipid nanoparticles (magnetocubosomes), were performed. 
Furthermore, for the first time Fluorescence Correlation Spectroscopy was 
employed to investigate the magnetoliposomes’ ability to encapsulate 
simultaneously both hydrophilic and hydrophobic drugs and also to study 
their diffusion inside the bicontinuous cubic phase domains. Finally, with the 
same technique a magnetically triggered release of a hydrophilic model drug 
toward an aqueous environment from aqueous channels of both bulk cubic 
phase, doped with MNPs, and magnetoliposomes was monitored highlighting 
that a low-frequency alternating magnetic field (LF-AMF) can act as an 
external trigger to boost the release of a model drugs confined in the cubic 
phase.   
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1 Introduction 
Nanostructured materials exhibit several physical and chemical properties 
which have made them an integral part of research in the nanoscience and 
nanomedicine fields. Nanostructured systems (inorganic, metallic, lipidic or 
mixed systems) show a wide potential applications range, one of which is 
their use as nano-carriers for the confinement and delivery of therapeutic 
molecules. Biocompatible and responsive nanostructured drug delivery 
systems (DDS) are of great interest for the development of smart, efficient 
and non-toxic vectors for therapeutic agents. The design and development of 
therapeutic vectors for drugs and/or diagnostic imaging agents, characterized 
by a controlled size in the submicron range, able to interact and be 
internalized by cells without toxic side effects, are among the main goals of 
research in this field.1,2 These carriers should promote therapeutic efficacy, 
by enhancing the circulation time of active principles inside the organism, by 
protecting them from degradation, and by targeting them to the designed 
biological objective. In addition, it is of utmost importance that, once the 
target is reached, the payloads are released with spatial and temporal control. 
But a main issue in the design of such biomedical devices is biocompatibility.  
For all these reasons this research work was focused on the design, synthesis 
and characterization of drug delivery systems based on inorganic and 
magnetic nanoparticles (MNPs) in a first time and, subsequently, on hybrid 
lipid/MNPs DDS in order to improve their biocompatibility. In fact, 
inorganic nanostructured systems are intrinsically characterized by a high 
surface energy: therefore they show robust interactions with biological fluids 
and interfaces, possibly causing toxic effects on cells and organisms.3,4 In this 
regard, lipid nanostructured assemblies are completely safe and non-toxic, 
and can be easily employed as scaffolds for the development of 
multifunctional devices. Lipid self-assembly in aqueous media gives rise to a 
multitude of architectures, characterized by the coexistence of separate 
hydrophobic and hydrophilic regions within the same nanosized structure, 
that can spontaneously host both hydrophilic and hydrophobic drugs. This 
feature provides a multifunctional integrated platform, where drugs or 
imaging agents with different water affinity can be stored and delivered to the 
same target and eventually released simultaneously in a controlled way. 
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1.1 Nanotechnology and Nanomedicine  
Nanotechnology is the engineering and manufacturing of functional materials 
at the atomic and molecular scale. The first use of the term 
“Nanotechnology” was in “There is Plenty of Room at the Bottom”5 a talk 
given by physicist Richard Feynman at an American Physical Society 
meeting in 1959 in which Feynman described the possibility of manipulating 
individual atoms and molecules, using one set of precise tools to build and 
operate another proportionally smaller set, and so on down to the needed 
scale. Nanotechnology and nanoscience got started in the early 1980s with 
two major developments: the birth of cluster science and the invention of the 
scanning tunneling microscopy (STM). This development led to the 
discovery of fullerenes, carbon nanotubes, semiconductor nanocrystals and to 
a fast increasing number of metal and metal oxide nanoparticles and quantum 
dots. Generally, with nanotechnologies refer to structures sized between 1 
and 100 nm, in at least one dimension, but it is also commonly referred to 
structures that are up to several hundred nanometers in size.6 Current 
nanotechnology progresses in chemistry, physics, materials science and 
biotechnology have created novel materials that have unique properties due 
to their sub-micron scaled structures. Moreover, nanotechnology has also 
found important application in the healthcare and disease diagnosis and 
treatment, giving rise to the specific branch of Nanomedicine. It is the 
medical application of nanotechnology and it has two main goals: 1) 
understand how the biological machinery inside living cells is built and 
operates at the nanoscale and 2) use this information to re-engineer these 
structures and develop new technologies that could be applied to disease 
diagnosis and treatment. Nanomedicine is based on the applications of 
nanomaterials and the current problems in nanomedicine involve 
understanding the toxicity and environmental impact of these nanoscaled 
materials toward the biological tissues. The size of nanomaterials is 
comparable to that of most biological molecules and structures, so they can 
be used as a tool for biomedical research and applications. In this way, 
through the integration of nanomaterials with biology, diagnostic devices, 
contrast agents, analytical tools, physical therapy applications and drug 
delivery vehicles are developed.7 Today artificial bone implants already 
benefit from nanotechlogical materials, nanostructured surfaces are used for 
controlled tissue growth,8,9 antibacterial surfaces incorporating photocatalytic 
or biocidal nanoparticles10 have reduced the risk of infections. Moreover, all 
kinds of medical devices profit from the miniaturization of electronic  
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components as they move beyond micro to nano. Nanoparticulate 
pharmaceutical agents can penetrate cells more effectively and, stimulated 
from outside the body, they can destroy the tumor cells. New contrast agents 
(MRI, Magnetic Resonance Imaging) and visualization tools provide a closer 
look at cellular processes by using nanoparticles.11 Portable testing kits allow 
for self-monitoring and speedy diagnosis.12 Nanoparticles can be used for 
separation and purification of biological molecules and cells or for protein 
detection.13 These are only some examples of nanomaterials applications to 
medicine and biology, but many others can be found in several reports on the 
prospects and promises of nanomedicine. 
1.2 Drug Delivery 
In the medicine field, one of the most promising applications of 
nanotechnology is to achieve selective delivery of pharmaceutical agents to 
specific area in the body in order to maximize drug action and minimize toxic 
side effects. The application of nanotechnology to drug delivery has been 
able to change the landscape of pharmaceutical and biotechnology 
industries.14 The development of nanotechnology products has played an 
important role in the introduction of new tools useful in several fields in the 
research medicine and biology area. The development of drug delivery 
started with the idea of Paul Ehrlich (1854-1915), who proposed the use of a 
“magic bullet” capable to target specificity disease cells in the body.  
Using nanotechnology it is possible to achieve: 
 
• Improved delivery of poorly water-soluble drugs; 
• Improved oral bioavailability; 
• Improved the stability of therapeutic agents against enzymatic 
degradation (nucleases and proteases); 
• Targeted delivery of drugs in a cell- or tissue-specific manner; 
• Transcytosis of drug across tight epithelial and endothelial barriers; 
• Delivery of large macromolecule drugs to intracellular sites of action; 
• Co-delivery of two or more drugs or therapeutic modality for 
combination therapy; 
• Visualization of sites of drug delivery by combining therapeutic 
agents with imaging modalities; 
• Real-time read on the in vivo efficacy of a therapeutic agent.15 
 
1 – Introduction 
 
 8 
Nanotechnology for drug delivery focuses on formulating therapeutic agents 
(as proteins, peptides, DNA, genes, etc.) in biocompatible nanocomposites 
such as nanoparticles, nanospheres (matrix-type nanodevices), nanocapsules 
(reservoir-type nanodevices), micellar systems and conjugates. Moreover, the 
distribution of these nanosystems and their loads through the body depends 
on many physico-chemical factors: size, toxicity, surface charge, capacity for 
protein absorption, drug loading and release kinetics, stability, degeneration 
of carrier systems, hydration behavior, electrophoretic mobility, porosity, 
surface characteristics, density and molecular weight. The nanometer size-
ranges of these delivery systems allow them to penetrate deep into tissues 
through fine capillaries, cross the fenestration present in the epithelial lining 
(e.g. liver) and are generally taken up efficiently by the cells. This provides 
efficient delivery of therapeutic agents to target sites in the body. 
Furthermore, by modulating the characteristic of the nanosystems (e.g. with 
magnetic materials, specific polymeric chain or with a biospecific ligand) it is 
possible to achieve a controlled (temporally and/or spatially) or triggered 
release of a drug in target tissue for an optimal therapeutic efficacy.  
Among the first drug delivery systems were liposomes,1 subsequently a 
variety of organic and inorganic biomaterials were developed for drug 
delivery systems. In 1976 the first polymeric nanosystems for delivery was 
described,16 while more complex DDS able to responding to changes in pH 
were described about 1980. The development of nanodevices based on 
biocompatible/biodegradable polymers has emerged with the discoveries of 
albumin, polyalkylcyanoacrylate, polylactate-co-glycolate, and later, solid 
lipid or chitosan nanoparticles.17 Others examples of DDS are inorganic 
nanoparticles constituted by several kind of inorganic materials as calcium 
phosphate, carbon nanotubes, silica, gold, magnetite, quantum dots, strontium 
phosphate, magnesium phosphate and double hydroxides.18  
The increase of therapeutic index, that is the margin between the doses 
resulting in a therapeutic efficacy and toxicity to the other organ of the body, 
is needed for the preparation of long-lived and target-specific nanodevices: in 
fact, one of the problem in the use of nanoparticulate drug carriers is their 
entrapment in the reticuloendothelial system (RES), mainly in the liver and 
spleen, which can drastically reduce the time of permanence in the 
bloodstream. Circulating mononuclear phagocytes (monocytes) clear the 
nanoparticles to the liver, spleen and bone where residence cells capture and 
expel them. In general, the larger the particles are, the shorter their plasma 
half-life period is. Surface coatings play an essential role in retarding 
clearance by the RES. For this purpose polyethylene glycol (PEG), a 
1– Introduction 
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hydrophilic and flexible polymer, is the most widely used coating that 
inhibits recognition and phagocytosis by the RES due to its protein-resistant 
feature, preventing opsonization and subsequent liver capture and so 
increasing circulation time.19 However, the “immunostealthing” function 
provided by PEG is frequently concurrent with the loss of biomolecular 
targeting capabilities. The nature of the coating is also important where the 
surface functionalization might cause hydrogen bonding and agglomeration 
of nanoparticles, reducing their stability in body fluids.20 Finally, the fate and 
toxicity of the nanocarrier also depend strongly on the dose and 
administration route (oral, intravenous, pulmonary, transdermal, ocular, etc.).  
Despite the progresses in the DDS field, only a few medicine-loaded 
nanodevices have reached the market (e.g. Abraxane® and Endorem® for 
imaging application) due to poor drug loading and too rapid release. 
Therefore, it appeared necessary to have better and safer (bio)materials for 
drug delivery purposes which can provide a more efficient loading and 
controlled release. The focus was so on the multifunctional drug delivery 
nanodevices that can possibly provide simultaneously personalized patient 
treatment and diagnosis (“Nanotheragnostics”).21  
Finally, most of innovations in the drug delivery area were centered on 
producing of DDS able to release therapeutics payload on-demand. 
Responsive DDS were designed in order to mimic the biological behavior in 
which external stimuli or changes in local environment can trigger a change 
in property like conformation, charge, shape, solubility and size. Therefore, 
drug release from responsive nanodevice-carriers can be regulated both 
spatial manner through targeting and temporal manner when the external 
stimuli are applied. For this purpose several kind of chemical (as pH and 
ionic strength), physical (as temperature, light, electricity, magnetic field, 
ultrasound, mechanical stress, etc.) and biological (like enzymes and 
proteins) signals were employed as triggering stimuli.22 
1.3 Inorganic Nanoparticles 
In this research work a study on calcium phosphate nanoparticles as 
nanocarriers for oligonucleotides delivery was first of all performed in order 
to highlight the possibility to use a highly biocompatible and biodegradable 
inorganic material to build DNA delivery nanosystems.  
The subsequent part of work has been focused on the synthesis and 
characterization of magnetic nanoparticles in order to obtain a responsive 
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DDS to an external magnetic stimulus and with the purpose to use them like 
triggers in the more complex lipid/magnetic nanoparticles DDS, which will 
be discussed further on.  
1.3.1 Calcium Phosphate Nanoparticles 
One of the most relevant challenges in biotechnology in the last years has 
been the possibility to modify the cell genome and therefore to influence the 
synthesis of defined proteins for therapeutic purposes. Through the 
transfection, in fact, it is possible to introduce into eukaryotic cells foreign 
nucleic acids, DNA or RNA, in order to control intracellular processes, like 
the expression of the desirable proteins and the silencing of chosen genes. 
But, nucleic acids itself are not able to penetrate the cell wall, thus efficient 
carriers and protectors are needed to internalize nucleic acids.23 Many carriers 
were investigated and applied but few of them showed satisfactory results in 
terms of toxicity or transfection efficiency. Generally, gene-delivery systems 
can be divided in two categories: viral and non-viral carriers. The viral 
systems are the most effective for transfection but dangerous because of the 
risk of immunogenicity, inflammatory response and carcinogenicity.24 
Among non-viral systems cationic compounds, recombinant proteins and 
inorganic nanoparticles are the most important. Although they show smaller 
transfection efficiency than that the viral systems, they possess some 
advantages: they are no subject to microbial attack, can be easily prepared, 
they have low toxicity and good storage stability. Inorganic materials 
generally used to built nano-carriers were silica, magnetite, carbon 
nanotubes, magnesium, manganese and calcium phosphate.25-27 Nanoparticles 
of noble metals as gold, silver, palladium and platinum were also explored.28 
Among all of these inorganic materials, Calcium Phosphate (CaP) has special 
properties: in fact, as constituent of biological hard tissue (bone and teeth) it 
possesses an excellent biocompatibility, biodegradability and moreover it is 
involved in the regulation of many cellular processes. For these features 
together to its adsorptive capacity for DNA, Calcium Phosphate 
Nanoparticles (CaP NPs) are widely used as non-viral vectors for transfection 
of a variety of cells. Another advantage is that these CaP NPs can also be 
suitably functionalized with fluorescent dyes, polymeric agents, pro-drugs or 
activators. Moreover, the small CaP monodisperse NPs only mildly influence 
the intracellular calcium level and so are non-toxic for the cells.  
It is very important to notice that, the transfection efficiency of the CaP NPs 
is strongly dependent on preparation parameters, such as pH, reagents’ 
1– Introduction 
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concentration, temperature and size of the nanoparticles. Many efforts have 
been made to prepare CaP NPs with appropriate and controlled size and good 
monodispersity. The first precipitation method for transfection with CaP NPs 
was described by Graham and var der Eb in 1973.29 The precipitation occurs 
in situ and consists in a subsequent mixing of calcium chloride solution, 
DNA and phosphate buffer saline solution to obtain CaP/DNA precipitates, 
then this dispersion can be added to a cell culture and the agglomerate will be 
taken from the cells.  
 
Figure 1.1 Cartoon sketching of calcium phosphate NPs with an oligonucleotide 
stabilizing agent and its possible pathway across a membranes.  
Another methods of nanoparticles’ preparation were then described, taking in 
to account that the concentration of calcium, phosphate and DNA are 
parameters that must be controlled to ensure supersaturation but avoiding 
precipitation. In order to prevent precipitation is necessary a stabilizing agent 
which could furthermore facilitate its penetration through vessel epithelium 
or cell membrane. It was early clear that to obtain a reproducible method a 
high control of nanoparticles size and morphology are essential. Wezel et al. 
developed a method of controlled precipitation of spherical CaP NPs 
functionalized with DNA.30 Sokolova et al. developed a multi-shell particles 
in which DNA was protected against nuclease attack.31 Bisht et al. prepared 
instead CaP NPs from microemulsions with DNA encapsulated into the CaP 
NPs core and so protected from the degradation by nucleases.32 Through the 
functionalization with DNA the growth of calcium phosphate crystals is 
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inhibited and also elements such as magnesium and aluminum have 
inhibitory effect respect to the growth of calcium phosphate crystals. CaP 
NPs may also be used as a template for more complex structures where e.g. a 
core of CaP is used for the synthesis of polymeric nanocapsules through 
layer-by-layer technique. Therefore, it is possible to use these nanocapsules 
loaded with a drug for drug delivery in vivo. CaP NPs have been also 
prepared with polymer to obtain porous nanospheres in order to increase the 
gene loading.38,39 
 
In the first part of this research work, inorganic Ca3(PO4)2 NPs decorated 
with single and double strand oligonucleotides were prepared and were 
characterized by Dynamic Light Scattering (DLS), Zeta Potential (ζ-Pot) and 
Atomic Force Microscopy (AFM). The aim of the work was to develop one-
pot synthetic process through the rapid and highly controlled mixing of the 
reagents in order to obtain a stable, monodisperse and size controlled calcium 
phosphate nanoparticles’ dispersion stabilized by an oligonucleotide. The 
precursors used to achieve CaP NPs’ dispersion were only an aqueous 
solution of calcium and phosphate with an aqueous solution of an 
oligonucleotide of 50 pairs of bases (that we called d(AT)-50 mers), both 
single and double strands. In this study oligonucleotide has two important 
roles: it is the stabilizing agent that inhibits the CaP crystals growth and it 
prevents the subsequent aggregation by steric and electrostatic repulsion. But 
at the same time, it is also the therapeutic agent which can be potentially 
carried and delivered from CaP NPs in a target tissues. The purpose of this 
oligonucleotide functionalization was to avoid the use of another stabilizing 
agent (e.g. polymer) that could affect the biocompatibility and 
biodegradability of the nanosystem and so to use the same drug present on 
the surfaces to achieve colloidal stabilization of the nanoparticles’ dispersion. 
This is was possible thanks to the electrostatic interaction between partially 
positively charged calcium phosphate nanoparticle’s surface and negatively 
charged phosphate backbone of the oligonucleotide. The presence of the 
nucleic acid on the CaP NPs surface was demonstrated by the negative values 
of the zeta potential. Moreover, the high control of the preparation method 
has allowed obtaining a control of size, distribution size and stability of the 
nanoparticles. These results were highlighted by also morphological 
investigation, which has showed nanoparticles with dimensions comparable 
with those obtained by the DLS measurements (Chapter 2, Section 2.1).  
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1.3.2 Magnetic Nanoparticles  
The first application of magnetism in medicine was reported in a pioneering 
work of the physician U. Hafeli.41 More recently, the miniaturization of 
electromagnets, the development of superconducting electromagnets and the 
introduction of permanent magnets have stimulated the medical use of 
magnets in several fields such as in cardiology, oncology and radiology area.  
Magnetic Nanoparticles (MNPs) have been commonly used in many 
technological applications especially for biomedical applications such as 
magnetic separation, cell labeling, drug targeting and delivery, hyperthermia 
treatment of solid tumors, contrast agents for magnetic resonance imaging 
(MRI), biosensors and bioimaging.42-45 All these applications require an high 
magnetization values of these MNPs and size smaller than 100 nm with 
overall narrow particle size distribution, in order to have homogeneity in 
physical and chemical properties. Moreover, their ability to distally control 
the position of the particles in a certain media to induce accumulation or 
separation from similar structures constitute a powerful application in 
innovative medicine.46 Despite the low toxicity and the suitability of MNPs 
for in vivo applications, many efforts have been done in order to modulate 
surface features and to improve the biocompatibility of the magnetic 
materials. Thanks to their magnetic properties a magnetic field would pull the 
MNPs to target specific organ or tissue, where the carrier would subsequently 
break down and so release drugs into surrounding environment, resolving the 
problem in drug therapy of the non-specific concentration of drugs.47  
Magnetic nanoparticles are more properly indicated as “superparamagnetic” 
nanoparticles (Superparamagnetic Iron-Oxide Nanoparticles-SPIONs) 
referring to their magnetization ability upon exposure to a magnetic field 
without permanent magnetization; so, after removing the magnetic field, the 
particles no longer show magnetic interaction, this make them very usable for 
the previous mentioned applications.48 
Among nanosized magnetic nanoparticles, the iron-oxides maghemite NPs γ-
Fe2O3 and magnetite Fe3O4 NPs are the most investigated in the magnetic 
nanoparticles field in which the magnetite is a very promising candidate since 
its biocompatibility has already proven. Magnetite, Fe3O4, has a cubic inverse 
spinel structure with oxygen forming a fcc closed packing and Fe cations 
occupying interstitial tetrahedral sites and octahedral sites. With proper 
surface coating, these MNPs can be dispersed into suitable solvents, forming 
homogeneous suspensions, called ferrofluids.49,50 
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Much work has been dedicated to the synthesis of iron-oxides nanoparticles 
because the synthesis process has a great influence on particles composition, 
size distribution and morphology from which physical properties depend. In 
addition, the inorganic or polymeric coating layers of magnetic nanoparticles 
can enhance desirable properties such as colloidal dispersion stability and 
biocompatibility. Usually, iron-oxide nanoparticles are coated by compatible 
materials such as polysaccharides, synthetic polymers, lipid, but also by 
noble metal obtaining a nano-composite morphology referred to as a core-
shell structure. 
In the literature, a lot of synthetic methods for the preparation of iron-oxides 
MNPs are reported. But the most used are the co-precipitation and the 
thermal decomposition methods.51 The first is based on a protocol introduced 
by Massart that consists in a co-precipitation of Fe3+ and Fe2+ aqueous 
chloride solutions by addition of a base.52 The main advantage of this 
synthetic pathway is the large quantities of nanoparticles obtained, however 
with a limited control of their size, shape and generally crystallinity, mainly 
due to kinetic factors that control the growth of the crystal; in fact, the co-
precipitation method consists of two stages, a short burst of nucleation 
followed by a slow growth of the nuclei by diffusion of the solutes to the 
surface of the crystal. MNPs prepared by this process tend to be rather 
polydispersed and the addition of chelating anions (carboxylate ions, such as 
citric, gluconic or oleic acid) or polymer surface complexing agents (dextran 
or polyvinyl alcohol) during the formation of magnetic core could help to the 
size control of the nanoparticles. Moreover, the parameters of this process are 
strongly influenced by the base (NH3 or NaOH), pH value, by the cations 
(N(CH3)4+, CH3NH3+, Na+, K+ and NH4+) and by the temperature. Through 
co-precipitation method, by modulating these parameters, it is possible to 
obtain particles with a size ranging from 2 to 20 nm. 
While, a higher control of the size and shape (with high monodispersity) of 
the MNPs, can be achieved by thermal decomposition of a metal-organic 
precursor in high-boiling organic solvents. Sun et al were the first to prepare 
Fe3O4 MNPs by pyrolyzing Fe3+ acetylacetonate (Fe(acac)3) in the presence 
of oleic acid, oleylamine and 1,2-hexadecanediol.53 However, in this case the 
formed MNPs are soluble in organic solvents and a crucial step is a ligand 
exchange procedure needed to transform the prepared MNPs into water 
soluble nanoparticles. It is important to remember that the size and the 
composition of the MNPs may affect their physical characteristic and so their 
relaxivity. 
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1.3.2.1 Magnetic Nanoparticles for drug delivery 
The first application of magnetic micro and nano-particles for drug delivery 
were proposed by Widder et al, in the late 1970s, who described the targeting 
of magnetic albumin microsphere encapsulating an anticancer drug 
(doxorubicin) in animal models.54 Ideally, magnetic nanoparticles could bear 
on their surface or in their bulk a pharmaceutical drug that could be directly 
driven and released into a specific site of the body by an external magnetic 
force. For these applications, the size, charge and surface chemistry of the 
MNPs are particularly important and the blood circulating time as well as 
bioavailability of the particles within the body is strongly affected by MNPs’ 
features. Moreover, the nanoparticle’s size influences also their 
internalization capacity. In fact, nanoparticles with 200 nm of diameters are 
generally sequestrated by the spleen as a result of mechanical filtration. But, 
MNPs with a less than 10 nm are rapidly removed through renal clearance. 
Thus, nanoparticles with 10 to 100 nm diameters range are optimal for 
intravenous injection, being able to evade the RES of the body as well as 
penetrate the small capillaries in the body tissues. It is possible to increase the 
blood circulation time by minimizing or eliminating the protein adsorption on 
the particle’s surface by covering it with amphiphilic polymeric surfactant 
such as poloxamers and PEG.55 As a result, a functional magnetic drug 
carrier should consist of a magnetic core, a protective coating and an active 
drug.  
Magnetically mediated hyperthermia is a particular application of magnetic 
nanoparticles in drug delivery. MNPs exposed to an external magnetic field 
are heated through either hysteresis loss or relaxation loss depending on their 
size and properties. Because cancer cells are killed at temperature over 44°C, 
whereas normal cells survive at these higher temperatures, magnetically 
mediated hyperthermia, induced by magnetic field, can be used to selectively 
destroy cancer cells in which MNPs have been accumulated.56 
Magnetic nanoparticles can be also used as carriers of therapeutic genes. The 
cellular entry of DNA is hindered by several barriers, including enzymatic 
degradation operated by nucleases and the high molecular weight and charge 
density of nucleic acids that prevent cellular uptake. It is possible to employ 
MNPs in Gene Therapy, by functionalization with DNA molecules, 
increasing their stability and circulation time, to avoid fast degradation and to 
overcome the barriers represented by the cell membranes. By employing 
magnetic properties of the MNPs the controlled release could be occur by the 
exposure to an external magnetic field. Magnetofection, i.e. magnetically 
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enhanced nucleic acid delivery method, provides a triggered delivery method 
by using magnetic force to release a nucleic acid from the magnetic 
nanoparticles into a target cell.57 
1.3.2.2 Gold-coated magnetic nanoparticles (core/shell 
system) 
Iron oxides, maghemite or magnetite, are magnetic nanostructures that 
combine their high magnetic susceptibilities with very low toxicity. But, the 
extent of biomedical applicability of these nanoparticles depends strongly 
upon their stability at physiological pH and as well as the degree to which 
their surfaces may be chemically functionalized. The most important limits 
that hinder their biomedical applications are the oxidizable surface of iron 
oxide nanoparticles and the magnetostatic interactions that generally lead to 
aggregation and so precipitation. Both limitations could be resolved through 
an extensive stabilizing coating layer, this strategy comprises grafting or 
coating with organic species such as surfactant or polymer or inorganic layer 
such as silica or gold. This latter, is widely used in biomedical application 
because of its biocompatibility, well defined synthesis routes, resistance to 
oxidation and flexible conjugation possibilities with different molecules. It is 
well established that Au nanoparticles can be functionalized with thiolated 
organic molecules.58,59 Thus, gold coating on the magnetic nanoparticles 
surface could prevent aggregation due to magnetostatic interaction improving 
the colloidal stability and could protect the iron oxide nanoparticle surfaces 
from oxidation. Finally, the Au coating allows a widely versatility of 
functionalization thanks to the thiol-gold chemistry. Mirkin et al have worked 
with success on coordination of thiol-modified DNA molecules to Au 
particles.60 So, it is possible to use the ability to tune chemical functionality 
based on alkanethiolate adsorption onto Au surfaces, when combined with 
magnetically susceptible Fe oxide cores, providing nanocomposite core-shell 
systems Au-Fe oxide that allow to integrate magnetic properties to a 
plasmonic materials, for drug an gene delivery. 
 
In this study we report the synthesis and characterization of hydrophilic and 
hydrophobic magnetic nanoparticles of magnetite Fe3O4, with a gold coating 
layer in order to obtain a core-shell nanosystem. The hydrophilic citrate-
coated Fe3O4 MNPs were prepared according to the Massart protocol.61 
Whereas the hydrophobic oleic acid-coated Fe3O4 MNPs were synthesized by 
employing the protocol introduced by Wang et al,62 modified for the 
preparation of two different gold shell thickness. The gold coating formation 
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on the Fe3O4 surface was obtaining through the Au3+ reduction on the 
surfaces of the nanoparticles by using as oxidant agents citrate and 
oleylamine and 1,2-hexadecanediol, respectively in the two synthetic 
pathways above mentioned (Chapter 2, Section 2.2 and 2.3). 
The first aim of this part of work was to obtain a simple, versatile and 
responsive drug delivery systems so constituted by a magnetic core, 
stabilized with citrate or oleic acid, coated with a different gold shell 
thickness that could be subsequently functionalized with thiolated-DNA 
molecules, with a specific biological function. 
Moreover, the subsequent chemical-physical characterization, performed on 
these magnetic nanoparticles by DLS, Zeta Potential and SAXS, has 
highlighted magnetic nanoparticles with suitable size, charge and 
polydispersity for to embed both hydrophilic and hydrophobic MNPs inside 
the aqueous core of liposomes (called “magnetoliposomes”) and inside the 
lipid bilayer of the cubosomes (obtaining that is “magnetocubosomes”), in 
order to use them like a triggers for spatially and temporally controlled drug 
release upon external magnetic field exposure. 
1.4 Liposomes and Magnetoliposomes 
Liposomes are colloidal systems constituted of lipid vesicles characterized by 
one or more lipid bilayers arranged around an aqueous core. Lipid vesicles 
are classified in function of their size and physical structure in: Multilamellar 
Lipid Vesicles (MLV) that are usually larger than 500 nm and consist of 
several concentric bilayers; Unilamellar Vesicles that are instead formed by a 
single bilayer and can be classified as: Small (SUV) for size range between 
20 and 100 nm, Large (LUV) for ranging from 100 to 1 μm and Giant (GUV) 
for larger than 1 μm vesicles. The presence of an aqueous domain (the 
aqueous pool) and a hydrophobic domain (lipid bilayer) together with a 
chemically tunable surface makes liposomes attractive vectors for the 
delivery of drugs, that can be both hydrophilic and thus encapsulated in the 
aqueous core, and hydrophobic and so interacting with the membrane. 
Alternatively the drug can chemically bound on liposomes’ surface. The 
simultaneous presence of different compartments within liposomes provides 
multifunctional carriers based on liposomes, able to encapsulate different 
species, depending on the affinity of the drug for the different domains of the 
liposome: pool, membrane or surface.68,69 For instance, the drugs can be 
inserted in the lipid chain bilayer region, intercalated in the polar head group 
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region, adsorbed on the membrane surface, anchored by hydrophobic tail or 
easily entrapped in the aqueous pool. Moreover, it is also possible to 
opportunely functionalize liposomes’ surface in order to have a specific 
targeted delivery, allowing the reduction of the drug doses and of side effects 
on the other tissues. Another advantages related to the liposomes are their 
high biocompatibility and biodegradability due to the possibility to prepare 
them with naturally occurring phospholipids, that are the main constituent of 
biological membranes, as well as synthetic lipids characterized by low 
toxicity and high biodegradability. All these properties have make liposomes 
valuable candidates for several applications in biomedical field such as the 
use of them as models for biological membranes and as multifunctional 
nanosized non-toxic vectors for in in vivo administration of drugs, vaccines, 
DNA, antibodies and other therapeutic molecules.70-72 
Relevant requisites in the preparation of liposomes for drug delivery are a 
good control of particle size, stability, encapsulation rates and leakage 
kinetics of the entrapped substances. Liposomes are prepared by 
spontaneously self-assembling of amphiphilic molecules that contain both 
hydrophobic (non-polar tail) and hydrophilic (polar head) moieties. These 
molecules aggregate spontaneously in water, due to the energetically 
unfavorable contact between the non-polar tails and water (hydrophobic 
interactions), giving rise to assemblies of different size and geometries 
depending on both hydrophobic and polar head properties such as tail length, 
multiple chains, charge and size of polar head. Moreover, temperature, pH, 
concentration and solvent can affect the size, geometry and stability of the 
aggregates. The packing parameter (P) contains information about the 
geometrical shape and curvature of the aggregate obtained with a specific 
amphiphilic molecule; it is given by P = ν/la0 where ν is the molecular 
volume, l is the molecular length and a0 is the cross sectional area of the 
polar head of the lipid.73 
Spontaneous reorganization of certain amphiphilic lipids in aqueous 
environment can led to the formation of liquid crystals with different kind of 
three-dimensional structures, such as lamellar (Lα), hexagonal (H) and cubic 
phase.74 By varying water content and temperature, different mesophases 
may form in which the order of the formed structure depends on the lipid 
used.75 A hypothetical sequence is shown in Fig. 1.2. The lamellar phase is 
characterized by a linear arrangement of alternating lipids bilayers and water 
channels, with zero mean curvature (P=1).  
Natural and synthetic phospholipids used for the preparation of liposomes are 
constituted from two acyl chains, usually saturated or unsaturated long fatty 
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acids, linked to a head group, generally choline, serine or ethanolamine. 
Phosphatidylcholines are the most widely used lipids in liposomes works; 
they are zwitterionic at all relevant pH and can therefore form lamellar 
structures independently of the pH of the solution.  
 
Figure 1.2 Hypothetical lipid/water phase diagram in which the phase transition 
depends on the water content. The regions indicated with a, b, c and d represent the 
intermediate phases, many of which are cubic.75 
Lipid vesicles can be prepared by different methods, the most common are: 
hydration for multilamellar vesicles, sonication for small unilamellar 
vesicles, extrusion for large unilamellar vesicles and electroformation for 
giant unilamellar vesicles. In this work the liposomes were prepared through 
hydration followed by sequential extrusion. This method consists on lipid
dissolution in an organic solvent (chloroform or chloroform-methanol 
mixture) that then is removed giving rise to a lipid film. After, the lipid film 
is dried to remove residual organic solvent under vacuum and then hydrated 
with an aqueous solution. The temperature of the hydrating medium should 
be above the gel-liquid crystal transition temperature (Tm) of the lipid and 
should be maintained during the entire hydration period. Swelling of the lipid 
film under vigorous agitation leads to the formation of a milky suspension of 
heterogeneous large MLV (with size around several microns). MLV are 
structures in which each lipid bilayer is separated by water layer and the 
spacing between lipid bilayers is dependent by the composition and charge of 
the lipid. These multilamellar vesicles can be reduced in size by providing 
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energy input via sonicating or by mechanical energy, i.e. extrusion. This 
latter is a technique in which lipid dispersion is forced through a filter with a 
specific pore size in order to obtain particles having a specific diameter that 
will depend from the pore size of the filter chosen. Several freeze-thaw 
cycles and several prefiltering steps through larger pore size filter must be 
done before the extrusion through the final pore size in order to disrupt MLV 
suspension. As with all procedures for downsizing vesicle dispersions, the 
extrusion should be done at a temperature above the Tm of the lipid used. 
Extrusion through filters with 100 nm pore size usually yields large 
unilamellar vesicles with a mean diameter of 120-140 nm. Mean particle size 
also depends on lipid composition and it is quite monodisperse and 
reproducible from batch to batch.  
1.4.1 Magnetoliposomes for drug delivery 
One of the most important features of a drug carrier is the release of the 
encapsulated drug selectively at the target site with an efficient rate.76 The 
diffusion of a drug can occur spontaneously through liposome membrane, but 
the drug release rate could be enhanced by an external stimulus, such as pH,77 
temperature,78 and mechanical ablation, for example, using low frequency 
ultrasounds.79,80 Drug release rate from liposomes could be also increased by 
encapsulating magnetic nanoparticles either in their lipid membrane or in 
their aqueous core, giving rise to the so-called magnetoliposomes (MLs). The 
combination of liposomes with magnetic iron-oxide nanoparticles provides 
valuable hybrid lipid/MNPs drug carriers in which the versatility and the high 
biocompatibility of liposomes as drug delivery vehicles can be combined 
with the possibility to remotely control their accumulation in the body 
through exposure to an external static or alternating magnetic field.81,82 When 
magnetic nanoparticles are embedded in liposomes, the application of an 
alternating magnetic field induces thermally activated processes, that 
typically result in the leakage of the drug contained in the lipid bilayer or in 
the aqueous pool, through enhancement of the bilayer permeability or 
alteration of diffusivity in the bilayer itself. Moreover, the encapsulated 
magnetic nanoparticles can also be used to direct the drug loaded 
magnetoliposome to targeted sites by means of an external magnetic 
stimulus.83,84 Generally, high-frequency alternating magnetic field (HF-AMF, 
50-400 kHz) has been used to promote local heating of magnetic 
nanoparticles (hyperthermia), placed in proximity of cancer cells, causing 
their thermal disruption with a high reduction of the damage to the healthy 
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tissues.78,81,85-87 Recently, it has been shown that a low-frequency alternating 
magnetic field (LF-AMF, 0.01-10 kHz) can also be applied to promote 
triggered release of drugs from magnetic nanosystems.88 In previous works, 
the effect of LF-AMF on magnetoliposome permeability in the presence of 
both hydrophilic and hydrophobic cobalt ferrite (CoFe2O4) NPs embedded in 
the aqueous pool and in the lipid bilayer respectively, was investigated.82,89,90 
Despite the promising results obtained from these multifunctional integrated 
soft matter architectures doped with superparamagnetic nanoparticles, that 
allow spatial and temporal responsivity with remote control, the behavior in 
biologically relevant fluids and the interaction with biological barriers for 
their in vivo application should also be addressed. It is known that in 
biological fluids nanosurfaces are modified by the adsorption of 
biomolecules such as proteins and lipids forming a biomolecular protein 
corona.91 Several factors may affect the formation of this protein corona on 
the surface of NPs such as, surface curvature, size, chemical composition and 
protein concentration.92,93 In general, both hydrophobic and electrostatic 
interactions are the responsible force for the protein adsorption on liposome 
membrane.94 It is thought that the protein corona determines the fate of the 
NPs in vivo, regulating interactions with cells and causing their removal from 
bloodstream. For example, adsorption of opsonins like fibrinogen, IgG, 
complement factor is believed to promote phagocytosis with removal of the 
NPs from the bloodstream,95 while binding of dysopsonins like human serum 
albumin (HSA), apolipoproteins, etc. promotes prolonged circulation time in 
blood.96 Furthermore, corona proteins can physically mask the NP surface, 
potentially affecting the function of molecules, antibodies, DNA oligomers, 
etc. bound to the NP surface and responsible of the therapeutic effect. 
Interestingly, recent studies have shown that in some case the presence of a 
protein corona enhances the ability of the NP to work as a drug delivery 
system, promoting high payloads. In fact, in a work of Cifuentes-Rius at al.97 
was found that it was possible to manipulate DNA release from NPs bearing 
protein coronas by varying the surrounding environment. They showed that 
the payload release profile of pre-formed NP-protein corona complexes 
(nanorods, gold nanobones, and carbon nanotubes) could be tuned placing 
them in different biological environments. In particular, fluids rich of hard 
corona proteins promoted a faster release of the payload than those bearing 
soft corona proteins.  
 
In this work the synthesis and characterization of magnetoliposomes, formed 
by 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), loaded either 
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with hydrophobic magnetic nanoparticles (oleic acid-coated γ-Fe2O3 NPs) 
and hydrophilic magnetic nanoparticles (citrate-coated Fe3O4 NPs) embedded 
in the lipid bilayer and in the aqueous core respectively, were performed 
(Chapter 3). First of all, we studied the different magnetically triggered drug 
release behavior of the two kinds of magnetoliposomes: those with MNPs 
encapsulated in the aqueous core and those with MNPs embedded in the lipid 
bilayer. But, this part of work was especially focused on the study of the drug 
release behavior from magnetoliposomes dispersed in biological fluids upon 
exposure to a LF-AMF, in order to understand how the serum-proteins affect 
the magnetic triggered drug release. In particular, the magnetically-actuated 
drug release from magnetoliposomes dispersed in bovine serum at different 
protein concentrations (10% and 55% v/v related to the in vitro and in vivo 
protein concentrations) was measured as self-quenching decrease of the 
fluorescent molecule Carboxyfluorescein (CF) entrapped in the liposome 
aqueous pool to mimic a hydrophilic drug. The leakage of CF was monitored 
as a function of the exposure time to 5.7 kHz alternating magnetic field. 
Control experiments were also performed for the same magnetoliposomes 
samples in aqueous physiological buffer (PBS, pH 7.4) and for empty 
liposomes as references. A structural characterization of both magnetic 
nanoparticles and magnetoliposomes was performed by Dynamic Light 
Scattering (DLS) and Small Angle X-ray Scattering (SAXS) in physiological 
buffer and in bovine serum, before and after LF-AMF exposure. 
1.5 Cubosomes and Magnetocubosomes 
Liposomes are the most popular and widely employed lipid carriers for 
therapeutics,98 while there are comparatively less studies on dispersions of 
cubic lipid nanoparticles. Cubosomes are dispersed non-lamellar lipid 
nanoparticles characterized by an internal cubic liquid crystalline structure, 
where a lipid bilayer folds in a tridimensional architecture forming a 
bicontinuous phase of lipid bilayered regions and aqueous channels.99-103 
Liquid crystalline phases share features of both a crystal and a melt, showing 
a partial order/disorder of atomic species.104 Because of this intermediate 
state they are also called as “mesophases”.105 Liquid crystalline phases can be 
distinguished into lyotropic, when the mesophase is obtained by adding 
specific solvent in certain concentration range and thermotropic when instead 
the liquid crystal is formed by varying the temperature. Thus, amphiphilic 
molecules, which contain a hydrophilic head-group and a hydrophobic 
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hydrocarbon chain region, self-assemble upon addition to water giving rise to 
different structures with long-range order, called lyotropic liquid crystalline 
phases. The driving force of the self-assembly that lies behind the formation 
of lyotropic liquid crystalline mesophases is the hydrophobic effect, which 
acts in order to minimize interactions between the hydrophobic tails and the 
aqueous environment.106 In the Figure 1.3 some of the possible liquid 
crystalline phases structures, which can be formed by amphiphilic molecules, 
are reported with the corresponding packing parameter (P, see parag. 1.4).73 
 
Figure 1.3 Different liquid crystalline phases with the corresponding packing 
parameters (P = ν/la0). Cryo-TEM images of dispersed reversed hexagonal phase 
(b); dispersed bicontinuous cubic phase (c); vesicles obtained from dispersed 
lamellar phase (liposomes) (d) and micelles (e).73 
Some of these structures, when prepared with very low aqueous soluble 
amphiphilic molecule, can be dispersed by several energy input methods in 
order to obtain dispersed liquid-crystalline nanoparticles which retain the 
internal order of the bulk “parent” material.101 But, unlike the liposomes 
which can form colloidally stable dispersions, for non-lamellar liquid-
crystalline dispersions is needed to use a stabilizing agent to avoid the 
aggregation and flocculation, obtaining in this way nanoparticles of diameter 
ranging from 100 to 400 nm. 
As previously mentioned (section 1.4), the lamellar phase (Lα) is 
characterized by a linear arrangement of alternating lipid bilayers and water 
channels and the liposomes are its corresponding dispersed phase. The 
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reversed hexagonal phase (HII) consists in cylindrical micelles each of which 
surrounded by six cylindrical micelles. The order of the cylindrical micelles 
is two-dimensional and they are separated by lipid bilayers. In the reverse 
hexagonal phase, the polar heads of the amphiphilic lipids point toward the 
inner part of the micelles, whereas in the normal hexagonal phase (HI) the 
polar heads are on the outside. The dispersed nanoparticles of hexagonal 
phase are called hexosomes. Also the reverse discontinuous micellar cubic 
phase (L2) (i.e. cubic phase consisting of ordered packing of micelles) can be 
dispersed giving rise to micellosomes or micellar cubosomes. Finally, the 
bicontinuous cubic phase (V2) characterized by curved three-dimensional 
bicontinuous lipid bilayers separated by two interpenetrating but not-
connected similar networks of water channels, when dispersed forms the so-
called cubosomes.74,75,106,107 In particular, there are three different types of 
cubic phase identified in lipid systems with different structural features and 
they are based on the double-Diamond (D), Primitive (P) and on Gyroid (G) 
minimal surface. Moreover, they are denoted as QIID phase (crystallographic 
space group Pn3m), QIIP phase (crystallographic space group Im3m) and QIIG 
phase (crystallographic space group Ia3d), respectively. The three possible 
networks of water or chain-filled channels generated by the three structures 
are showed in the Fig. 1.4.73,108,109  
 
Figure 1.4 Labyrinth networks in the (a) Primitive, (b) double-Diamond and (c) 
Gyroid phase. These channels are water-filled or chain-filled depending of the 
normal or inverse phase.109 
Lipid-based colloid nanoparticles’ dispersions can be prepared by several 
emulsification methods that generally consist in the application of high-
energy input (such as ultrasonication, microfluidization and homogenization) 
to fragment bulk cubic phase; this is the typical top-down approach. Another 
synthesis process can be the application of mechanical stirring during the 
hydration of a dry lipid/stabilizer film or a dilution process of lipids in the 
presence of ethanol or the application of microfluidization followed by a heat 
treatment at 125 °C that allows the formation of dispersions (of cubosomes or 
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hexosomes) with narrow particle size distributions and a good colloidal 
stability.101 The two most common type of lipids used in the preparation of 
non-lamellar lyotropic liquid-crystalline dispersions are glyceryl monooleate 
(GMO, also called monoolein) and phytantriol. Monoolein has been 
extensively studied since it acts as a model lipid for several trivial or 
challenging studies. It is a non-ionic polar lipid composed of a hydrocarbon 
chain (oleic acid) which is attached to a glycerol backbone by an ester bond. 
The remaining two hydroxyl groups of the glycerol moiety confer polar 
characteristics to this part of the molecule, constituting the polar-head, that is 
responsible for the hydrogen bonds with water in aqueous solution. Instead, 
the C18 hydrocarbon chain (referred as tail) featuring a cis double bond at the 
9,10 position is the hydrophobic part, rendering monoolein an amphiphilic 
molecule, with an overall hydrophilic lipophilic balance value (HLB) of 3.8. 
It is non-toxic, biodegradable and biocompatible material classified as GRAS 
(generally recognized as safe), and is included in the FDA Inactive 
Ingredients Guide and in non-parental medicines licensed in the UK. Its 
biodegradability is due to the fact that monoolein is the substrate of the 
lipase.110,111 
 
Figure 1.5 Chemical structure of monoolein. 
Figure 1.6 Glyceryl monooleate phase diagram adapted from Qiu and Caffrey.112 
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Monoolein-water is one of the most well characterized lipid-water systems, 
GMO is able to self-assemble into different liquid-crystalline structures 
depending on the water content and temperature. A transition from the 
lamellar phase to the gyroid cubic phase then to the double-diamond cubic 
phase results by increasing the water content. All these cubic phases can 
coexist in equilibrium with excess water. A very detailed phase diagram of 
the GMO-water system (Fig. 1.6) was reported in a work of Qiu and 
Caffrey.112 Other lipids that have been shown cubic phase structure are 
phosphatidylcholines, phosphatidylethanolamines, PEG-ylated phospholipids 
and various monoglycerides. 
In order to gain a stable aqueous dispersion of nanoparticles with a cubic 
liquid-crystalline inner structure, it is need to employ a dispersing/stabilizing 
agent will participate in the lipid-water assembly without disrupting the cubic 
inner structure. Aqueous dispersions of cubosomes have been prepared by 
using bile salts,113 amphiphilic proteins114 or amphiphilic block copolymers115 
as stabilizing agents. The stabilizer most used for the preparation of lyotropic 
cubic liquid-crystalline particles is the Pluronic® F-127 (Polaxamer 407) that 
is a non-ionic tri-block copolymer composed of polyethylene oxide (PEO) - 
polypropylene oxide (PPO) – polyethylene oxide (PEO) with PEO chains of 
100 units and 65 units of PPO (Fig. 1.7). The hydrophobic PPO domain is 
thought to anchor to the cubosomes’ surface imparting long-term stability
whilst the hydrophilic PEO blocks extend to cover the surface providing 
steric stabilization.116 
 
Figure 1.7 Chemical structure of Pluronic® F-127. 
The cubosomes due to their three-dimensional inner cubic structure exhibit 
several advantages over liposomes as DDS such as a high internal interfacial 
surface that allows to encapsulate and protect a higher amount of both 
hydrophilic and hydrophobic drugs, with respect to liposomes. They are also 
characterized by high heat stability, relatively high mechanical rigidity and 
structural stability, capability to affect compound release rate and 
thermodynamic stability in excess of water.106,117 Moreover, the structure of 
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the assemblies improves the ability of the DDS to interact with the lipid 
bilayer of the cell membrane, and therefore reach the designed biological 
targets inside the cells.118 
Several applications in these last years have been demonstrated that GMO 
bulk cubic phase is able to form sustained-release drug carriers for the 
delivery of small and protein drugs via different routes and it was found that 
the proteins encapsulated in the cubic phase appear to retain their native 
conformation and biological activity.74 Cubic phase with protein encapsulated 
have been used in different applications such as, tissue engineering, 
biosensors, medical diagnostic: as carriers for imaging agents and as filtering 
membranes by channel size control.108,119 Thus, bulk cubic phase offers many 
advantages as potential drug delivery systems but its high viscosity 
complicate the direct application for the pharmaceutical purposes. For this 
reason, cubosomes have attracted great interest for new potential applications 
as DDS. The production and use of cubosomes were first proposed by 
Larsson and co-workers.105,120,121 In contrast to the success of liposomes as 
DDS, relatively limited progresses have been made on developing of 
nanodispersed cubic liquid-crystalline based drug delivery vehicles; for 
instance, the loading of rifampicin,122 the encapsulation and release of 
somatostatin123 and the efficiency of oral administration of loaded insulin124 
have been studied. In this regard, it should be done further advances on the 
effective loading and the controlled delivery of bioactive materials such as 
proteins, poorly water-soluble drugs and foods. But, whilst there is an 
increasing volume of research on loading of compounds into dispersed 
lyotropic liquid-crystalline phases, few data exist about the release of drugs 
from dispersed phases. 
1.5.1 Magnetocubosomes for drug delivery 
As already mentioned, one of the main goals in the development of DDS is to 
control the temporal (i.e., at a given time after administration) and spatial 
(i.e., in proximity of a selected tissue or cell) drug release profile from the 
vector, with the aim to improve the efficacy and the selectivity of the drug, 
and to limit its side effects on healthy tissues. To this purpose, many 
examples of responsive systems have been proposed, employing specific 
responsive features of the lipids with respect to the environment of the 
biological target, i.e. variations in temperature,125 pH126 or molecular 
composition of the media,127 as triggers for drug release. 
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As already seen in the previous section (1.4.1) a different approach to address 
this point is also to make use of an external trigger, such as an alternating 
magnetic field, by exploiting the magnetic properties of super-paramagnetic 
iron oxide nanoparticles (SPIONs) embedded in the delivery device. Aqueous 
ferrofluids composed of iron oxide nanoparticles have obtained clinical 
approval as contrast agents for magnetic resonance imaging (MRI), as iron 
substitute products for intravenous therapy.128,129  Like in the previous section 
we have viewed examples concerning magnetoliposomes, i.e. lipid vesicles 
containing SPIONs in their aqueous pool or in the bilayer, as responsive DDS 
which have been proposed and widely study.130 
 
In this work the potential of hybrid SPION/lipid systems is extended to 
cubosomes by incorporating magnetic nanoparticles in the lipid bilayer of the 
inner cubic structure of the cubosomes. In particular, this last part of research 
work was focused on the design, preparation and characterization of 
magnetocubosomes as lipid DDS endowed with magnetic responsiveness. 
This study highlights that magnetocubosomes are able to release a model 
hydrophilic drug upon application of a low frequency alternating magnetic 
field (LF-AMF). To the best of our knowledge, only one recent study reports 
on the preparation of hybrid cubosomes/SPION from iron oxide NPs,131 
which where designed for MRI purposes. 
 
 
 
(a) (b) 
Figure 1.8 Chemical structure of Rhodamine 110 (a) and Octadecyl Rhodamine B 
(b). 
The goals of this part of work are to include hydrophobic MNPs within the 
bilayer and to use them as an internal trigger to actuate the release of both 
hydrophobic and hydrophilic active principles. So, a bulk cubic phase of fully 
hydrated GMO was prepared and characterized in the absence and in the 
presence of hydrophobic magnetite nanoparticles (oleic acid-coated Fe3O4 
NPs) through Small Angle X-ray Scattering (SAXS). With Fluorescence 
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Correlation Spectroscopy (FCS) we investigated the encapsulation both of 
model hydrophilic and hydrophobic molecules within the cubic phase, and 
their diffusion behavior was monitored within the liquid crystalline structure, 
respectively inside the aqueous channels and in the lipid bilayer. As 
hydrophilic model drug was used Rhodamine 110 (λex=488 nm and λem=500-
530 nm) while as hydrophobic model drug was employed the Octadecyl 
Rhodamine B (λex=561 nm and λem=607-683 nm), shown in the Fig. 1.8. 
Then, cubosomes and magnetocubosomes by dispersing the bulk cubic phase 
with Pluronic F-127, in the presence and in the absence of MNPs were 
prepared. Cubosomes and magnetocubosomes were fully characterized 
through SAXS, Dynamic Light Scattering (DLS) and Zeta Potential to assess 
the physicochemical features of the designed DDS and their stability in time. 
Finally, FCS was employed to monitor the ability of both the bulk cubic 
phase and of cubosomes loaded with MNPs, to release a model drug in 
aqueous environment upon application of a LF-AMF (Chapter 4). 
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2 Inorganic Nanoparticles 
The first part of this research work has been focused on the synthesis and 
characterization of two different inorganic nanosystems: Calcium Posphate 
nanoparticles (CaP NPs) decorate with single and double strand 
oligonucleotide and magnetic nanoparticles of Magnetite (FeO?Fe2O3 ? 
Fe3O4 NPs). Fe3O4 nanoparticles with a gold shell were also synthesized in 
order to obtain a composite core-shell system, more biocompatible and more 
suitable for the subsequent relative ease of biofunctionalization.   
2.1 Synthesis and Characterization of CaP NPs 
Chemicals: Calcium nitrate tetrahydrate Ca(NO3)2?4H2O ≥99% and NaOH 
≥97% in pellets were purchased from Sigma Aldrich (St Louis MO) and di-
ammonium  hydrogen phosphate (NH4)2HPO4 ≥99% from Fluka. The DNA 
d(AT)-50 mers purified by HPLC was purchased from ATDbio- University 
of Southampton. Ultrapure Milli-Q (from Milli-Q Merk-Millipore system) 
water was employed for the synthesis of the nanoparticles. 
 
A simple, flexible and reproducible synthetic method has been developed to 
prepare aqueous dispersions of CaP nanoparticles by using the nucleation 
from homogeneous phase method.1 This method consists in a rapid and 
controlled mixing, in aqueous phase, of the Ca(NO3)2 and (NH4)2HPO4 
aqueous salts. Subsequently, the dispersion obtained is added to the 
oligonucleotide aqueous solution, both single and double strand. The 
electrostatic interaction, between the oligonucleotidic chains negatively 
charged and the surface partially positively charged, was employed to 
functionalize the CaP nanoparticles with DNA. This is the stabilizing agent 
that is very useful during the synthetic phase because it limits the growth and 
the following aggregation of the nanoparticles. But, at the same time it is 
itself the therapeutic agent that it must been carried.2 Therefore, its selection 
is crucial and especially it is determinated univocally by the particular 
therapeutic purpose. Like therapeutic agent a model oligonucleotide 
constituted by an alternated and palindromic sequence of 50 bases, of adenine 
and thymine, has been chosen, called d(AT)50-mers, single and double 
strand.
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d(AT)-functionalized calcium phosphate nanoparticles (d(AT)-CaP NPs) 
were prepared by using an apparatus as that shown in Fig. 2.1. In order to 
have a high rate control of the mixing of the reagents a peristaltic pump has 
been used and the additional rate was 5 μl/sec. An aqueous solution (0.75 ml) 
of Ca(NO3)2 (12.5 mM and pH 9) and 0.75 ml of (NH4)2HPO4 (7.48 mM and 
pH 9) were pumped at rate seen above into a glass vial at room temperature. 
The pH of both solutions was adjusted beforehand to 9 with NaOH (0.1 M). 
After 30 seconds, whole the nanoparticles dispersion was rapidly pumped at 
the same rate of 5 μl/sec into a glass vial containing 0.250 ml of a aqueous 
solution of d(AT) 63 μM at room temperature. The resulting dispersion of 
d(AT)-CaP NPs was colourless and slightly cloudy and it can be stored in 
fridge at 6°C. 
 
Figure 2.1 Schematic setup of the apparatus used to prepare d(AT)-CaP NPs. Two 
solutions containing calcium nitrate and ammonium hydrogen phosphate, 
respectively, are mixed in a glass vessel to form CaP NPs dispersion. This 
dispersion, after 30 sec, is pumped into a d(AT) solution. 
The same process was repeated both for the d(AT)-single strand-CaP NPs
(d(AT)ss-CaP NPs) and for d(AT)-double strand-CaP NPs (d(AT)ds-CaP 
NPs). The d(AT) double strand has been prepared by thermal annealing of 
the d(AT) single strand aqueous solution. This process consists in to warm up 
the d(AT) single strand aqueous solution at 65°C (melting temperature) for 
15 minutes into a thermal block. In this step, the DNA sequence single strand 
from its random configuration with hydrogen bonds between nucleotidic 
bases in the same filament gets on to a completely freedom configuration 
without hydrogen bonds and so it became ready to anneal to another 
complementary filament.  Therefore, after the heating it was cooled very 
slowly at room temperature in order to allow the pairing of the 
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complementary sequence. The concentration of the two oligonucleotidic 
solutions (single and double strand), in terms of monomeric concentration, 
was the same. 
 
DLS Measurements 
DLS measurements were carried out on a Brookhaven Instrument 200 SM 
goniometer. The light source was the second harmonic of a diode Nd:YAG 
laser, λ= 532 nm Coherent DPY315M-100. The d(AT)-single/double-strand-
CaP NPs dispersed in water were characterized by DLS to obtain size and 
polydispersity degree of the system. To avoid multiple scattering, the samples 
were diluted 10 times with water milli-Q. Moreover, the samples were 
filtered through a sterile syringe filter with a 0.200 μm cellulose acetate 
membrane (single use syringe filter, Sartorius) to remove larger aggregates. 
Measurements were performed at 25 °C on 1 ml of sample. Each single 
measurement was repeated 3 times and standard deviation was calculated. 
The autocorrelation function obtained soon after the synthesis (t0) of the 
d(AT)-single and double strand  is showed in the Fig.2.2 below.  
 
 
Figure 2.2 Autocorrelation functions of the scattering intensity obtained from the 
samples d(AT)ss-CaP NPs t0 and d(AT)ds-CaP NPs t0 diluted 1:10. 
As it possible to see from the autocorrelation functions of the two samples in 
Fig. 2.2 there are no very pronounced differences of the decay time between 
the samples functionalized with single or double strand. The Fig. 2.3 shows 
the autocorrelation functions of the same samples but at different times, after 
24h, 48h, 72h and 144h from the synthesis. In the Fig. 2.3 (c) the differences 
between the single and double strand functionalized samples are more 
marked because the d(AT)ds-CaP NPs samples start to aggregate before than 
the d(AT)ss-CaP NPs samples. Instead, the ACFs showed in the Fig. 2.3 (d) 
2 – Inorganic Nanoparticle 
 42 
highlight the lost of the colloidal stabilization of the system due to 
aggregation of the nanoparticles. 
 
  
(a) (b) 
  
(c) (d) 
Figure 2.3 Autocorrelation functions of the scattering intensity obtained from the 
samples d(AT)ss-CaP NPs and d(AT)ds-CaP NPs diluted 1:10 at different times; 
after 24h (a); after 48h (b); after 72h (c) and after 144h (d). 
 
  
(a) (b) 
Figure 2.4 Autocorrelation functions of the scattering intensity obtained from the 
samples d(AT)ss-CaP NPs and d(AT)ds-CaP NPs diluted 1:10 in the time; (a) for 
the d(AT)ss-CaP NPs from 0 to 144h; (b) for the d(AT)ds-CaP NPs from 0 to 144h. 
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From the comparison between all ACFs in the time (Fig. 2.4) for the 
functionalized d(AT)ss and d(AT)ds nanoparticles it is possible to state that 
the d(AT)ss-CaP NPs samples are more stable than the CaP nanoparticles 
decorated with double strand d(AT) during the 144h. 
The hydrodynamic diameter values (Dh) and the polydispersity were obtained 
by analyzing the autocorrelation functions through a cumulant analysis 
stopped to the second order. For the samples with more polydispersity (> 0.2) 
the algorithm CONTIN was used for the interpretation of the autocorrelation 
functions. In the Table 2.1 the average of Dh values are showed.  
Table 2.1 Average hydrodynamic diameter and polydispersity indexes of the d(AT)ss-CaP NPs 
and d(AT)ds-CaP NPs samples.  
 d(AT)ss-CaP NPs d(AT)ds-CaP NPs 
 <Dh> 
(nm) 
polydispersity <Dh> 
(nm) 
polydispersity 
t0 162 ± 18  0.21 178 ± 10 0.28 
24 h 162 ± 20  0.26 180 ± 20 0.29 
48 h 176 ± 18  0.27 190 ± 18 0.28 
72 h 178 ± 16  0.26 315 ± 16 0.25 
144 h 640 ± 80 0.5 570 ± 80 0.4 
 
In the Fig. 2.5 are reported the Dh values showed in Table 2.1. From this 
graph is possible to observe the trend of the hydrodynamic values for the two 
samples in the time. 
 
 
Figure 2.5 Schematic representation of Dh trend of the d(AT)ss-CaP NPs and 
d(AT)ds-CaP NPs samples in the time. 
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Zeta-Potential 
Zeta potential determinations were performed with a Zeta Plus-system by 
Brookhaven Instruments. Measurements were carried out at 25 °C on 1.6 ml 
of sample and analyzed by the Smoluchowki approximation (see 5.2 section) 
The samples were dialyzed before the measurements in order to remove the 
salt’s excess that could compromise the measure of the zeta potential. The 
dialysis was carried out against milli-Q water for 8 h through a cellulose 
dialysis bag (avg. flat width 23 mm, MCWO 12400, 99.99% retention). The 
samples inside the membrane were analyzed by DLS before and after dialysis 
in order to control the particle size variation due to the dialysis process. The 
Fig. 2.6 illustrates the autocorrelation functions obtained from this 
experiments on the d(AT)ss-CaP NPs and d(AT)ds-CaP NPs samples before 
and after dialysis. 
 
  
(a) (b) 
Figure 2.6 Autocorrelation functions of the scattering intensity obtained from the 
samples d(AT)ss-CaP NPs (a) and d(AT)ds-CaP NPs (b), diluted 1:10 before and 
after 2h, 4h, 6h and 22h of dialysis. 
It can be seen that after only two hours of dialysis the autocorrelation 
functions of the nanoparticles change, that is the size and distribution size are 
modified showing aggregation of the nanosystems. This behavior is probably 
due to fact that with the dialysis ionic species, that could have a stabilizing 
effect on the colloidal system, are removed, leading to aggregation. The zeta 
potential values before and after dialysis that are reported as average from 5 
measurements on each sample are reported in the Table 2.2. The standard 
deviations of each measurement are also showed. 
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Table 2.2 Zeta potential data of the d(AT)ss-CaP NPs and d(AT)ds-CaP NPs before and after 
dialysis at room temperature. 
 d(AT)ss-CaP NPs d(AT)ds-CaP NPs 
 Zeta Potential (mV) 
Conductance 
(μS) 
Zeta Potential 
(mV) 
Conductance 
(μS) 
Before 
dialysis -30 ± 2 419    -28 ± 3 419  
2h -37 ± 1 210  -33 ± 2 229  
4h -32 ± 2 102  -34 ± 2 179  
6h -30 ± 2 112  -31 ± 3 140  
22h -37 ± 2 103  -31 ± 3 76  
 
 
Atomic Force Microscopy 
The calcium phosphate nanoparticles functionalized with single and double 
strand oligonucleotide, d(AT)ss-CaP NPs and d(AT)ds-Ca NPs diluted 1:10, 
were investigated by atomic force microscopy in order to study their 
morphologic features. 20 μl of the each dispersion were deposited on a 
substrate of mica through spin coating that is a procedure generally used to 
deposit uniform thin films to flat substrates. Atomic force microscopic 
images were taken in air under non-contact mode. The AFM images of the 
CaP nanoparticles with single and double strand d(AT) diluted 1:10 are 
reported respectively in Fig. 2.7 and 2.9. 
The dimensional analysis of the images obtained through AFM for the CaP 
nanoparticles with single strand d(AT) shows nanoparticles having a height 
about 3-5 nm and a diameter, measured as width at half height, between 40 
and 50 nm. In the following picture (Fig. 2.8) are reported AFM images and 
dimensional analysis of the same samples but with a lower scan size of 0.5 
μm. 
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(a) (b) 
 
(c) 
Figure 2.7 Representative atomic force microscopic images (obtained with a 1μm 
of scan size x-y) of the d(AT)ss-CaP NPs samples diluted 1:10 few hours after the 
synthesis; (a) 3D image; (b) image in grey gradation; (c) dimensional analysis of 
the nanoparticles. 
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(a) (b) 
 
(c) 
Figure 2.8 Representative atomic force microscopic images (obtained with a 0.5 
μm of scan size x-y) of the d(AT)ss-CaP NPs samples diluted 1:10 few hours after 
the synthesis; (a) 3D image; (b) image in grey gradation; (c) dimensional analysis 
of the nanoparticles. 
 
The AFM images of the d(AT)ss-CaP nanoparticles at 0.5 μm of scan size 
confirm the previous dimensional analysis, i.e. on the surface there were 
nanoparticles with a height about 4 nm and a diameter of 40-50 nm. The 
same dimensions are evident in the AFM images of the CaP nanoparticles 
samples functionalized with double strand d(AT) represented in the Fig. 2.9 
and 2.10 below. 
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(a) (b) 
  
(c) (d) 
 
(e) 
Figure 2.9 Representative atomic force microscopic images of the d(AT)ds-CaP 
NPs samples diluted 1:10 few hours after the synthesis; (a) AFM image and (b) 
image in grey gradation at 2 μm scan size; (c) 3D image, (d) image in grey 
gradation and (e) dimensional analysis at 1 μm scan size. 
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(a) (b) 
 
(c) 
Figure 2.10 Representative atomic force microscopic images (obtained with a 0.5 
μm of scan size x-y) of the d(AT)ds-CaP NPs samples diluted 1:10 few hours after 
the synthesis; (a) 3D image; (b) image in grey gradation; (c) dimensional analysis 
of the nanoparticles. 
 
The system d(AT)ss-CaP NPs was investigated also 10 days after the 
synthesis and similar dimensional features of the nanoparticles were observed 
(Fig. 2.11). Finally, the sample CaP NPs with d(AT) single strand after 4 
hours of dialysis was studied (Fig. 2.12) through AFM. In this case, the 
surface appears uniformly covered by nanoparticles with a height about 4 nm, 
as those revealed in the previous analysis, but the diameter was slightly larger 
than the nanoparticles before dialysis. This result confirms the aggregation 
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noted in DLS investigation, where an increment of dimensions was observed, 
see Fig. 2.6 (a).  
 
 
 
 
(a) (b) 
Figure 2.11 Representative atomic force microscopic images (obtained with a 1 μm 
of scan size x-y) of the d(AT)ss-CaP NPs samples diluted 1:10, 10 days after the 
synthesis; (a) 3D image and (b) dimensional analysis of the nanoparticles. 
 
 
 
(a) (b) 
Figure 2.12 Representative atomic force microscopic images (obtained with a 1 μm 
of scan size x-y) of the d(AT)ss-CaP NPs samples diluted 1:10 after 4h of dialysis. 
(a) 3D image and (b) dimensional analysis of the nanoparticles. 
2.1.1 Discussions 
Calcium phosphates are very attractive for many biomedical applications due 
to their good biocompatibility, biodegradability and bioactivity. Calcium 
phosphate nanoparticles, for this reason, are good candidates as efficient and 
safe carriers to deliver nucleic acid or another therapeutic macromolecule in 
to living systems. In fact, they can be surface-functionalized in many 
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different ways and they are able to penetrate the cell wall via endocytosis, 
thus CaP NPs can be used like a DNA-nanovectors. For all these reasons, the 
aim of this part of work was to develop a rapid, easy, reproducible, low-cost 
synthetic method and to study the chemical-physics characteristics of the 
nanosystems obtained. An easy method highly controlled, in terms of rate of 
addition of the reagents, that consists in the rapid mixing of aqueous 
solutions followed by addition of dispersion to the oligonucleotidic solution 
was carried out. We expect that, like DNA, negatively charged 
oligonucleotide interacts with the positively charged calcium phosphate 
surface.3,4 Another possible reason for the good absorption is the chemical 
similarity between the phosphate backbone of the oligonucleotide and the 
phosphate of the nanoparticles surface. The relatively high negative zeta 
potential values of the nanoparticles (Table 2.2) recorded demonstrate a high 
degree of absorption. From a previous work, a positive zeta potential of CaP 
nanoparticles of about +7 mV has been achieved.5 Therefore, it is possible 
state that the oligonucleotide probably stabilize the dispersions both by 
electrostatic repulsion and by steric stabilization. Similar results were 
obtained both the single strand and double strand functionalized 
nanoparticles. 
An aggregation of the nanosystems begins after the first hours of the dialysis 
process (Fig.2.6 a and b) probably due to the decrease of the ionic species in 
solution, evidenced by the lower conductance values (Table 2.2). This could 
affect the interaction forces between oligonucleotide and nanoparticles, 
resulting in a solubilization of some oligonucleotide molecules and 
consequently in a destabilization of the system. In fact, the characteristic 
peak of an oligonucleotide in aqueous solution was revealed in the UV-Vis 
spectra of the external water during the dialysis process (Fig. 2.13). 
 
 
Figure 2.13 UV-VIS spectrum of the external water after 22h of dialysis of the 
sample d(AT)ss-CaP NPs. 
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Nevertheless, the zeta potential values after the dialysis were still negative 
and about -30 mV more or less like the zeta potential before the dialysis. This 
could mean that despite alteration of the forces of interaction between DNA 
and CaP nanoparticles, the surface charge negative density of the 
nanoparticles does not undergo a significant change. So, maybe the 
contribution to the stabilization due to steric hindrance lower because some 
molecules of oligonucleotide solubilize, but a part of stabilizing effect related 
to the electrostatic repulsion persists, in fact precipitation of the colloids was 
not identified.  
The DLS investigation performed have revealed a hydrodynamic diameter 
about 170-180 nm for the single strand and double strand functionalized 
calcium phosphate nanoparticles until about 72 hours. In particular, the 
double strand decorated nanoparticles showed an increment in the diameter 
already at 72h; so the d(AT)ds-CaP NPs are less stable than the d(AT)ss-CaP
NPs that exhibit loss of stability after 72h (Fig. 2.5).  But on the other hand, 
the AFM study has shown that the nanosystems, both single and double 
strand functionalized, have two dimensions (see Fig. 2.7 and Fig. 2.9): an 
height about 4-7 nm and a diameter between 40-50 nm. Therefore, this result 
suggests that the nanosystems prepared are not real sphere-particles but rather 
the calcium phosphate nanoparticles studied have a disk-like shape.  
?? ?
??????
? ? ? ?
? ? ? ? ?? ?? ? ? ? ? ?
? ? ? ? ?
??
(2.1) 
  
where, if we consider a schematic disk-like shape: 
 
 
 Figure 2.14 Schematic representation of a disk-like shape. 
? ? ? ??????????? (2.2) 
 
The relation 2.1 allows to determine a hypothetic hydrodynamic radius by the 
two dimensions observed through dimensional analysis of the images 
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performed by AFM.6 This ?? value can be compared to the hydrodynamic 
diameter found by DLS study. 
It is possible to state that in our system ?????, that is the thickness or the 
height of the disk, is 4 nm and ????? that is the radius of the disk is 25 nm, 
see Fig. 2.14. Thus, replacing the value of ? in the equation (2.1) we can 
achieve ?? ?19.5 nm that corresponds to a diameter of 39 nm. From the 
comparison between this diameter value and that obtained by DLS 
measurement (about 170 nm) it is possible to conclude by stating that clusters 
of 3 or 4 primary nanoparticles are formed and these clusters with a hydration 
layer have been revealed through DLS investigation. 
2.2 Synthesis and Characterization of bimetallic core-
shell hydrophilic Au@Fe3O4NPs  
Chemicals: Ferric (III) Chloride FeCl3 ? 6H2O, Ferrous Chloride (II) 
FeCl2?4H2O and NH3 were purchased from Sigma-Aldrich. Sodium Citrate 
and Hydrogen tetrachloroaurate(III) were purchased from Fluka. Ultrapure 
Milli-Q water (18.2mΩ/cm) was used in all experiments (Milli-Q Merk-
Millipore system).  
 
Iron oxide nanoparticles were synthesized according to the Massart 
protocol.7 It consists in a co-precipitation method in alkaline medium that is 
probably the simplest and most efficient chemical pathway to obtain 
magnetic nanoparticles. Usually, metal oxides are prepared by a 
stoichiometric mixing of metal salts in aqueous medium. In the case of Fe3O4 
nanoparticles, they have been prepared by mixing ferrous and ferric salt 
solutions. 1.622 g of FeCl3?6H2O and 0.994 g of FeCl2?4H2O were dissolved 
in 40 mL of water milli-Q under constant mechanical stirring. When the 
reagents were completely dissolved, 5 ml of NH3 solution (28% w/v) were 
added to the reaction mixture. A color change of the mixture from yellowish 
to black was observed (see Fig. 2.13 a and b). After 10 minutes, 4.4 g of 
sodium citrate were added and the temperature of the system was brought to 
90°C. The mechanical stirring was maintained for 30 minutes at this 
temperature, obtaining sharp color black dispersion. Later, the reaction 
mixture was cooling to room temperature (25°C) and a black precipitate was 
achieved. In order to separate the precipitate (i.e. the nanoparticles) from 
supernatant the sample was left on a permanent magnet over night. The next 
day, the precipitate was separated from the supernatant and thoroughly rinsed 
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with water; during rinsing it was always separated from the rest by using the 
same permanent magnet. Finally, dialysis was performed employing a 
cellulose dialysis bag (avg. flat width 23 mm, MWCO 12400, 99.99% 
retention) to remove the excess of non-absorbed citrate. In the Fig. 2.15 
several steps of the synthetic process are represented. 
 
   
(a) (b) (c) 
Figure 2.15 Reaction mixture before the addition of NH3 28% (a), after the 
addition (b) and the mixture inside the membrane for dialysis (c). 
The concentration of the Fe3O4/citrate dispersion was demonstrated to be 
0.972 μM. We have done different tests to found a satisfying protocol to 
covering the Fe3O4 nanoparticles with a gold shell (covered nanoparticles that 
we’ll indicate from now like Au@Fe3O4) following the Grabar’s method.8 
Thus, 1 mL of the Fe3O4 suspension (0.972 μM) was transferred into 100 mL
of 1 mM sodium citrate aqueous solution and it was heated until boiling 
under continuous stirring. 10 mL of 10 mM HAuCl4 were heated until boiling 
and were rapidly added to the hot dispersion under stirring that was 
maintained for 30 minutes. A continuous color change from brown to 
burgundy was denoted. Stirring was maintained for another 10 minutes. The 
mixture turned deep red indicating the presence of metallic gold. The 
colloidal suspension was cooled to room temperature leaving it continually 
under magnetic stirring. The Au@Fe3O4 nanoparticles were precipitated 
using the permanent magnet over night (see Fig. 2.16). The day after, the 
nanoparticles (red-Au@Fe3O4) were separated from the supernatant and 
washed with ultrapure water by centrifugation and re-suspended. The 
suspension was centrifuged at 10.000 rpm for 10 minutes and supernatant 
containing very small particles, excess surfactant and reaction by-products 
such as salts were decanted away. The process was repeated until that the 
supernatant, after the application of permanent magnet, appeared colorless. In 
order to obtain a different gold shell thickness a slight variation of the 
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concentration of the reagents was employed. In particular, 10 mL of the 
Fe3O4 suspension were added to 100 mL of 1 mM sodium citrate aqueous 
solution, like before. It was heated until boiling under continuously stirring. 
After that, 5 mL of 5 mM HAuCl4 boiling were added to the dispersion. The 
stirring was maintained for several minutes and then the dispersion was left 
cool at room temperature still under stirring. The purple precipitate (purple-
Au@Fe3O4 NPs) was separated from the supernatant as previously described.   
 
Figure 2.16 Au@Fe3O4 dispersion with the permanent magnet. 
The stability of the Fe3O4 citrate dispersion is due to the presence of citrate on 
the particles’ surface. It interacts with them through the coordination of the 
carboxylate functionalities. That way it hinders the aggregation of 
nanoparticles through steric and electrostatic repulsion allowing colloidal 
stability to the system (see Fig. 2.17). 
 
Figure 2.17 Schematic representation of Fe3O4 nanoparticle with citrate ion on its 
surface. 
But at the same time, the citrate of Fe3O4 NPs surfaces is the reducing agent 
that reduces the gold salt (Au3+) in solution to metallic Au and therefore a 
homogeneous gold covering of the nanoparticle’s surface should be formed. 
In the Fig. 2.18 the schematic representation of the covering process is 
showed.  
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Figure 2.18 Schematic representations of reaction steps and images of the 
nanoparticle dispersions of Fe3O4 (Fe3O4 NPs), red-Au@Fe3O4 NPs and purple-
Au@Fe3O4. 
A possible reaction mechanism has already been postulated in order to 
explain the gold layer formation on the Fe3O4 NPs surfaces through reduction 
of Au3+ by sodium citrate, which was based on the experimental evidence and 
the existing literature.9-11 
 
DLS Measurements 
The Fe3O4-citrate and Au@Fe3O4 nanoparticles were characterized in terms 
of dimensions and size distribution through DLS investigation, by using the 
90Plus/BI-MAS system by Brookhaven Instruments apparatus, with a 15 mW 
solid state laser λ= 635 nm as light source.  
 
Figure 2.19 Autocorrelation functions of the scattering intensity obtained from the 
samples Fe3O4 NPs (black), Red-Au@Fe3O4 NPs (red) and Purple-Au@Fe3O4 NPs 
(green) diluted 100 times.  
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The measurements were carried out at 25 °C on 1.5 ml of sample previously 
transferred into cells. The autocorrelation functions achieved for the 
dispersions were analyzed with Cumulant analysis stopped to the second 
order.  
To avoid multiple scattering, the samples were diluted 100 times with 
ultrapure water. Each measurement was repeated 5 times and the standard 
deviation was calculated. In the Fig. 2.19 the autocorrelation functions of the 
Fe3O4 and Fe3O4 Au coated nanoparticles are reported. The hydrodynamic 
diameters and polydispersity indexes are showed in Table 2.3. 
Table. 2.3 Average hydrodynamic diameters (<Dh>) and polydispersity indexes of the Fe3O4 NPs, 
Red-Au@Fe3O4 NPs and Purple-Au@Fe3O4 NPs. 
 Fe3O4 Red-Au@Fe3O4 Purple-Au@Fe3O4 
<Dh> (nm) 395 ± 6 258 ± 8 213 ± 3 
Polydispersity  0.24 ± 0.08 0.15 ± 0.05 0.21 ± 0.10 
 
The results of DLS investigation evidence that the dimension of the Fe3O4-
citrate nanoparticles are larger than red and purple Au@Fe3O4 NPs.  In the 
DLS technique, the mean Dh value is given by the core together with 
hydration layer and if there is by stabilizing agent too. Whereas, the Fe3O4 
NPs are stabilized with citrate, no stabilizing agent on the surface of 
Au@Fe3O4 is present. Thus, the Dh of the latter is smaller than the Dh of the 
Fe3O4 nanoparticles. Moreover, due to the magnetic features of the 
nanoparticles, when they interact with the magnetic component of the 
incident radiation they tend to align themselves, resulting in a bigger value of 
the Dh obtained from the analysis of the autocorrelation function.  
 
Furthermore, like reported in a previous work of Wang et al.12 the magnitude 
of the magnetization for Au coated Fe3O4 NPs is much smaller than that of 
Fe3O4 nanoparticles. The coercivity showed a clear increase for Au@Fe3O4 
reflecting the fact that coercivity in a superparamagnetic nanoparticles is 
related to a change in dipolar coupling or a change in the magnetic core 
size.13 The decrease coupling of the magnetic moments is a result of the 
increased interparticle spacing of the magnetic cores by gold shell.14 In 
addition, the larger size of Au@Fe3O4 causes a less-effective coupling of the 
magnetic dipole moments, increasing coercivity. According to this, the 
interpretation of the ACFs of the gold coated nanoparticles leads to diameters 
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smaller than those uncoated. Finally, it is well known that the magnetic 
susceptibility provides a further contribution to the attractive component of 
the DLVO interaction.  
 
Zeta Potential  
The zeta potential of the superparamagnetic Fe3O4 and Au@Fe3O4 red and 
purple was determinated by using the zeta potential analyzer Zeta-Plus 
Brookhaven Instrument. The values of zeta potential have been acquired 
according to Smoluchowski method15 and are reported in Table 2.4. Each 
measurement was repeated 5 times and the standard deviation on these results 
was calculated. 
Table 2.4 Average Zeta Potential values of the Fe3O4 NPs and Au@Fe3O4 red and purple 
nanoparticles. 
 Fe3O4 Red-Au@Fe3O4 Purple-Au@Fe3O4 
<ζ- Pot> 
(mV) 
-45.9 ± 0.6 -28.1 ± 1.7 -17.2 ± 0.6 
 
The results obtained suggest that the magnetic nanoparticles Fe3O4 are rather 
stable also for electrostatic repulsion. The decrease of the zeta potential value 
of the coated nanoparticles respect those uncoated is due to loss of the 
citrate’s stabilizing effect leading to smaller surface charge density of the 
core/shell nanoparticles. 
 
SAXS Measurements 
The dimensional features of the Fe3O4 NPs and of core-shell red-Au@Fe3O4 
and purple-Au@Fe3O4 have been also studied with Small Angle X-ray 
Scattering (SAXS). In particular, through this technique it was possible to 
determinate gold shell thickness too. SAXS spectra were recorded at 25°C by 
using a glass capillary with 1 mm of diameter for the samples. 
For the uncoated citrate-Fe3O4 nanoparticles the scattering intensity was 
modelled according to the formalism introduced by Barlett and Ottewill for 
polydisperse spherical particles.16 In this approach, the particles are described 
as spherical objects with a Schulz distribution of radii.17,18 In particular, the 
model accounts for a polydispersed population of spheres with uniform 
scattering length density. Structure factors are not included in this model 
because, due to the low concentration of particles in the dispersion, the inter-
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particle interference effects can be neglected. The Schulz model-fitting 
analysis is represented by the eq. 2.3: 
 
? ? ? ???
?
????? ?
?
?
? ???? ?? ?? (2.3) 
 
where ??  is the total number of the spheres for unit volume, ??  is the 
difference in the scattering length density, ? ??  is the scattering amplitude 
for a sphere and ? ?  is the Schulz distribution of the radii, given from eq. 
2.4: 
 
? ? ? ? ? ? ????? ??? ? ? ? ? ?????? ? ? ?  (2.4) 
 
where ???? is the mean radius, ??is the variance of distribution related to 
polydispersity and ? is the gamma function.  
For the sample core-shell Au@Fe3O4 the scattering intensity was investigated 
according to polyCore form model.16 In this approach the spherical particles 
have a polydisperse core with a constant shell thickness. The form factor is 
normalized by the average particle volume such that: 
 
? ? ? ????? ?? ? ? ? ???? ? ??? (2.5) 
 
where ? is the single particle scattering amplitude, appropriately averaged 
over the Schulz distribution of radii.  
SAXS spectra of the samples uncoated Fe3O4 nanoparticles and Au@Fe3O4 
NPs red and purple, corrected for the solvent, are showed in the following 
Fig. 2.20. 
The fitting results for the core average radius, the shell thickness and the 
polydispersity index of the magnetic nanoparticles uncoated and coated are 
reported in Table 2.5. 
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(a) (b) 
 
(c) 
Figure 2.20 SAXS spectra measured for the Fe3O4-citrate NPs (green markers) (a), 
red-Au@Fe3O4 NPs (red markers) (b), purple-Au@Fe3O4 NPs (violet markers) (c). 
Fitting curves of the experimental data according to the model chosen is showed by 
the black solid line. 
Table 2.5 Average hydrodynamic radius of the cores, polydispersity and shell thickness values by 
SAXS experiments. 
 Fe3O4 Red-Au@Fe3O4 Purple-Au@Fe3O4 
core <Rh> 
(nm) 3.1 ± 0.2 3.2 ± 0.2  3.1 ± 0.6 
shell 
thickness 
(nm) 
/ 3.4 6.2 
core 
polydispersity 
0.5 0.3 0.6 
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Morphological studies: SEM and TEM 
Morphological studies of the magnetic nanoparticles citrate-Fe3O4 and the 
gold coated nanoparticles Au@Fe3O4 red and purple were performed through 
Scanning Electron Microscopy (SEM) and Transmission Electron 
Microscopy (TEM). In particular SEM (see section 5.3.2) coupled with 
energy dispersive X-rays spectroscopy like qualitative detection system 
(EDS) was employed for the composition valuation of the nanosystems. In 
fact, the analysis of characteristic X-rays emitted from the sample gives 
quantitative and qualitative elemental information on the sample. Moreover, 
it was possible to use the fact that such X-ray analysis can be confined to a 
very low analytical area. The electron beam can be focused over the particles 
projection area during the X-ray acquisition for the particles’ compositional 
analysis.  
SEM images were collected by using a working distance of 9 mm, optimizing 
the voltage at 5 kV on aluminum substrate, upon which the samples were 
deposited and dried under vacuum. The estimation of the structural features 
and composition was done on these same substrates. A better evaluation of 
the Fe3O4 sizes has been done by using TEM, because SEM images not 
highlights primary particles, due to the drying process during the sample 
pretreatment that leads to their aggregation. Nevertheless, good SEM images 
were obtained which reveal a surface covered by monodisperse nanoparticles. 
SEM images of citrate-Fe3O4 NPs with its compositional analysis and the 
respective EDX spectrum are reported in Fig. 2.21. 
 
 
Element 
Weight 
% 
Atomic 
% 
C (K) 12.85 29.19 
O (K) 24.07 41.04 
Fe (L) 60.11 29.36 
Au (M) 2.98 0.41 
 
(a) 
 (b) 
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(c) 
Figure 2.21 SEM image of citrate-Fe3O4 NPs sample diluted 30 times in the left 
(a), in the right the percentage of elements with the line of emission for each of 
them (b) and in the bottom its spectrum EDX (c). 
EDX analysis reveals an atomic percentage of Fe and O with a ratio of 3 to 4, 
and carbon according to citrate-Fe3O4 NPs composition. In the following 
picture (Fig. 2.22) TEM images of the same sample are showed and the mean 
radius about 4 nm was disclosed.  
 
  
(a) (b) 
Figure 2.22 TEM images of citrate stabilized Fe3O4 NPs.  
SEM images of the red-Au@Fe3O4 sample (that is the sample with the 
smaller shell thickness of gold) with its compositional analysis and spectrum 
EDX, related on a brighter spot, are reported in Fig. 2.23. Brighter globular 
particles appear clearly in the picture due to the higher electron density of the 
gold. As it is possible to see from the image, the surface results to be 
homogeneous in size of nanoparticles. 
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Element 
Weight 
% 
Atomic 
% 
C (K) 21.44 50.95 
O (K) 16.51 29.45 
Fe (L) 28.95 14.80 
Au (M) 33.11 4.80 
 
(a) 
 (b) 
  
(c) (d) 
Figure 2.23 SEM image of red-Au@Fe3O4 NPs sample diluted 10 times in the left 
(a), in the right the percentage of elements with the line of emission for each of 
them (b) and in the bottom its spectrum EDX (c) obtained from analysis on the 
brighter spot (d). 
The average diameter is about 20 nm with about 5 nm of shell thickness. The 
EDX analysis was performed on several spots, both on brighter sphere and on 
darkest area. In all of these spots the EDX investigation has revealed 
presence of gold. Moreover, as it is possible to see in the table (Fig. 2.23 b) 
the atomic percentage of Fe and O is in a ratio equal 2 to 3 respectively, 
accounting for the presence of the γ-Fe2O3 NPs. This highlights the role of 
HAuCl4 as an oxidizing agent at high temperature in the coating process. The 
Fig. 2.24 shows the SEM image and the compositional analysis on a darkest 
spot. 
The same analysis was performed on the purple-Au@Fe3O4 NPs samples 
diluted 10 times, both on darkest and brighter spots (Fig. 2.25 and Fig. 2.26 
respectively) and as expected it reveals a greater percentage of gold respect to 
red-Au@Fe3O4 NPs. In addition, from the SEM image it is possible to 
disclose that the dispersion appears clearly characterized by monodisperse 
and shaped spheres, with diameters of about 40-50 nm.  
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Element 
Weight 
% 
Atomic 
% 
C (K) 29.28 56.12 
O (K) 19 31  7.78 
Fe (L) 34.19 14.06 
Au (M) 17.21 2.01 
 
(a) 
 (b) 
 
(c) 
Figure 2.24 SEM image of red-Au@Fe3O4 NPs sample diluted 10 times in the left 
(a), in the right the percentage of elements with the line of emission for each of 
them (b) and in the bottom its spectrum EDX (c) obtained from analysis on the 
darkest spot (a). 
 
Element 
Weight 
% 
Atomic 
% 
C (K) 15.21 43.81 
O (K) 14.86 32.13 
Fe (L) 26.55 16.44 
Au (M) 43.38 7.62 
 
(a) 
 (b) 
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(c) (d) 
Figure 2.25 SEM image of purple-Au@Fe3O4 NPs sample diluted 10 times in the 
left (a), in the right the percentage of elements with the line of emission for each of 
them (b) and in the bottom its spectrum EDX (c) obtained from analysis on the 
darkest spot (d). 
 
Element 
Weight 
% 
Atomic 
% 
C (K) 13.41 47.64 
O (K) 9.67 25.81 
Fe (L) 18.05 13.80 
Au (M) 58.87 12.76 
 
(a) 
 (b) 
 
(c) 
Figure 2.26 SEM image of purple-Au@Fe3O4 NPs sample diluted 10 times in the 
left (a), in the right the percentage of elements with the line of emission for each of 
them (b) and in the bottom its spectrum EDX (c) obtained from analysis on the 
brighter spot (a). 
The EDX results highlight a higher percentage of gold in the purple-
Au@Fe3O4 than the red-Au@Fe3O4 NPs sample, showing an atomic gold 
percentage of about 10% respect to the only 3% in the two different samples. 
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UV-Vis Spectroscopy study 
Nanoparticles of noble metal display a strong optical absorbance when the 
incident photon frequency is in resonance with the collective excitation of the 
conduction electrons, setting up the condition of localized surface plasmon 
resonance (LSPR). The plasmon mode in pure Au nanoparticles produces an 
absorption peak in the visible region of the electromagnetic spectrum.19 The 
LSPR gives the distinct ruby red color to many gold colloid suspensions. 
Normally, the position of this peak lies in the range between 515-530 nm and 
its resonant frequency is strongly dependent on the nanoparticle size20,21 
shape,22 stabilizing ligand, as well as the local dielectric properties of the 
surrounding medium.23 On the basis of Mie theory is possible to investigate 
the factors that affect the position of the SP peak.24 The SP absorbance peak 
would undergo significant broadening and red shift due to the aggregation of 
the Au nanoparticles correlated to a collective interaction of the electrons of 
the interconnected sub-micron particles. Moreover, the core-shell 
nanocomposite systems have a tunable plasmon resonance that depends on 
the ratio of the core radius respect to the total radius. In a work of Brullot et 
al.25 was disclosed that in the Au core-shell nanospheres for equal core radius 
a thinner shell exhibits a greater red shift in comparison with a thicker shell 
that shows a blue shift of the SP peak.26-29 This effect is explained in terms of 
the domination of Drude-like electrons that participate in the collective 
plasmon resonance based on Mie scattering theory and quasi-scattering 
calculations.  The UV-Vis spectra of the citrate-Fe3O4, red and purple 
Au@Fe3O4 nanoparticles are reported in the Fig. 2. 27. 
 
 
Figure 2.27 UV-Vis spectra of as synthesized citrate-Fe3O4, red-Au@Fe3O4 and 
purple-Au@Fe3O4 nanoparticles. The samples were diluted 15 times. 
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The spectrum of the Fe3O4 dispersion would display an absorbance peak in 
the UV region. This peak may be suppressed both in red and purple 
Au@Fe3O4 samples due to the Au character increasing for which the Fe 
oxide becomes buried beneath the Au shell, thus resulting in a change of the 
optical properties of the nanosystems. Mutually, the electronic properties 
induced by the presence of Fe core may also affect the Au SP peak position. 
However, probably the red shift of the purple-Au@Fe3O4 NPs accounts for 
an increased dimension of the particles. Moreover, the lack of a uniform Au 
shell around the cores may have also an effect on SP peak position, meaning 
that the second iteration, besides increase the thickness of already formed 
shell, may start the nucleation on cores (or on a area of the same core just 
covered) that remain uncoated from the first iteration. In fact, in the 
absorbance curve of the red-sample a weak shoulder near 400 nm is 
disclosed. It seems a typical peak of γ-Fe2O3 NPs that decreases or disappears 
in the purple-sample, and the bandwidth of the SP peak changes in terms of a 
peak broadness caused by a non-uniform shell around the Fe3O4 cores.  
2.2.1 Discussions 
Iron oxide-gold nanoparticles exhibit both magnetic and plasmonic behaviors 
that have great potential for biomedical application. Composite magnetic-
plasmonic nanoparticles have advantages in two areas. First, the ability to 
remotely control the spatial position of a nanoparticle in a real time without 
perturbing the biological system (as would occur with a large electric field). 
Second, the magnetic-gold NPs could be used for increased range in selective 
binding. Moreover noble-metal surfaces are beneficial for their relative ease 
of biofunctionalization, high chemical stability, biocompatibility, but also for 
“plasmonic” biosensing, i.e. the detection of biomolecular targets through 
shift in LSPR spectrum. The gold layer on the surface of the magnetic 
nanoparticles has also the rule to stabilize the dispersion, because ferri- or 
ferromagnetic NPs require an extensive stabilizing hydrophilic coating layer 
in aqueous environments to prevent precipitation due to the magnetostatic 
interactions.30 
In this part of work, a rapid and effective rout to synthesis magnetic core-
shell nanoparticles soluble in aqueous medium was performed. Two different 
thicknesses of gold shell were obtained on nanoparticle’s surfaces, by 
modulating the respective concentration of NPs and HAuCl4. On these 
nanosystems gained DLS, SAXS, TEM and SEM investigations were 
employed to a chemical-physical characterization. Furthermore, the intensity 
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and position of the plasmon resonance was accounted to control the growth 
of the gold shell on the nanoparticles surfaces. The results obtained for the 
magnetic and magnetic core/shell, with two different thicknesses, are 
summarized in the Table 2.6. The values display that the size of nanoparticles 
is usually different in each of employed techniques; this is due to the 
different parameters involving in the size estimation in each of them.  
If we consider the reaction steps, reported in the Fig. 2.18, it is possible to 
estimate the thickness of the growing gold shell simply by knowing the 
quantity of added HAuCl4 (that is 10 mM for the red-Au@Fe3O4 and 5 mM 
fore the purple-Au@Fe3O4), the mean radius of the citrate-Fe3O4 NPs (that is 
4 nm from TEM analysis) and the number of the magnetic nanoparticles used 
in the aliquot for the step reaction. It was calculated that 1 ml of Fe3O4 
dispersion contains 4.45?1015 NPs; this number was obtained by weighting 1 
mL of SPIONs dispersion previously dried in the stove and since the Fe3O4 
nanoparticles have a mean radius and a density noted, through them the mass 
value and then the number of the NPs in the dried aliquot were achieved. The 
shell thickness values expected were 0.5 nm for red-Au@Fe3O4 NPs and 1.3 
nm for the purple-Au@Fe3O4 NPs. 
Table 2.6 Values of hydrodynamic diameter from DLS experiments, Zeta Potential, core 
diameter and shell thickness from SAXS, sizes from SEM and TEM of citrate-Fe3O4 and red and 
purple-Au@Fe3O4. 
 Fe3O4 Red-Au@Fe3O4 Purple-Au@Fe3O4 
<Dh> (nm) 395 ± 6 258 ± 8 213 ± 3 
<ζ-Pot> 
(mV) 
-45.9 ± 0.6 -28.1 ± 1.7 -17.2 ± 0.6 
<Rsaxs> 
core (nm) 3.1 ± 0.2 3.2 ± 0.2  3.1 ± 0.6 
shell (nm)  
thickness  
/ 3.4 6.2 
TEM/SEM 
(nm) 8 20  40-50 
shell (nm) 
thickness / 5 8-10 
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The results of the measurements reported in the table are rather far than those 
calculated. As already mentioned, DLS measures are affected by the 
hydration layer and by magnetic susceptibility that provides a further 
contribution to the interaction of particles in solution, leading to aggregation. 
Instead, the SAXS data are close enough to those achieved from 
morphological investigation. The deviation from expected thickness lies on 
the presence of Fe3O4 clusters of primary nanoparticles that decreases the 
number of free SPIONs and therefore it leads to a less free surface available 
for the coverage.  
From the UV-Vis investigation the broad absorption peaks in the 500 nm to 
600 nm range indicate the presence of Au shell in the samples. Instead the 
absorbance peak in the UV region highlights the SPION presence. As 
previously mentioned, the two components of the composite core-shell 
nanosystem influence the intensity and the position of respective peaks each 
other.  
A red shift and broadening of the SP peak of the purple-sample was noticed 
probably due to the increased dimension of the purple nanoparticles 
compared to the red core-shell nanoparticles.  
Another important remark is that, during the first coverage could occur an 
inhomogeneous and/or incomplete coating of the nanoparticles surfaces. This 
phenomenon may lead to two consequences during the second iteration: a 
thickening of the previous formed gold shell or a growth of new coating on 
the surface areas still available. But this means that, during the first iteration 
there could be Fe3O4 nanoparticles, or better parts of their surfaces, still 
uncoated. For this reason in the absorbance spectrum of red-Au@Fe3O4 NPs 
appears a weak shoulder around 400 nm that seems to be typical peak of γ-
Fe2O3 that decreases or disappears in the absorbance of purple-sample in 
which the whole surface should be covered by Au layer. Thus, that shoulder 
in the spectrum could demonstrate the γ-Fe2O3 presence in the red-Au@Fe3O4 
samples. The evidence of the maghemite presence was found also in the 
SEM-EDX investigation on the sample red-Au@Fe3O4 (see Fig. 2.23 b).  
The formation of γ-Fe2O3 is due to the presence of HAuCl4 at high 
temperature, necessary for the Au shell coverage step. The gold in the ionic 
form AuCl4- is a strong oxidizing agent and it during the gold coating step at 
high temperature leads to the oxidation of the magnetite (oxide of Fe2+ and 
Fe3+) to the maghemite (oxide of Fe3+). However, Fleming et al. demonstrate 
that either γ-Fe2O3 or Fe3O4 may be used as cores, because the magnetic 
properties are maintained.28 The oxidation of Fe3O4 to γ-Fe2O3 occurs in 
aqueous solutions, exposed to air also at room temperature, even if much 
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more slowly. Once oxidized to γ-Fe2O3, the magnetic fluid is remarkably 
stable, lasting for years in acidic or alkaline medium. They also reported that 
the Fe3O4 are more resistant to Au deposition than are γ-Fe2O3, suggesting 
that Au3+ reduction may preferentially occur at more oxidized sites, but the 
cause for this difference in deposition behavior in unclear. 
2.3 Synthesis and Characterization of bimetallic core-
shell hydrophobic Au@Fe3O4 NPs  
Chemicals: Iron(III) acetylacetonate (Fe(acac)3, 99.9%), 1,2-hexadecanediol 
(C14H29CH(OH)CH2(OH), 90%), oleylamine (OAM, C9H18=C9H17NH2, 
70%), oleic acid (OA, C9H18=C8H15-COOH, 99%), phenyl ether (C12H10O, 
99%), hexane and ethanol employed for the synthesis were purchased from 
Sigma Aldrich (St Louis MO). Gold acetate (Au(OOCCH3)3 99%) from 
Fluka. Ultrapure Milli-Q water (18.2mΩ/cm) was used in all experiments 
(Milli-Q Merk-Millipore system). 
 
The citrate stabilized Fe3O4 nanoparticles described in the previous section 
have given good results in terms of size and gold covering. But, on the other 
hands the polydispersity indexes of these nanosystems (coated and uncoated) 
have not showed a good monodispersity of the nanoparticles’ dispersions (see 
Table 2.5). So, since the ability to control the size and the monodispersity is 
very important for the properties of the nanoscale core, shell and their 
combination in the subsequent technological applications, a different 
synthetic pathway based on thermal decomposition of a metal complex was 
performed. This process is able to provide a very good control of the 
formation of the gold’s shell at the iron oxide nanocrystal cores with high 
monodispersity and controllable surface capping properties, which facilitates 
the following control and manipulation of the interparticle interactions and 
rectivities.  
Hydrophobic iron oxide nanoparticles were synthesized according to the 
protocol reported by Wang et al.13 Substantially, 0.71 g Fe(acac)3 (2 mmol) 
were dissolved in 20 mL of phenyl ether with 2 mL of oleic acid (~ 6 mmol) 
and 2 mL of oleylamine (~ 4 mmol) under argon atmosphere and vigorous 
stirring. 1,2-hexadecanediol (2.58 g, 10 mmol) was added into the solution. 
The solution was heated to 210 °C, refluxed for 2 h and then cooled to room 
temperature. Ethanol was added to the solution and the precipitate collected, 
washed with ethanol and re-dispersed in 20 mL of hexane in the presence of 
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~ 75 mM each of oleic acid and oleylamine. A stable black dispersion of the 
magnetic nanoparticles with a hydrophobic coating of oleic acid and 
oleylamine in hexane was thus obtained. 
The synthesis of the hydrophobic Fe3O4 NPs with a gold shell (HF-
Au@Fe3O4) involve the previous initial preparation of Fe3O4 NPs that will be 
used as seeds and a subsequent reduction of Au3+ (thanks to oleylamine and 
1,2-hexadecanediol) in the presence of the seeds. Thus, 10 mL of the phenyl 
ether reaction solution of Fe3O4 NPs (~ 0.33 mmol Fe3O4), 0.83 g (2.2 mmol) 
of Au(OOCCH3)3, 3.1 g (12 mmol) of 1,2-hexadecanediol, 0.5 mL (~ 1.5 
mmol) of oleic acid, 3 mL (~ 6 mmol) of oleylamine were added into 30 mL 
of phenyl ether, under argon atmosphere and vigorous stirring. The reaction 
solution was heated to 190 °C slowly and was kept at this temperature for 1.5 
h. After cooling at room temperature, ethanol was added into the solution. A 
dark-purple precipitate was collected and separated by centrifuging. Then it 
was washed with ethanol and re-dispersed in hexane in the presence of ~ 75 
mM each of oleic acid and oleylamine. A stable dark-purple dispersion of 
hydrophobic SPIONs gold covered in hexane was gained. 
Figure 2.28 Cartoon sketching of the process involved in the synthesis of the HF-
Fe3O4 and HF-Au@Fe3O4 nanoparticles. 
DLS Measurements 
The samples achieved HF-Fe3O4 and HF-Au@Fe3O4 were analyzed through 
dynamic light scattering by using 90Plus/BI-MAS system by Brookhaven 
Instrument apparatus (with a 15 mW solid state laser, λ= 635 nm like light 
source) in order to obtain dimensional features of the nanosystems. The 
measurements were carried out at 25 °C on 1.5 ml of sample. The 
autocorrelation functions, reported in the Fig. 2.29, were fitted with cumulant 
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analysis. While, the size distributions of the nanoparticles have been 
extracted from CONTIN analysis. Each measurement was repeated 5 times. 
 
 
(a) 
 
(b) 
Figure 2.29 Autocorrelation functions of the scattering intensity obtained from the 
samples HF-Fe3O4 NPs and HF-Au@Fe3O4 NPs (a) and size distribution for HF-
Fe3O4 NPs (grey bars) and HF-Au@Fe3O4 NPs (white bars), obtained with 
CONTIN analysis. 
In particular, CONTIN analysis was calculated in function of the number of 
nanoparticles and it has shown a higher population around 7 nm and smaller 
populations with lower diameters for the Fe3O4 NPs. Instead data analysis, 
performed by using the same model, has displayed a population of the coated 
nanoparticles with 11 nm of diameter. The diameters obtained from DLS 
study, are summarized in Table 2.7. Only the diameter value of the 
population with higher number is reported in table, i.e. the higher frequent 
value (modal value). 
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Table 2.7 Hydrodynamic diameter values (modal value) and polydispersity indexes for the 
samples HF-Fe3O4 and HF-Au@Fe3O4 nanoparticles. 
 HF-Fe3O4 NPs HF-Au@Fe3O4 NPs 
core Dh (nm)  7 11 
 
 
SAXS Measurements  
The sizes of the samples HF-Fe3O4 and HF-Au@Fe3O4 NPs with its gold’s 
shell thickness were studied through Small Angle X-ray Scattering. SAXS 
spectra were recorded at 25 °C by using a sealed glass capillary of 1 mm of 
diameter. Each measurement was collected for 2 h. The data analysis for the 
uncoated Fe3O4 nanoparticles have been done applying the SchulzSphere 
model-fit (see eq. 2.3 in the previous section). Whilst for the study of the 
experimental data of the gold coated Fe3O4 nanoparticles polyCore model-fit 
(see eq. 2.5) has been used. The SAXS spectrum recorded for the HF-Fe3O4 
NPs sample is reported in Fig. 2.30. 
 
 
Figure 2.30 SAXS spectrum measured for the sample HF-Fe3O4 NPs in hexane, 
black markers. Curve Fit of the experimental data according to a fitting model is 
showed with a red continuous line. 
The size, polydispersity index and shell thickness values achieved through 
the model fit used are reported in Table 2.8. 
2 – Inorganic Nanoparticle 
 74 
Table 2.8 Mean core radius, shell thickness and polydispersity index values obtained from the 
experimental data according to the models fit used. 
 HF-Fe3O4 NPs HF-Au@Fe3O4 NPs 
core <Rh> (nm)  2.7 ± 0.3 2.5 ± 0.2 
shell thickness (nm) / 0.8 
polydispersity 0.17 0.15 
 
The SAXS investigation displays a nanoparticles’ dispersion of core radius of 
2-3 nm with high monodispersity. The thickness of the gold shell on the 
Fe3O4 NPs is 0.8 nm. 
 
Morphological study: TEM 
The synthesized SPIONs, gold coated and uncoated, were also studied with 
TEM microscopy in order to obtain the sizes of the sub-micron particles and 
so compare them with the values achieved from SAXS investigation. The 
figure 2.31 shows representative TEM images for the Fe3O4 NPs with 
hydrophobic coating of oleic acid and oleylamine. 
 
Figure 2.31 TEM micrographs for HF-Fe3O4 nanoparticles with hydrophobic 
coating of oleic acid and oleylamine. 
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TEM micrographs show highly monodisperse nanoparticles with 6 nm of 
diameter according to the SAXS data. From the representative picture, shown 
above, the monodispersity of the system studied is very highlighted. 
Likewise, the same high monodispersity is displayed from the TEM images 
of the Fe3O4 gold covered reported in the Fig. 2.32. 
 
Figure 2.32 TEM micrographs for HF-Au@Fe3O4 nanoparticles with hydrophobic 
coating of oleic acid and oleylamine and dimensional analysis. 
The dimensional analysis of the TEM images for the gold-coated 
nanoparticles shows high monodispersity, as expected, with total diameter 
about 7 nm. If we consider the diameter found in the previous micrographs 
(~6 nm) we can state that the gold’s shell thickness obtained from the TEM 
analysis is about 1 nm, this is a result one more time in agreement with the 
SAXS studies.  
2.3.1 Discussions 
The importance to synthesize magnetic nanoparticles and core-shell SPIONs 
with high monodispersity and with a good shell thickness control is relevant 
for their further technological applications, like magnetic resonant imaging 
for medical diagnosis, biological targeting or separation, catalysis and 
controlled drug delivery.31-35 In particular, in this work a good size control of 
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the synthesized magnetic nanoparticles is required because these 
nanoparticles with hydrophobic coating of oleic acid and oleylamine will 
subsequently be used in the mixed systems lipid based for a controlled 
release triggered through application of a magnetic field. Since, these triggers 
will be embedded in a bilayered lipid channels of specific dimensions, it is 
very important that the nanoparticles size is highly controlled. For this 
reason, a synthesis procedure that provides small and monodisperse magnetic 
nanocores, through thermal decomposition in organic solvent at high 
temperature of the ferric metal complex, has been performed.  Moreover, a 
good control of the thickness of the gold's covering was also achieved. In this 
case, the molar ratio of the Au precursor to the iron oxide nanoparticles was 
approximately 7:1. The structural features of the synthesized nanosystems are 
summarized in Table 2.9 following showed. 
Table 2.9 Hydrodynamic diameter, shell thickness and polydispersity indexes of the HF-Fe3O4 
and HF-Au@Fe3O4 nanoparticles. 
 HF-Fe3O4 NPs HF-Au@Fe3O4 NPs 
DLS 
core Dh (nm)  
 
7 
 
11 
SAXS   
core <Rh> (nm)  2.7 ± 0.3 2.5 ± 0.2 
shell thickness (nm) / 0.8 
polydispersity 0.17 0.15 
TEM 6 7 
 
Thus, from this synthetic procedure based on the thermal decomposition of a 
ferric complex it was possible to achieve SPIONs of about 7 nm of diameter 
and a gold shell with about 1 nm of thickness. The monodispersity reached 
was very high. Furthermore, the results obtained with the different techniques 
used are very much agreed between them. 
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3 Magnetoliposomes for controlled drug release 
A part of my research project was dealt on the synthesis and characterization 
of lipid based nanosystems containing hydrophobic (oleic acid-coated γ-
Fe2O3) and hydrophilic (citrate-coated Fe3O4) SPIONs (nanocomposite 
systems called magnetoliposomes, MLs) in order to obtain a highly 
biocompatible, flexible, responsive and very stable nanometer-scaled systems 
for drug delivery. Moreover, the release behavior of a model drug from 
magnetoliposomes under magnetic field and either in aqueous physiological 
buffer and in bovine serum at two different concentrations was investigated. 
The aim of this study was to understand the release’s kinetics and understand 
how the magnetically triggered drug release is influenced by the interaction 
with the serum proteins. The magnetic nanoparticles and MLs were 
characterized by Dynamic Light Scattering and Small Angle X-ray Scattering 
in physiological buffer and in bovine serum. Finally, the leakage of a model 
drug fluorescent molecule (Carboxyfluorescein) was monitored in order to 
study the liposomes and magnetoliposome’s permeability upon external 
alternating magnetic field. 
 
Chemicals: Iron(III) chloride hexahydrate (97%), Iron(II) sulfate 
heptahydrate (99%), Iron pentacarbonyl Fe(CO)5, octyl ether (purity grade, 
99%), oleic acid (99%), trimethylamine N-oxide (98%), cyclohexane 
(>99.9%), ethyl alcohol (>99.8%), hydroxide solution 33%, hydrogen 
chloride solution 37%, tetramethylammonium hydroxide 25% wt solution in 
water (TMAOH), sodium chloride minimum (99.5%), tri-Sodium citrate 
dehydrate (>99%), citric acid monohydrate (>99.5%), 5(6)-
carboxyfluorescein (>>95% HPLC, CF), chloroform (99.9% HPLC grade), 
ethylenediaminetetraacetic acid (EDTA, 99.5%), TritonX-100 were 
purchased from Sigma Aldrich (St Louis, MO). 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) was purchased from Avanti Polar Lipids. 
Concentrated nitric acid (90%) was purchased from Fluka. Methanol (99.8%) 
was purchased from Panreac Quimica Sau and Sephadex G-25 Superfine 
from Pharmacia Fine Chemicals. Fetal bovine serum was purchased from 
HyClone. All the reagents were used as supplied, except for trimethylamine 
N-oxide that was dehydrated immediately before using it. Ultrapure Milli-Q 
water (18.2mΩ/cm) was used in all experiments (Milli-Q Merk-Millipore 
system). 
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3.1 Synthesis and Characterization of magnetic Iron-
Oxide nanoparticles  
3.1.1 Citrate-coated Fe3O4 nanoparticles 
Magnetite nanoparticles (Fe3O4 NPs) were prepared introducing minor 
modifications to a method described elsewhere.1 Briefly, a solution of 1 M 
FeCl3 (1 mL) in 2 M HCl was added to 4 mL of 2 M Fe2SO4 solution in 2 M 
HCl. An aqueous solution of NH3 was added dropwise to the mixture under 
vigorous agitation. A black precipitated of magnetite was formed 
immediately. The particles obtained were separated by magnetic decantation, 
washed with water and re-dispersed in 10 mL of 2 M HCl solution and stirred 
for 5 minutes. The precipitate was again separated through magnetic 
decantation and washed several times with water. The citrate coating of the 
nanoparticles was done by dispersing the precipitate in 20 mL of 100 mM 
citric acid solution and stirring for 1 h at room temperature. After recollecting 
the precipitate by using the permanent magnet, NPs were dispersed in 20 mM 
tri-sodium citrate (20 ml) and kept under stirring for 45 minutes. The 
achieved nanoparticles were separated again by magnetic decantation and 
washed several times with water and acetone in order to remove any excess 
of citric acid. The citrate-coated NPs were with care dried under a nitrogen 
gas flux, dispersed in the buffer solution (10 mM PBS, 150 mM NaCl, pH 
7.4) and kept under slight stirring for 24h. Finally the dispersion was 
centrifuged at 1000 g for 2 minutes and the supernatant was dialyzed against 
water for 24 h through a cellulose dialysis bag (avg. flat width 23 mm, 
MWCO 12400, 99.99% retention) in order to remove the non-adsorbed 
citrate species.  
3.1.2 Oleic acid-coated γ-Fe2O3 nanoparticles 
Maghemite nanoparticles (γ-Fe2O3 NPs) were prepared according to the 
previous protocol described by Hyeon.2 Substantially, oleic acid (1.197 g, 6 
mmol) was added to 15 mL of octyl ether and the solution heated up to 100 
°C. Iron pentacarbonyl Fe(CO)5 (260 μl, 2 mmol) was then added and the 
resulting mixture kept refluxing for 1 h, during which the color of the 
solution changed from orange to brown-black. At the end of this step, the 
black dispersion of NPs was cooled at room temperature and purged with 
nitrogen. Still under nitrogen atmosphere, the previously dehydrated
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trimethylamine N-oxide (447 g, 6 mmol) was added and the dispersion was 
heated to 130 °C and kept to this temperature for 2 h. The nitrogen flux was 
then removed and the temperature was slowly increased up (3 °C/min) to the 
boiling point. After refluxing for 2 h, the dispersion was cooled to room 
temperature. The NPs were then collected adding ethanol (50 ml) and the 
dispersion was centrifuged at 6000 rpm. The precipitate was washed twice 
with 20 mL of ethanol and then the dried precipitate was finally dissolved in 
cyclohexane to obtain a stable magnetic fluid.  
3.1.3 DLS and Zeta Potential 
Both citrate-coated Fe3O4 and oleic acid-coated γ-Fe2O3 in PBS buffer were 
investigated through Dynamic Light Scattering in order to obtain their size. 
The measurements were carried out by using 90Plus/BI-MAS system by 
Brookhaven Instrument apparatus (with a light source constituted by a 15 
mW solid state laser, λ= 635 nm). The measurements were performed at 25 
°C on 1.5 mL of sample previously transferred into cells. In DLS 
experiments, the normalized time autocorrelation function of the intensity of 
the scattered light is measured. The autocorrelation functions were analyzed 
through a cumulant analysis stopped to the second order.  
Table 3.1 Average hydrodynamic diameters from DLS analysis and surface charge by Z-Potential 
analysis of the hydrophilic and hydrophobic magnetic nanoparticles. 
 Citrate-Fe3O4 Oleic acid γ-Fe2O3 
<Dh> (nm) 178.4 ± 3.7 116.8 ± 5.6 
Z-pot (mV) -16.4 ± 1.7 -0.5 ± 0.1 
 
Z-potential determination on the same samples was also performed. The 
measurements have been done at 25 °C on 1.6 mL of sample. In Table 3.1 the 
average hydrodynamic diameters and Z-potential values are reported.  
3.1.4 SAXS measurements  
The magnetic nanoparticles both citrate-coated Fe3O4 and oleic acid-coated γ-
Fe2O3 were also characterized by means of Small Angle X-ray Scattering. In 
the Fig. 3.1 SAXS spectra of both nanoparticles with their fitting curve are 
reported.  
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Figure 3.1 SAXS spectra of citrate-coated Fe3O4 NPs in PBS (gray markers, ?) 
and oleic acid-coated γ-Fe2O3 NPs in cyclohexane (black markers, Δ). 
The SAXS spectrum of citrate coated-Fe3O4 NPs dispersed in PBS was 
modelled according to the formalism introduced by Barlett and Ottewill for 
polydispersed spherical particles.3 As previously seen (paragraph 2.2, 
equations 2.3-2.5) in this approach the particles are described as spherical 
objects with a Schulz distribution of radii.4,5 No structure factors were 
included in this model as, due to the low concentration of particles in the 
dispersion, the inter-particles interference effects can be neglected. Moreover, 
no aggregates are visible al low q value and the experimental data 
interpretation, through Schulz sphere model, leads to diameter value of the 
magnetite nanoparticles about 15 nm. 
While, SAXS spectrum of γ-Fe2O3 NPs dispersed in cyclohexane were 
analyzed according to the “pearl necklace” model.6 This model was 
developed to describe the scattering pattern produced by a string of micelles 
(i.e. spherical objects) distributed along a polypeptide chain, therefore nick-
named as “pearl necklace” model.7 The model is analogous to that used for 
the SAXS spectra of the magnetoliposomes, that it is showed in detail ahead 
(paragraph 3.2.3). The only difference lies in the fact that, owing to the low 
concentration of NPs in the dispersion, the inter-particle structure factor S(Q) 
in equation 3.5 is set equal to 1 and so it becomes: 
 
? ? ? ? ? ???? (3.1) 
 
where ? is the particle volume fraction and ???? is the form factor. Thus, 
apart from that, the fitting procedure and model are the same.  
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Table 3.2 Structural features of the citrate coated-Fe3O4 NPs and oleic acid-coted γ-Fe2O3 NPs 
obtained from SAXS measurements. 
 Citrate-Fe3O4 Oleic acid γ-Fe2O3 
model fit Schulz sphere Pearl necklace model 
core <R> (nm) 7.7 ± 0.2 3.3 ± 0.2 
shell (nm) − 1.2 
polydispersity 0.3 0.1 
Fractal dimension, D − 2.8 
NP correlation length 
ξ (nm) − 31.1 
 
The optimal fitting was obtained for nanoparticles having a diameter of about 
9 nm, in particular a core of 6.6 nm of diameter and a shell of 1.2 nm. The 
resulting fractal dimension was 2.8, not close to 1, indicating that γ-Fe2O3 
NPs are not arranged into linear chains, but rather into more compact 
structures. The correlation length value obtained indicates that probably the 
aggregates are constituted by a few units around 3 or 4 nanoparticles. The 
structural parameters extracted by the fitting of the experimental SAXS data 
are reported in Table 3.2. The corresponding scattering length densities 
(SLD), necessary for the model’s application, were calculated from the X-ray 
scattering lengths of the atoms. SLD of each component was kept constant 
during the fitting of the experimental data.8  
3.2 Synthesis and Characterization of Liposomes and 
Magnetoliposomes 
Liposomes and magnetoliposomes were prepared by the extrusion method, 
which is based on lipid film hydration followed by sequential extrusion 
(section 1.4).9-14 In particular, the lipid suspension is forced through a 
polycarbonate filter with a defined pore size to yield particles having a 
diameter near the pore size of the filter used. Prior to extrusion through the 
final pore size, the multilamellar vesicles (MLV) suspensions were disrupted 
by several freeze-thaw cycles and by prefiltering the suspension through a 
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larger pore size filter. The amphiphilic molecule used for the liposomes and 
magnetoliposomes synthesis is represented in the Fig. 3.2. 
 
Figure 3.2 Chemical structure of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC). 
Magnetoliposomes with hydrophilic magnetic nanoparticles (citrate coated-
Fe3O4 NPs) embedded in the aqueous pool were prepared by evaporation of 
the solvent from a CHCl3/MeOH solution of the lipid POPC. Then, the dry 
lipid film was hydrated with a buffer solution of carboxyfluorescein (30 mM 
CF, 10 mM PBS, 130 mM NaCl, 94 mM NaOH, 1 mM EDTA, pH 7.4) and 
Fe3O4 nanoparticles to have a lipid concentration of 20 mM.   
Magnetoliposomes with hydrophobic magnetic nanoparticles (oleic acid 
coated γ-Fe2O3 NPs) entrapped in the lipid bilayer of the vesicles were 
prepared by evaporation of the solvent from a CHCl3/MeOH solution of the 
lipid (POPC) and an aliquot of maghemite NPs coated with oleic acid in 
cyclohexane. Then, the dry film was hydrated with the buffer solution of CF 
to have a lipid concentration of 20 mM. Finally, control liposomes (i.e. 
without magnetic nanoparticles) were prepared by adding CF in buffer to the 
dry POPC lipid film.  
 
Figure 3.3 Schematic representations of magnetoliposomes with embedded oleic 
acid-coated γ-Fe2O3 NPs (on the left) and with citrate coated-Fe3O4 NPs (on the 
right).15 
The three dispersions were homogenized by vortex mixing and then freeze-
thaw for six times was done. Multilamellar polydispersed vesicles were then 
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downsized by sequentially extrusion at room temperature through 
polycarbonate membranes of 0.8 μm, 0.4 μm and 0.2 μm pore size 
(Whatman). Each step of extrusion was repeated 21 times. Non-entrapped 
nanoparticles and carboxyfluorescein were removed by gel exclusion 
chromatography (GEC) with Sephadex G-25 micro-column (1 mL syringe) 
saturated with 20 mM POPC solution so that the three liposome samples 
were recovered without dilution. Under these conditions, liposome 
dispersions (300 μl) were eluted by centrifugation at 2000 g for 3 minutes 
without loss or dilution of material. The collected fractions were investigated 
by DLS and SAXS.  
3.2.1 DLS measurements 
The fractions of purified liposomes and magnetoliposomes were collected 
and investigated by Dynamic Light Scattering in order to obtain their size 
distributions. The analysis was carried out by using 90Plus/BI-MAS system 
by Brookhaven Instrument apparatus (with a light source constituted by a 15 
mW solid state laser, λ= 635 nm). The measurements were performed at 25 
°C on 1.5 mL of sample previously transferred into cells. Data analysis has 
been performed according to the standard procedure; the field autocorrelation 
functions were analyzed through a cumulant analysis stopped to the second 
order. Moreover, in order to obtain a distribution of the decay rates (Γi) a 
Non-Negatively constrained Least-Squares (NNLS)16 algorithm was used to 
invert the experimental data. 
Liposomes and magnetoliposomes were characterized in PBS buffer, in 10% 
serum and 55% serum, in order to observe the stability of the system, in 
terms of size distribution, with the different media employed. Hydrodynamic 
diameters, Dh, of the vesicles in PBS were obtained by fitting the 
autocorrelation functions with a cumulant analysis. In particular, the obtained 
diameters range between 100 nm and 250 nm with a polydispersity between 
0.10 e 0.30. The size distributions of the liposomes and magnetoliposomes 
(MLs) with citrate coated-Fe3O4 NPs and oleic acid-coated γ-Fe2O3 NPs in 
PBS buffer, obtained by NNLS analysis are reported in Fig. 3.4. This 
investigation showed that, empty liposomes and MLs loaded with citrate 
Fe3O4 NPs are characterized by a single population (monomodal distribution) 
centered at the Dh values obtained by the cumulant analysis. Instead, MLs 
with embedded oleic acid-coated γ-Fe2O3 NPs show the presence of two 
populations, probably due to some free nanoparticles clusters. Although the 
size of the smaller population is larger than of isolated single nanoparticle. 
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This might indicate that free oleic acid-coated γ-Fe2O3 NPs could remove 
some lipids from the bilayer to coat their surface and improve their stability 
in the aqueous solution. This process probably leads to the formation of 
larger aggregates in PBS, explaining the presence of the two populations: 
magnetoliposomes and agglomerates of free lipid-coated NPs. 
 
Figure 3.4 Representative size distributions of liposomes (empty grey bars), 
magnetoliposomes with citrate-coated Fe3O4 NPs (empty black bars) and 
magnetoliposomes with oleic acid-coated γ-Fe2O3 NPs (grey bars) dispersed in PBS 
from NNLS analysis, before LF-AMF exposure. 
DLS analysis was also performed on the same samples immediately after 15 
minutes exposure to the low-frequency alternating magnetic field (LF-AMF) 
at a frequency of 5.7 kHz (LF-AMF features are explained in the section 5.6). 
This frequency was chosen according to previous results.9,10,11 The exposure 
of the samples to the LF-AMF for 15 minutes increase the temperature to 42 
°C independently of their composition, due to over-heating of the magnetic 
equipment. DLS analysis of the magnetic-treated samples did not show large 
variations in magnetoliposomes size distributions, except for MLs loaded 
with oleic acid-coated γ-Fe2O3 NPs, as shown in the Fig. 3.5. The presence of 
hydrophobic NPs into the liposome bilayer seems to promote a strong vesicle 
aggregation during the LF-AMF exposure, more likely due to local 
hyperthermic effects of the magnetic NPs. In a previous work,9 was 
demonstrated that on MLs embedded with CoFe2O4 NPs, for field frequency 
higher than 10 kHz the local hyperthermia is the main destabilizing element 
of the tested system. Thus, in the case of γ-Fe2O3 MLs, exposure to 5.7 kHz 
LF-AMF causes a local temperature increase in proximity of the magnetic 
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NPs localized into the phospholipid membrane, inducing destabilization of 
the bilayer and subsequent formation of aggregates. 
 
Figure 3.5 Representative size distributions of liposomes (empty grey bars), 
magnetoliposomes with citrate-coated Fe3O4 NPs (empty black bars) and 
magnetoliposomes with oleic acid-coated γ-Fe2O3 NPs (grey bars) dispersed in PBS 
from NNLS analysis, after magnetic treatment at 5.7 kHz for 15 min. 
DLS analysis was also performed on the samples dispersed in serum at 
protein concentration of 10% and 55% v/v. But, in this case it was very 
difficult to evaluate the size distribution of protein-liposomes complexes in 
serum through DLS measurements due to the high background signal from 
the free proteins, as it can be possible to see in the Fig. 3.6. 
 
  
(a) (b) 
Figure 3.6 Representative size distributions of pure (a) serum 10% v/v and (b) 
serum 55% v/v, from NNLS analysis. 
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Because of this limitation, as it is possible to see in the Fig. 3.7 where are 
showed only the DLS results on liposome samples, we could detect the 
presence of a main population, not found in pure serum, of hydrodynamic 
size of about 500 nm in serum 10% and of about 700 nm in serum 55%. The 
same behavior was observed with both magnetoliposomes loaded with 
hydrophobic and hydrophilic nanoparticles (data are not showed). 
 
Figure 3.7 Representative size distributions of liposomes in serum 10% (grey bars) 
and liposomes in serum 55% (empty black bars), from NNLS analysis. 
DLS measurements were also carried out on the samples in serum 10% and 
55% after of 5.7 kHz LF-AMF exposure for 15 minutes. In Fig. 3.8 the 
comparison between the size distributions of the liposomes and both MLs 
before and after LF-AMF exposure are reported, only for the measurements 
performed in serum 10%. From this DLS analysis, we could not extract any 
definitive conclusions but the results obtained suggest that magnetoliposomes 
form agglomerates in the presence of the environmental proteins and this 
behavior is even more enhanced after the LF-AMF application. In particular, 
in the MLs samples the vesicles’ agglomeration was so extensive to form 
objects that tended to sediment over time. Obviously, this behavior was more 
emphasized for the MLs samples in serum 55%. 
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Figure 3.8 Representative size distributions of (a) liposomes, (b) 
magnetoliposomes with oleic acid-coated γ-Fe2O3 NPs and (c) magnetoliposomes 
with citrate-coated Fe3O4 NPs in serum 10% v/v before (empty black bars) and after 
LF-AMF exposure (grey bars). 
3.2.2 Optical microscopy 
The aggregation of the liposomes and magnetoliposomes in the biological 
fluids after the magnetic treatment has been also detected by using optical 
microscope. The images of the liposomes and MLs with oleic acid-coated γ-
Fe2O3 NPs in serum 55% before and after LF-AMF exposure are showed in 
Fig. 3.9 and 3.10. 
The images related to the magnetically treated samples show large aggregates 
ranging from 0.2 to 3 μm for the liposomes and from 1 to 9 μm for the 
magnetoliposomes. These results clearly confirm that the local heating due to 
the 5.7 kHz of LF-AMF exposure promotes the formation of large protein-
vesicle agglomerates probably enhanced by the local heating of the magnetic 
nanoparticles located in the lipid bilayer of the magnetoliposomes, for which 
a higher aggregation and sedimentation was revealed. 
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(a) (b) 
Figure 3.9 Optical microscopy images of liposomes in serum 55% v/v (a) before 
LF-AMF and (b) after LF-AMF exposure. 
  
(a) (b) 
Figure 3.10 Optical microscopy images of magnetoliposomes with oleic acid-
coated γ-Fe2O3 NPs in serum 55% v/v (a) before LF-AMF and (b) after LF-AMF 
exposure. 
3.2.3 SAXS measurements 
SAXS measurements were done to obtain insights on the local structure of 
the lipid membrane as a function of nanoparticles encapsulation, LF-AMF 
exposure and serum incubation. SAXS spectra of liposomes and 
magnetoliposomes loaded with citrate coated-Fe3O4 NPs and oleic acid-
coated γ-Fe2O3 NPs dispersed in PBS were reported with the corresponding 
best fittings in Fig. 3.11.  
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Figure 3.11 SAXS spectra of liposomes (), magnetoliposomes with citrate 
coated-Fe3O4 NPs (Δ) and oleic acid-coated γ-Fe2O3 NPs (?) in PBS. The curves 
fit are reported as solid line. 
Data analysis has been done using two fitting models, one for liposomes and 
another one for magnetoliposomes. In particular, the SAXS spectrum of 
liposomes (control sample) were analyzed according to a model proposed by 
Nallet et al.17 for lamellar phases of amphiphilic bilayer, through the 
following equation: 
 
? ? ? ??? ?? ?? ? ?? ?? ? ???? (3.2) 
 
where the form factor ? ?  is given by: 
 
? ? ? ??? ??? ??? ? ?? ? ?? ? ??? ??? ? ??? ??? ???
? (3.3) 
 
and ?? is the head group thickness, ?? is the tail length, ??? ?? ? ?????  
and ??? ?? ? ??  are the scattering length density contrast, where???, ?? 
and ????? are the scattering length density of head group, tail and solvent, 
respectively. In the fitting, the scattering length densities corresponding to the 
theoretical atomic compositions were used. In this model no inter-lamellar 
structure factor S(Q) is included. 
Magnetoliposomes were modelled taking in account both scattering intensity 
arising from liposomes (amphiphilic bilayer) and that arising from 
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nanoparticles arranged in fractal clusters. Thus, SAXS spectrum of 
magnetoliposomes has been modelled according to the following equation: 
 
? ? ? ????? ? ??????? ? ???? (3.4) 
 
where ????? is the scattering intensity from the liposomes, while ??????? is 
the scattering intensity arising from magnetic nanoparticles arranged in 
fractal clusters and modelled according to pearl necklace model.7 This model 
was previously used to describe polydispersed spherical nanoparticles with a 
core-shell structure, arranged into fractal clusters.6 The spherical particles 
have a constant shell thickness and a core with a Schulz distribution of 
radii.18 The contribution to the total scattering intensity arising from these 
objects was calculated according to the follow relationship: 
 
??????? ? ??? ? ? ?  (3.5) 
 
where ? is the particle volume fraction, ? ?  is the form factor and ? ?  is 
the inter-particle structure factor accounting for the inter-particle correlations. 
The form factor was modelled as: 
 
? ? ? ? ?? ? ??
?
?
?? ??? ??? (3.6) 
 
? ??? ?
??
?? ?????? ? ????? ???????? ??? ?
?
?? ??? ? ??????  (3.7) 
 
??????? ? ????? ? ?????? ????? ? ??????  (3.8) 
 
? ??? ? ??? ??? ? ??? ??? ???  (3.9) 
 
where ?? is the core radius, ? is the shell thickness, ?? is the particle volume, 
and ?????, ?????? and ????? are the scattering length densities (SLDs) of the 
core, shell and solvent respectively. In the fitting, the scattering length 
densities corresponding to the theoretical atomic compositions were used. 
The function ? ??  is the normalized probability of finding a particle with a 
core radius between ?? and ?? ? ???, and it accounts for the polydispersity of 
the cores according to a Schulz distribution (eq. 3.10).19,20 
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? ?? ?
???
? ? ? ?
? ? ?
??
???
??? ? ?????? ? ? ?  (3.10) 
 
where ? ? ? ?  is the gamma function and the parameter ? is related to the 
polydispersity ?? of the core radius by the expression 3.11: 
 
?? ?
??? ? ?? ? ? ?
?? ?
?
? ? ? ? ? (3.11) 
 
The interparticle structure factor ? ?  describes how the scattering intensity 
is modulated by interference effects between radiations scattered by different 
scattering objects. In our case, it should account for the aggregation of the 
magnetic nanoparticles, in analogy with the distribution of the micelles along 
the polypeptide backbone. Therefore, we used the same expression derived 
by Chen and Teixeira:7 
 
? ? ? ? ? ?? ? ? ??? ? ??? ? ? ? ???
?? ?? ? ? ?????
??? ?
 (3.12) 
 
where ? is the mean radius of the particles as resulting from the sum of the 
core radius ?? and the shell thickness ?, ? is the gamma function and ? is the 
correlation length, i.e. a cut-off factor related to the dimensions of the 
aggregates that are eventually formed by the particles. ?  is the fractal 
dimension that describes the spatial distribution of the individual scatters and 
it is related to their number ? ?  within a sphere of radius ? through the 
equation 3.13: 
 
? ? ? ? ?
?
 (3.13) 
 
Corresponding scattering length densities (SLDs) were calculated from the 
X-ray scattering lengths of the atoms, considering the molecular volumes of 
phospholipid fragments evaluated by Armen at al..21 SLD of each component 
was kept constant during the fitting of the experimental data. 
The results from the data analysis are reported in Table 3.3. It is possible to 
observe that citrate coated-Fe3O4 NPs not affects the structure of the lipid 
bilayer, confirming their presence only in the aqueous pool of the liposomes. 
While, the slight change of the lipid tail length in the presence of oleic acid-
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coated γ-Fe2O3 NPs indicates the direct interaction of nanoparticles with the 
lipid bilayer. This can schematically correspond to either a physi-sorption of 
these nanoparticle aggregates onto the liposome surface or an insertion of the 
nanoparticles in the lipid bilayer (see Fig. 3.3).  
Table 3.3 Structural parameters of liposomes and both MLs by SAXS analysis. 
 Liposomes MLs with citrate Fe3O4 
MLs with oleic 
acid γ-Fe2O3 
Lipid head 
group thickness, 
?? (nm) 
0.36 0.35 0.38 
Lipid tail length, 
?? (nm) 1.71 1.70 1.91 
NPs shell 
thickness, ? 
(nm) 
- 0.12 0.96 
NPs core 
polydispersity, 
??  
- 0.98 0.30 
NP mean core 
radius, <R> 
(nm) 
- 6.90 3.48 
NP fractal 
dimension, D - 3.01 2.90 
NP correlation 
length, ? (nm) - 15.91 14.72 
 
In fact, given that γ-Fe2O3 NPs have diameters exceeding the thickness of the 
lipid bilayer, POPC membrane can distort to accommodate NPs both inside 
and/or on the surface of the lipid membrane. This result can be consistent 
with the ability of cell membrane to accommodate transmembrane proteins.22 
No changes of lipid structure were observed by SAXS analysis after 
magnetic treatments.  
Finally, SAXS spectra of liposomes in serum (10% and 55%) were also 
recorded, but liposome signal is completely covered by serum as shown in 
the graph reported Fig. 3.12. 
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Figure 3.12 SAXS spectra of liposomes in (?) PBS, (?) serum 10% and (Δ) 
serum 55%. SAXS spectra of (blue markers) pure serum 10% and (green markers) 
55% are also reported. 
3.3 Release study with carboxyfluorescein 
The carboxyfluorescein (CF) fluorescence of the magnetically untreated 
samples and of the samples exposed to the LF-AMF for 15 minutes was 
measured over time in order to obtain a kinetics release study. The release 
behavior was checked as a function of the LF-AMF exposure time by 
measuring the fluorescence intensity of CF at regular time intervals. 
Fluorescence experiments were also performed on liposomes and MLs kept 
at the highest temperature reached during the magnetic treatment (42 °C) for 
the same exposure time, in order to evaluate the contribution to the release 
due to heating caused by the exposure of the sample to the 5.7 kHz of LF-
AMF for 15 minutes. Release experiments were performed on all the samples 
dispersed in the three different investigated fluids (PBS, 10% v/v serum and 
55% v/v serum). 
The CF release was monitored by measuring the fluorescence emission 
increase. In fact, CF inside the aqueous pool of the liposomes or 
magnetoliposomes is confined and so highly concentrated. In this condition it 
forms a non-fluorescent dimer, giving rise to self-quenching.23 For this 
reason the leakage of CF was studied like an increment of the fluorescence 
intensity of the probe. Fluorescence emission was continuously monitored 
during the first 1000 minutes (about 16 h) at time points of 10 min and 
eventually, single measurements were performed at 18, 24 and 40 h after the 
LF-AMF exposure. The emission fluorescence spectra of CF were recorded 
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between 500 and 610 nm in the corrected spectrum mode with excitation 
wavelength set at 492 nm and 2.5 nm slit. At least 5 scans were averaged for 
each spectrum. Liposome and magnetoliposome samples were diluted 1:67 
with PBS and bovine serum 10% and 55% v/v respectively, before and after 
LF-AMF. All samples were then diluted to the measurement concentration 
with a solution of TritonX-100 to achieve complete release of CF through 
vesicles disruption. The release percentage was calculated from the 
fluorescence intensity through the following equation: 
 
????????? ? ? ??? ? ? ??? ????? ? ??? ? ? ??? (3.14) 
 
where ??? ?  is the measured fluorescence intensity, ??? ?  is the 
fluorescence intensity of the untreated sample and ????  is the maximum 
fluorescence emission after TritonX-100 addition. However, the interaction 
of TritonX-100 with serum makes impossible the direct measurements of 
???? in biological medium; for this reason the theoretical value of ???? for 
MLs dispersed in biological fluid was extrapolated from the calibration 
curves of CF in serum 10% and 55% v/v using the experimental value of 
????  obtained for MLs in PBS as reference. Calibration curves of the 
carboxyfluorescein in PBS and serum 10% and 55% is reported in the Fig. 
3.13. 
 
Figure 3.13 Calibration curves of the Carboxyfluorescein (CF) in (red) PBS, (blue) 
serum 10% v/v and (green) serum 55% v/v. 
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The experimental data obtained were fitted using the Ritger-Peppas equation 
(eq. 3.15),24,25 a semi-empirical equation used to describe drug release 
kinetics from polymeric systems: 
 
??
?? ? ??
? ?????? ?? ? ??? (3.15) 
 
where ?? ?? is the drug fraction released at time ?, ? is the kinetic constant 
that include the structural and geometric characteristics of the system, and n 
is the diffusion exponent which is related to the drug transport mechanism. 
The power-law equation can be seen as the superposition of a Fickian 
diffusion and a zero order kinetics:24,26-28 n values around 0.5 indicate pure 
Fickian diffusion, while n value around 1.0 indicates that erosion or 
relaxation processes lead the release process (zero-order release, case II 
transport). Intermediate n values between 0.5 and 1.0 suggest that diffusion 
and erosion contribute to the overall release mechanism (anomalous 
transport). Occasionally, values of n>>1 have been observed and considered 
as kinetics dominated by disruption processes of the matrix (supercase II 
transport). The kinetics of the CF release from empty liposomes (i.e. without 
nanoparticles) was investigated and the results are shown in Fig. 3.14. The 
kinetic parameters (n and k) related to the CF’s release obtained from the 
experimental data by using the Ritger-Peppas model for the liposomes 
without NPs are reported in Table 3.4.  
Table 3.4 Kinetic parameters related to the CF release from empty liposomes obtained from the 
fitting of the kinetic curves with the Ritger-Peppas model (eq. 3.15). 
 PBS Serum 10% Serum 55% 
No-field    
n 0.55±0.01 0.46±0.01 0.44±0.02 
k 5.01?10-3±0.48?10-3 1.17?10-2±0.12?10-2 1.57?10-3±0.01?10-3 
LF-AMF    
n 0.85±0.02 1.10±0.02 0.79±0.07 
k 5.09?10-4±0.36?10-4 9.89?10-5±0.44?10-3 1.57?10-3±0.01?10-3 
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Figure 3.14 Release kinetics of empty liposomes during the first 16h, (red) 
untreated samples, (blue) samples heated at 42 °C for 15 minutes and (green) 
samples exposed to LF-AMF for 15 minutes at 5.7 kHz of frequency, in (a) PBS, 
(b) serum 10% v/v and (c) serum 55% v/v. Solid curves (in black) are the best 
fittings obtained by means of equation 3.15. Single measurements of the release in 
(a’) PBS, (b’) serum 10% v/v and (c’) serum 55% v/v were taken within 40 hours. 
In the Fig. 3.15 and 3.16 the kinetics of CF release from MLs containing 
citrate coated-Fe3O4 NPs and oleic acid-coated γ-Fe2O3 NPs are showed, 
respectively.  
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Figure 3.15 Release kinetics of citrate coated-Fe3O4 NPs embedded-
magnetoliposomes during the first 16h, (red) untreated samples and (green) samples 
exposed to LF-AMF for 15 minutes at 5.7 kHz of frequency, in (a) PBS, (b) serum 
10% v/v and (c) serum 55% v/v. Solid curves (in black) are the best fittings 
obtained by means of equation 3.15, except for the samples in serum 55% (c), 
where it was no possible to use the Ritger-Peppas model for the data analysis. 
Single measurements of the release in (a’) PBS, (b’) serum 10% v/v and (c’) serum 
55% v/v were taken within 40 hours. 
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Figure 3.16 Release kinetics of oleic acid-coated γ-Fe2O3 NPs embedded-
magnetoliposomes during the first 16h, (red) untreated samples and (green) samples 
exposed to LF-AMF for 15 minutes at 5.7 kHz of frequency, in (a) PBS, (b) serum 
10% v/v and (c) serum 55% v/v. Solid curves (in black) are the best fittings 
obtained by means of equation 3.15. Single measurements of the release in (a’) 
PBS, (b’) serum 10% v/v and (c’) serum 55% v/v were taken within 40 hours. 
The kinetic parameters obtained from the experimental data analysis by 
applying Ritger-Peppas model for both MLs are reported in Table 3.5. 
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Table 3.5 Kinetic parameters related to the CF release from both MLs in PBS, in serum 10% and 
serum 55% obtained from the fitting of the kinetic curves with the Ritger-Peppas model (eq. 
3.15). 
 MLs-citrate Fe3O4 NPs MLs-oleic acid γ-Fe2O3 NPs 
 PBS 
No-field   
n 0.71±0.01 0.55±0.01 
k 1.16?10-3±0.07?10-3 8.67?10-3±0.88?10-3 
LF-AMF   
n 0.82±0.01 0.87±0.01 
k 7.21?10-4±0.37?10-4 4.66?10-4±0.26?10-4 
 Serum 10% v/v 
No-field   
n 0.44±0.01 0.44±0.01 
k 8.5?10-3±0.03?10-3 2.47?10-2±0.20?10-2 
LF-AMF   
n 0.68±0.01 0.63±0.01 
k 1.06?10-3±0.01?10-3 1.70?10-5±0.16?10-3 
 Serum 55% v/v 
No-field   
n 0.45±0.11 0.66±0.01 
k 2.59?10-2±0.54?10-2 3.13?10-3±0.03?10-3 
LF-AMF   
n - 0.99±0.01 
k - 1.69?10-4±0.02?10-3 
 
All the samples, included empty liposomes, show a lower release of CF in 
serum than in PBS (see Fig. 3.15 and 3.16), indicating a typical trend of 
anomalous transport and zero-order kinetics of perturbed systems likely due 
to the formation of protein-vesicle complexes. In fact, these complexes 
display to aggregate after exposure to LF-AMF strongly hindering the CF 
leakage from the surface of the MLs. Specifically, as shown in Fig. 3.16, the 
kinetic profiles of MLs loaded with oleic acid-coated γ-Fe2O3 NPs in buffer 
and serum differ mainly for the fluorescence intensity, which decreases with 
protein concentration. Moreover, the release of the magnetically treated MLs 
in serum is higher at short times after application, while after 15 h is 
comparable to that of untreated MLs. This suggests that the release is mostly 
promoted by the application of the magnetic field and is higher during the 
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magnetic exposure. Once the field was removed, the leakage decreases 
probably because of the aggregation process favored by the formation of 
protein-ML complexes. This was also strengthening by behavior in PBS, 
where the release after magnetic exposure was still higher with respect to the 
untreated MLs even after 40 h. This is an indication that the magnetic field 
acts as trigger that actuates the release of CF from the magnetoliposomes. 
The analysis of the kinetic curves reveals different mechanisms of release for 
each of the cases considered above. LF-AMF treated-MLs showed 
anomalous transport mechanism in PBS and in serum 10%, while a case II 
transport mechanism (zero kinetic order) in serum 55% is associated to the 
formation of larger protein-ML complexes. Protein-ML complexes and 
aggregates were likely induced by the local temperature increase, driven 
mainly by the exposure to the LF-AMF (hyperthermia) that lead to lateral 
aggregation of the vesicles. 
 
Figure 3.17 Schematic representation of protein- γFe2O3 MLs complexes.15 
Similarly, MLs loaded with citrate coated-Fe3O4 NPs have exhibit lower 
releases in serum than in PBS, as shown in Fig. 3.15. On the other side, the 
release of both LF-AMF treated and untreated samples, is comparable for the 
entire monitored period. These results suggest that the LF-AMF does not 
provide any improvement to the drug release from MLs loaded with citrate 
coated-Fe3O4 NPs in serum. So, it is possible to state that the presence of the 
oleic acid-coated γ-Fe2O3 NPs in the lipid bilayer boosts the CF release in the 
LF-AMF presence thanks to the local heating due to the friction of the NPs in 
the lipid bilayer that destabilizes the lipid membrane and thus promotes the 
CF release. In fact, the CF leakage from MLs with oleic acid-coated γ-Fe2O3 
NPs is higher than the release upon LF-AMF application on the citrate 
coated-Fe3O4 NPs magnetoliposomes. 
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Figure 3.18 Schematic representation of protein-citrate Fe3O4 MLs complexes.15 
Kinetic data analysis of the release by Ritger-Peppas equation highlights that 
the mechanism in 10% serum after magnetic exposure corresponds to 
anomalous transport process as well as for the untreated sample. MLs in 55% 
serum gave a very noisy release curve with a shape that could not be 
analyzed by Ritger and Peppas equation, so kinetic parameters are not 
showed in Table 3.5. 
The low response to the alternating magnetic field of MLs loaded with citrate 
coated-Fe3O4 NPs dispersed in serum is also likely due to the presence of a 
high concentration of NPs (13 times higher than MLs loaded with oleic acid-
coated γ-Fe2O3 NPs). Nanoparticles can promote a stronger serum protein 
adsorption on ML’s membrane and the formation of larger serum-ML 
aggregates (not detectable by DLS measurements because too large). The 
huge amount of serum proteins adsorbed on ML surface hinders completely 
the CF release, resulting in a low release-response even to the magnetic field.  
Since DLS, SAXS and microscope analysis of MLs loaded with hydrophobic 
and hydrophilic nanoparticles have shown similar structure, the different 
kinetic behavior might be related to the local perturbation of the 
magnetoliposome bilayer permeability, which is not detectable by anyone of 
the above mentioned techniques because of their experimental limits. 
It is important to consider that the two systems differ for many variables 
making difficult a comparison. 
First, γ-Fe2O3 and Fe3O4 NPs are two distinct iron oxides having also different 
diameters that can strongly influence their magnetic properties. Secondly, the 
two ML samples differ for NP loading: the concentration is 13 times higher 
in MLs loaded with citrate coated-Fe3O4 NPs. Finally, the two investigated 
nanoparticles have different coatings that lead to different interactions with 
MLs and the environment.  
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On the basis of these considerations, the local increase of the temperature and 
the alteration of the ML membrane can be influenced by several parameters. 
The release took place according to various paths on different portions of the 
lipid vesicles, giving rise to distinct release processes for oleic acid-coated 
and citrate-coated magnetic nanoparticles. 
3.4 Final Remark 
In this part of work, the drug release behavior of two different MLs (oleic 
acid-coated γ-Fe2O3 NPs and citrate-coated Fe3O4 NPs embedded MLs) and 
liposomes upon exposure to a LF-AMF was studied. Their release behavior 
in PBS and in biological fluids was also investigated in order to evaluate how 
the release of a drug model is influenced by the interaction of phospholipid 
vesicles with serum proteins. 
Both MLs and liposomes, dispersed in serum 10% and 55% v/v have 
displayed a weak CF release with respect to the same samples dispersed in 
PBS. Although the release is triggered by thermal and magnetic treatments, 
the percentage of release does not change significantly. In particular, it is 
possible to state that probably the local heating induced by the LF-AMF 
exposure in the presence of magnetic nanoparticles (hyperthermia) promotes 
the interaction of the ML phospholipids with the proteins of serum, resulting 
in the formation of protein-liposome complexes and micro-sized aggregates, 
which obstruct the drug leakage. 
However, we demonstrated that the CF release from magnetoliposomes with 
magnetic NPs in the lipid bilayer is higher than that from magnetoliposomes 
with magnetic NPs in the aqueous pool after LF-AMF exposure. This 
experimental result highlights that the application of the LF-AMF to the 
magnetoliposomes endowed of MNPs in the lipid bilayer boosts the CF 
leakage, so the magnetic field can be considered as a trigger to the release of 
a hydrophilic model drug. 
Considering the obtained results, it is clear the importance of testing nano-
systems designed for biomedical applications in biological fluids, in order to 
understand their behavior in the presence of proteins and biomolecules that 
can interact with them. However, here it still remains unclear if the major 
destabilization observed after magnetic exposure in the biological fluids is 
directly bound to the protein adsorption or to a combined effect of a first 
destabilization of the membrane due to the presence of magnetic 
nanoparticles, that leads to a further extensive agglomeration. A strategy to 
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reduce the protein adsorption without affecting the magnetic responsivity of 
the system could be the use of PEGylated magnetoliposomes. 
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4 Magnetocubosomes for controlled drug release 
The last part of my research work has been focused on the study of a 
responsive and biocompatible drug delivery systems (DDS) constituted by a 
bulk cubic phase or a dispersed cubic phase (called cubosomes) as efficient 
and non-toxic vectors for therapeutics. The design, preparation and 
characterization of bulk cubic phase and magnetocubosomes as lipid DDS 
endowed with a magnetic responsiveness were investigated. The aim of this 
part of work was to include hydrophobic nanoparticles within bilayer and to 
use them as an internal trigger to actuate the release of both hydrophobic 
(Octadecyl Rhodamine B) and hydrophilic (Rhodamine 110) drug models. 
The encapsulation and the diffusion behavior of both model hydrophilic and 
hydrophobic molecules were monitored inside the aqueous channels and in 
the lipid bilayer respectively, through Fluorescence Correlation Spectroscopy 
(FCS). Moreover, the ability of both bulk cubic phase and cubosomes loaded 
with oleic acid-coated Fe3O4 NPs, to release a model drug in the aqueous 
environment upon external magnetic field application was investigated, in 
order to demonstrate that this kind of DDS constitute a useful responsive 
hybrid lipid/MNPs platform for the delivery and controlled release of 
therapeutics. 
 
Chemicals: Iron(III) acetylacetonate (Fe(acac)3, 99.9%), 1,2-hexadecanediol 
(C14H29CH(OH)CH2(OH), 90%), oleylamine (OAM, C9H18=C9H17NH2, 
70%), oleic acid (OA, C9H18=C8H15-COOH, 99%), phenyl ether (C12H10O, 
99%), hexane and ethanol employed for the synthesis of the NPs were 
purchased from Sigma Aldrich (St Louis MO), the same for the glyceryl 
monooleate (Monoolein, GMO) and Pluronic F-127. GMO is a polar lipid 
included in the FDA Inactive Ingredients Guide, used as a food additive and 
classified as “generally recognized as safe”, (GRAS).1 Rhodamine 110 
Chloride and Octadecyl Rhodamine B Chloride employed for the 
Fluorescence Correlation Spectroscopy experiments were purchased 
respectively from Sigma Aldrich (St Louis MO) and from Invitrogen 
(Heidelberg, Germany). The same for Alexa 568 employed for FCS 
calibration. Ultrapure Milli-Q water (18.2mΩ/cm) was used in all 
experiments (Milli-Q Merk-Millipore system). 
 
4 – Magnetucubosomes for controlled drug release 
 
 114
The synthesis and characterization of the oleic acid-coated Fe3O4 NPs, that 
have been embedded in the lipid bilayers of both bulk cubic phase and 
cubosomes, are described in the section 2.3. 
 
The amphiphilic molecule that was used for the preparation of the cubic 
phase and cubosomes is the Glyceryl monooleate (GMO), that featuring a 
polar head group and a non-polar hydrocarbon chain clearly it shows 
amphiphilic properties (section 1.5) that provide different structural geometry 
due to thermic treatment or solvent addition. In our case, a proper amount of 
water was added to the GMO in order to obtain a specific self-assembly 
geometry: bicontinuous cubic phase, with a double diamond Pn3m 
symmetry. 
4.1 Bulk Cubic Phase 
4.1.1 Synthesis  
30 mg of GMO were weighted in a glass vial and a small volume of hexane 
was added to completely dissolve the powder. The solvent was then 
evaporated under a stream of nitrogen and kept under vacuum overnight. 
Subsequently, the proper amount of H2O (50% w/w or more) was added to 
obtain a fully hydrated paste. The samples were homogenized with ten cycles 
centrifugation (1000 rpm, 5’ each, alternating one cycle with the glass vial 
upward and the following the other way round). For the preparation of the 
cubic phases loaded with nanoparticles, first the proper amount of NPs’ 
dispersion in hexane was weighted in a glass vial, in order to have 6 mg of 
NPs, the solvent was then evaporated under a stream of nitrogen obtaining a 
dry film of NPs on the walls of the vials. Then, 30 mg of GMO were added 
and the previously described protocol adopted. For the preparation of the 
cubic phases for the FCS experiments a similar procedure was followed. For 
the addition of the lipophilic fluorescent tag, Octadecyl Rhodamine B, a 
proper amount of the solution of the probe was added to the GMO solution in 
hexane, in order to obtain a 0.01% mol:mol amount of the probe with respect 
to the total lipid quantity. For the addition of the hydrophilic drug, a 1 µM 
(for the study on the diffusion of Rhodamine 110 inside the cubic phase 
channels) or 10 µM (for the study on the release of Rhodamine 110 from the 
cubic phase channels) aqueous solution of Rhodamine 110 was employed to 
hydrate the GMO or GMO-NPs films, instead of H2O. 
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                      (a)               (b) 
Figure 4.1 Schematic representations of the (a) Pn3m cubic phase structure and (b) 
Pn3m cubic phase structure with hydrophobic magnetic NPs within the lipid 
bilayer. 
4.1.2 Characterization  
Fully hydrated GMO bulk cubic phase was characterized in the absence and 
in the presence of oleic acid-coated Fe3O4 NPs through SAXS and FCS, in 
order to investigate the inner structural features of the studied systems.  
Figure 4.2 reports the SAXS spectra of the bulk cubic phase prepared as 
described in previous section (4.1.1), in the absence of NPs. As expected, the 
Bragg reflections of a Pn3m cubic phase can be detected. The cubic lattice 
parameter a can be obtained through the linear fit of the plot of qhkl vs 
(h2+k2+l2)1/2 (4.2, inset), according to the crystallographic relation 
a=2π/qhkl(h2+k2+l2)1/2 , being qhkl the measured position of each peak defined 
by hkl Miller indices. The resulting value a = 95.4 ± 0.9 Å is in agreement 
with the data reported in the literature for the same system.2-4 The structure of 
the Pn3m cubic phase, sketched in the Fig. 4.1, is characterized by a 
continuous curved lipid bilayer region, which forms a complex three-
dimensional cubic structure separating two continuous non-intersecting water 
channels.5 The radius of the inner water channels rw can be calculated 
according to the following relation: 
 
?? ? ?? ??? ? ?? ?? (4.1) 
 
where l is the lipid length (17 Å) and σ and χ  are topological constants, 
characteristic of a given cubic phase, equal to 1.919 and -2 for the Pn3m 
structure, respectively.2 The obtained value is 20.3 Å, which is consistent 
with the literature data.2 The structure of the cubic phase is able to host at the 
same time, embedded in separated compartments, hydrophobic and 
hydrophilic drugs. However, the open structure of the cubic phase, with the 
channels connected to the surface and the aqueous medium, determines a 
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non-permanent encapsulation of the hydrophilic drugs, which can diffuse 
spontaneously inside the channels and reach the surface. 
 
 
Figure 4.2 SAXS profile of the GMO bulk cubic phase without NPs. 
Several studies have addressed this issue both in terms of diffusion of model 
drugs inside the structure of the cubic phase (e.g. through NMR Self-
Diffusion experiments and theoretical studies),6-8 and in terms of release rate 
of a model drug from the cubic phase inside an aqueous environment.9 
However, this point still stirs debate. In this regard, fluorescence correlation 
spectroscopy (FCS) provides spatially resolved information on the diffusion 
both of hydrophilic and hydrophobic molecules inside the cubic phase. 
This technique monitors fluctuations of fluorescence emission in the confocal 
volume; the time autocorrelation of these fluctuations provides information 
on the diffusion coefficient of the fluorescent species. FCS provides spatial 
selectivity with the resolution provided by a confocal geometry and chemical 
selectivity, since only the fluorescent species are detected and their behavior 
in a complex matrix can be singled out. 
In order to characterize the encapsulation of model drugs and their dynamics 
when confined in the DDS, an amphiphilic (Octadecyl Rhodamine B, 
 
 
Pn3m 
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carrying an extended highly hydrophobic lipid chain) and a hydrophilic 
(Rhodamine 110) fluorescent tag, as drug models, were inserted in the cubic 
phase and their diffusion monitored through FCS. Very few studies10-12 have 
been performed on the diffusion of fluorescent probes inside mesophases. 
These investigations demonstrated that the diffusion mode of the probes (in 
terms of dimensionality of diffusion environment), as well as the normal or 
anomalous time dependence of the mean square displacement of a species, 
provide information on the viscosity, size and structure of the medium.  
 
 
(a) 
 
(b) 
Figure 4.3 Confocal microscopy image of the GMO bulk cubic phase, prepared in 
the presence of the fluorescently-labeled lipid Octadecyl Rhodamine B (red), 
representative FCS curve acquired for Octadecyl Rhodamine B inside the cubic 
phase (red markers) and curve fit of the experimental data according to a 3D normal 
diffusion model (continuous line) (eq. 4.3, i=1) (a); confocal microscopy image of 
the GMO bulk cubic phase, prepared in the presence of the water soluble 
fluorescent probe Rhodamine 110 (green), representative FCS curve acquired for 
Rhodamine 110 in pure water (black markers) inside the cubic phase (green 
markers) and curve fit of the experimental data according to a 3D normal diffusion 
model (continuous lines) (eq. 4.3, i=1) (b). 
Figure 4.3a reports representative FCS curves acquired for the lipophilic 
Octadecyl Rhodamine B (red markers). The curves can be analyzed 
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according to a 3D normal diffusion mode (eq. 4.3, i=1, the fitting curve is 
reported as a continuous red line), which provides a value of 4.7 ± 0.5 μm2s-1 
for the 3D diffusion coefficient of the probe within the lipid structure. 
 
The analysis of the motion of an amphiphilic probe diffusing along the 
tridimensional bilayered structure of a cubic phase is not straightforward. 
Generally, the diffusion of a fluorescently-labeled lipid in a lipid bilayer (i.e. 
a Supported Lipid Bilayer or a Giant Unilamellar Vesicle  (GUV) or a 
lamellar liquid crystalline phase)13,14 is analyzed according to 2D diffusion, 
since the curvature of the lipid membrane is significantly lower with respect 
to the single molecule size and to the FCS detection volume. The motion can 
be then described as confined in the bilayer plane. Conversely, the cubic 
phase is characterized by a bilayered structure with a high local curvature, 
since the radius of the aqueous channels is generally around 2 nm, three 
orders of magnitude lower than the radius of a typical GUV, in the range of 
several microns. A 3D diffusion mode can be consistent with the structure of 
the diffusing environment experienced by the fluorescent probe. However, 
the FCS investigation of the motion of a hydrophobic molecule embedded in 
a complex liquid crystalline structure is a complex issue, that will require 
further modeling. 
 
Figure 4.3b compares the FCS curves of the hydrophilic probe Rhodamine 
110 freely diffusing in water (black markers) and inside the aqueous channels 
of the GMO cubic phase (green markers). Also in this case the curves were 
analyzed according to a 3D normal diffusion mode, with the diffusion 
coefficient of the free diffusing Rhodamine 110 (in water) at 25°C equal to 
430 μm2s-1.15 Interestingly, the diffusion of the Rhodamine 110 inside the 
cubic phase can still be analyzed as a 3D diffusion inside the aqueous 
channels, but its diffusion rate is slowed down of more than one order of 
magnitude (11 ± 1 μm2s-1). This effect could be related to the restricted 
mobility of water confined into the water channels16,17 of the cubic phase 
and/or to the possible interaction of the probe molecules onto the internal 
surface of the aqueous channels. The hydrodynamic size of Rhodamine 110, 
evaluated through the Stokes-Einstein equation, considering the diffusion 
coefficient of the molecule in pure water, yields a value of 1 nm. Therefore, 
the molecular hydrodynamic size, comparable with the size of the channels 
(around 4.6 nm), might suggest a hampered 3D diffusion of the molecule, 
due to confinement cage effects.9,18,19 
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As already stated, the overall structure of the cubic phase is characterized by 
the communication of the aqueous channels with the external aqueous 
environment, thus, hydrophilic guest molecules are spontaneously released 
from the cubic phase. From FCS data it is possible to see that the 
spontaneous diffusion towards the surface is two orders of magnitude slower 
with respect to the normal diffusion in the bulk phase. Therefore the 
hydrophilic fluorescent molecules are efficiently retained inside the cubic 
phase, possibly due to confinement effects. Concerning the hydrophobic 
molecules embedded within the lipid structure of the cubic phase, FCS data 
show that they exhibit a relatively free mobility inside the lipid bilayered 
structure. It can then be expected that they are released only upon interaction 
with a lipid bilayer20 through fusion of the cubic phase with the lipid 
membrane of the target cells, while an external trigger can be used to boost 
the release of the hydrophilic drug, accelerating its diffusion from the 
aqueous internal channels to the external aqueous environment. 
The control over release of a model hydrophilic drug can be provided by 
incorporation of magnetic nanoparticles inside the lipid structure of the cubic 
phase. Very few examples have been presented concerning the incorporation 
of superparamagnetic iron oxide nanoparticles (SPIONs) inside a cubic 
phase. In particular, it has been reported that ferrite NPs can be synthesized 
in situ inside the water channels of the cubic phase;21 in addition, pre-
synthesized NPs were incorporated in the cubic phase, to build-up a new 
class of MRI contrast agents.22 
 
In this work, for the first time, the inclusion of hydrophobic magnetic NPs in 
the bilayer of the bicontinuous structure as a responsive system for drug 
release is reported. It has been proved that magnetic NPs encapsulated inside 
liposomes lead, upon application of a low frequency-alternating magnetic 
field (LF-AMF), a structural destabilization of the bilayer with the formation 
of pores, which can allow the escape of drugs from the aqueous pool of 
liposomes, thus acting as a release trigger (section 3.3).23-25 Moreover, 
previous studies, performed on magnetic NPs clusters connected through 
pairing of complementary DNA strands, have demonstrated that the effect of 
local heating, generated by the application of a LF-AMF, can be employed to 
reach the melting temperature of the ds-DNA and release a single-stranded 
DNA in the aqueous environment.26 In this study the SPIONs as an internal 
responsive component to actuate, thanks to the application of a LF-AMF, the 
release of a hydrophilic molecule confined within the aqueous channel of the 
cubic phase were employed. 
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(a) (b) 
Figure 4.4 TEM micrography of oleic acid-coated Fe3O4 NPs (a); SAXS spectrum 
measured for the oleic acid-coated Fe3O4 NPs (black markers) in hexane and curve 
fit (in red) of the experimental data according to the Schulz-spheres fitting model 
(b) (see paragraph 2.3). 
The hydrophobic Fe3O4 NPs were synthesized according to the procedure 
described in the paragraph 2.3, yielding a stable hexane dispersion of 
SPIONs passivated by oleic acid and oleylamine. The NPs were 
characterized in terms of size and size-distribution through TEM and SAXS 
measurements. Figure 4.4a shows a representative TEM image acquired for 
the NPs, which yields a size of 6 ± 1 nm diameter and provides evidence of 
the presence of monodisperse and non-aggregated particles. The SAXS data 
acquired on the same sample are displayed in Figure 4.4b (black markers). A 
model-free analysis in the low-q range according to the Guinier asymptotic 
law provides a value for the diameter of gyration equal to 6.9 nm. 
Alternatively, the data were interpreted with a spherical form factor and a 
Schulz polydispersity model (Figure 4.4b, red continuous line). From the 
fitting of the experimental curves, a value of 5.4 nm for the diameter of the 
spheres and 0.17 as polydispersity index, which are in agreement with the 
TEM data, was obtained. Taking into account that the bilayer has a thickness 
of around 3.5-4 nm, the hydrophobic nanoparticles have a suitable size to be 
inserted inside the lipid bilayer, causing only a local destabilization of the 
lipid structure. 
The fully hydrated GMO cubic phases were prepared with incorporated 
hydrophobic nanoparticles, to monitor the effect of the NPs on the structure 
of the cubic phase. SAXS experiments on the cubic phase loaded with the 
NPs were performed, as shown in Fig. 4.5. The presence of a low-q small 
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angle contribution (highlighted by a red ellipse), can be ascribed to the 
structure factor deriving from the spatial correlation of the NPs inside the 
cubic structure. The effect of the presence of NPs on the structure of the 
cubic phase is modest, i.e., all the six Bragg reflections observed for the 
cubic phase in the absence of NPs (Figure 4.2) are still detectable, 
highlighting that the order on the mesoscale is not disrupted by the inclusion 
of the NPs. From the linear fit of qhkl vs (h2+k2+l2)1/2 (Fig. 4.5, inset) a lattice 
parameter a = 86.4 ± 0.8 Å was obtained. Apparently, the incorporation of 
the nanoparticles in the cubic phase results in the shrinkage of the structure, 
with a decrease of the lattice parameter of about 1 nm. 
 
Figure 4.5 SAXS profile of the GMO bulk cubic phase loaded with hydrophobic 
oleic acid-coated Fe3O4 NPs within the lipid bilayer. 
Taking into account the tortuosity of the cubic phase, which determines an 
interfacial area of about 400 m2/g, the number of NPs per surface unit can be 
estimated. Considering the cross section of each nanoparticle (calculated as 
πr2, with r the radius of the NPs’core, obtained from TEM and SAXS 
measurements) and the density of bulk magnetite, it is possible to estimate 
the number of particles included in the cubic phase and hence the total 
interacting surface of the nanoparticles. By comparing this value with the 
 
 
Pn3m-MNPs 
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inner surface of the cubic phase, one obtains that the nanoparticles are 
covering around 2.5% of the inner surface of the cubic phase structure, with 
an average nanoparticles' distance of 12.5 nm, which nicely matches the 
structure factor position in the scattering vector space. This amount 
determines a clearly detectable effect on the lattice parameters of the cubic 
phase (i.e. the shrinkage of the lattice parameter), without disrupting the 
overall symmetry. 
4.2 Cubosomes and Magnetocubosomes 
The main limitations in the employment of the cubic phases as drug delivery 
systems, are their rheological properties (they are highly viscous systems, 
which are not suitable e.g. for injection) and their irritating effect on the 
tissues. Discrete cubic nanoparticles (cubosomes), obtained by dispersion of 
the bulk phase, have been developed, in order to overcome these drawbacks. 
27 
4.2.1 Synthesis 
We prepared cubosomes with a well-established “top-down” approach, by 
hydrating the cubic phase in the presence of a stabilizing agent (the block 
copolymer PEO/PPO/PEO Pluronic F-127) and then providing an energy 
input by heating, vortexing and sonicating in order to obtain a stable 
dispersion, stabilized by a surface cushion of the triblock copolymer. 
In more detail, first a GMO or GMO with oleic acid-coated Fe3O4 NPs dry 
film was obtained, as previously described in the paragraph 4.1.1. 
Subsequently, 8 mg of Pluronic F-127 were added to the dry films and the 
mixture was put in a water bath at 70°C for 5’ to melt the Pluronic F-127 and 
then vortexed for 5’. Five cycles of heating-vortexing were carried out and 
then 500 µL of preheated H2O at 70°C were added. The dispersion was then 
sonicated in a bath-sonicator for 6h, to homogenize the system. For the 
preparation of fluorescently-labeled cubosomes and magnetocubosomes the 
same preparation protocol was employed. The proper amount of Octadecyl 
Rhodamine B (0.01% with respect to total GMO amount) was added to the 
GMO solution, as previously described for the preparation of the cubic phase. 
500 µL of preheated Rhodamine 110 solution was employed instead of pure 
water to hydrate the GMO-(NPs)-Pluronic F-127 hot paste, in order to insert 
the fluorescent probe Rhodamine 110 inside the cubosomes. The excess of 
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Rhodamine was eliminated by purification through a size exclusion column, 
by using a column of Sephadex G-25 (from Sigma-Aldrich). 
4.2.2 Characterization  
SAXS spectra obtained for the cubosomes as prepared (black line) and 
loaded with Fe3O4 NPs (red line) are reported in Fig. 4.6. Clearly, the Bragg 
peaks of the inner cubic phase are superimposed to a form factor due to the 
dispersed nature of the lipid nanoparticles, and only four peaks can be 
recognized (q=6.66x10-2Å-1; q=8.14x10-2Å-1; q=9.39x10-2Å-1; q=1.15x10-1Å-
1). By indexing the peaks according to a Pn3m cubic structure, the lattice 
parameter results 133 Å, which is considerably higher than that of the bulk 
cubic phase. It is known that the presence of solutes can affect the internal 
structure of cubosomes, both concerning the lattice parameter and in terms of 
cubic phase nature. 
 
Figure 4.6 SAXS profile of the cubosomes in the absence (black line) and in the 
presence (red line) of oleic acid-coated Fe3O4 NPs in the lipid bilayers.  
For instance, it has been proved28 that high percentages of Pluronic with 
respect to the GMO amount, leads to an increase of the Pn3m lattice 
parameter and even to a structural variation, where the penetration of 
Pluronic inside the water channels shifts the equilibrium towards a cubic 
structure of Im3m geometry. Interestingly, the Im3m phase is also compatible 
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with the SAXS pattern that is observed for cubosomes. However, the quality 
of the data does not allow discriminating between the two cubic phases, since 
the fingerprint for the Pn3m geometry, the second peak at q=8.14x10-2Å-1, is 
barely distinguishable from the background noise. In the presence of the NPs, 
the form factor of the lipid nanoparticles covers almost completely the 
cubosomes' internal structure factor; however, the fourth peak of the Pn3m 
(or the third peak of the Im3m) is still very visible, confirming that the 
nanoparticles are indeed incorporated in the cubosomes without affecting 
their liquid-crystalline structure. 
Figure 4.7, instead, shows some representative DLS curves of the cubosomes  
(black line and markers) and of magnetocubosomes (red line and markers). It 
is possible to notice a slight increase of the decay time in the presence of 
nanoparticles; however, this effect is limited and no destabilization or 
occurrence of multiple size populations is detected.  
 
Figure 4.7 Representative normalized DLS curves obtained for the cubosomes as 
prepared (black line) and cubosomes loaded with oleic acid-coated Fe3O4 NPs (red 
line).  
Table 4.1 summarizes the DLS and zeta potential data acquired on the 
cubosomes, whose hydrodynamic size is about 200 nm both in the absence 
and in the presence of nanoparticles and is stable in time (24h). The slightly 
negative charge of the cubosomes (see zeta potential data, Table 4.1) can 
provide an additional contribution to their stability against aggregation, 
which sums up to the steric stabilization due to Pluronic F-127. 
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Table 4.1 Hydrodynamic diameter (Dh) and polydispersity index (PDI) of cubosomes’ 
dispersions, in the absence (Cubosomes) and in the presence (Magnetocubosomes) of oleic acid-
coated Fe3O4 NPs, obtained from the analysis of DLS measurements carried out just after and 
after 24h from samples preparation; zeta potential values (ζ-potential) measured for cubosomes in 
the absence and in the presence of NPs. 
 Cubosomes Magnetocubosomes 
 Dh (nm) PDI Dh (nm) PDI 
t = 0 210 ± 30 0.08 ± 0.05 230 ± 50 0.09 ± 0.05 
t = 24 h 250 ± 40 0.12 ± 0.05 240 ± 50 0.13 ± 0.05 
ζ- Potential (mV) -16 ± 4 -14 ± 3 
 
The magnetocubosomes containing the fluorescent tag Octadecyl Rhodamine 
B in the lipid bilayer were also characterized through FCS. In Fig. 4.8 a 
representative FCS curve obtained for labeled magnetocubosomes is reported 
(black markers). The curve was analyzed according to a simple 3D diffusion 
model (see eq. 4.2 an 4.3), obtaining for the diffusion coefficient a value of 
2.4 ± 0.4 μm2s-1, consistent, according to the Stokes-Einstein equation, with a  
 
Figure 4.8 Representative FCS curve measured for cubosomes loaded with oleic 
acid-coated Fe3O4 NPs, containing an Octadecyl Rhodamine B tag within the lipid 
region.  
hydrodynamic diameter of 180 nm. The diffusion coefficient obtained is 
related to the translational motion of the entire magnetocubosome in the 
water. Considering that the FCS analysis does not take into account any 
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polydispersity for the particles and the size distribution range of the z-
averaged values for the hydrodynamic diameters (see Table 4.1) we can 
consider the agreement between the sizes obtained for the batches as 
satisfying.  
4.3 Release from bulk cubic phases 
Finally, the release of a model hydrophilic drug from the aqueous channels of 
the hybrid lipid/SPION DDS cubic phase was investigated upon application 
of a LF-AMF, as external trigger with space and time control. Both the 
release from the bulk cubic phase and from the magnetocubosomes through 
FCS was investigated. Fluorescence Correlation Spectroscopy offers a unique 
opportunity to study spatially resolved phenomena in situ. In this work 
samples were monitored during the application of the LF-AMF. 
As described in the previous section, a solution of the hydrophilic fluorescent 
probe Rhodamine 110 was employed to hydrate the dried GMO-NPs mixture.  
The fluorescent probe is confined inside the aqueous channels of the cubic 
phase and its diffusion is slowed down with respect to the free diffusion in 
water. However, it can be expected that upon addition of an excess of water 
to the bulk cubic phase, the fluorescent molecules partition, due to the 
concentration gradient, to the surface of the cubic phase in the aqueous 
environment. The leakage of the dye can be investigated in situ through FCS, 
which provides, through the intercept of the correlation function, a 
quantitative measurement of the average concentration of the fluorescent 
molecule in the observation volume (see eq. 4.2 and 4.3). Therefore, thanks 
to the spatial resolution of the technique, if this volume is selected in the 
excess water solution which hydrates the cubic phase, it is possible to directly 
determine the dye concentration, the dimensionality of its diffusion motion, 
and the diffusion coefficient. These two latter pieces of information are 
important to rule out any presence of mixed lipid/Rhodamine assemblies.  
 
The models employed for the analysis of the autocorrelation functions 
(ACFs) take into account the shape and the exact size of the detection 
volume, which is approximated as 3D-ellipsoidal Gaussian shape with axial 
(??) and lateral (??) defining parameters, determined through a calibration 
performed with a reference fluorescent dye with known diffusion coefficient 
(50 nM standard solutions of Rhodamine 110 and Alexa 568, with 
respectively D = 430 µm2s-1 and D = 332 µm2s-1 in water at 25°C). For a 
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three-dimensional Brownian diffusion mode in a 3D Gaussian volume shape, 
the ACFs profiles can be analyzed according to the equation 4.2:29,30 
 
? ? ? ???? ??? ????? ? ?
???
???
??
? ? ??????
?? ?
 (4.2) 
 
with ???  the averaged fluorophore concentration, ??the diffusion coefficient 
of the probe (μm2s-1). 
In the case of a multicomponent system the measured autocorrelation 
function is a weighted sum of the autocorrelation function of each 
component.31 The general expression for the analysis of the autocorrelation 
function of the fluorescence intensity due to the 3D diffusion contribution of 
different i diffusing entities, is given by the relation 4.3: 
 
? ? ? ???? ??? ????? ???
? ? ???????
??
? ? ???????
?? ?
 (4.3) 
 
being ???  the average fluorophore concentration and ?? ?the weight factor of 
each i diffusing component characterized by diffusion coefficient ??. 
Figure 4.9 FCS curves acquired for Rhodamine 110 released from GMO bulk 
cubic phase to the surrounding aqueous medium spontaneously (a) and upon 
application of a LF-AMF (b). Curves measured at t = 0; 10’; 20’; 30’ after the 
addition of water to the measurement chamber containing the bulk cubic phase 
(markers); curve fitting of the experimental data (continuous lines) by using eq. 4.3 
with i=1. 
Figure 4.9a displays some representative FCS curves acquired in the excess 
aqueous phase of the measurement well containing the cubic phase, just after 
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the addition of the excess water (t = 0') and every 10 minutes for thirty 
minutes. The same experiment was performed by applying to the 
measurement chamber a LF-AMF (Figure 4.9b).  
The main parameters characterizing a FCS curve are the decay time, which 
corresponds to the τ value of the inflection point and is connected to the 
diffusion coefficient of the fluorescent species, and the intercept value G(0), 
which is inversely proportional to the concentration of the fluorescent 
molecule. The diffusion coefficient of Rhodamine 110 in water at 25°C is, as 
already stated, known (430 μm2s-1). Conversely, the concentration of the 
probe inside the aqueous phase of the well is the unknown quantity and 
should increase with time due to the diffusion of Rhodamine 110 from the 
cubic bulk phase to the excess water. This effect is clear from the progression 
of the profiles of the FCS curves acquired for increasing elapsed times, which 
exhibit a steady decrease of the ACF intercept value, i.e. an increase of the 
probe concentration in solution. In the presence of the applied magnetic field 
this effect is however much more pronounced, (Figure 4.9b) with respect to 
the “spontaneous”, i.e. driven by thermal equilibrium, process (Figure 4.9a). 
All the curves were analyzed according to a 3D diffusion of the dye (equation 
4.3, i = 1), with the diffusion coefficient of Rhodamine 110 kept constant, to 
obtain a more robust estimate of the dye concentration.  
The Fig. 4.10a displays the time progression (monitored for 60 minutes) of 
Rhodamine 110 concentration in the excess solution, obtained from the 
analysis of the FCS curves in the absence (black markers) and in the presence 
(red markers) of the magnetic field. The concentration values are normalized 
with respect to the concentration measured at t = 0 minutes (C/C0) and a 
linear fit of the experimental points is included as a guide for the eye. As 
already visible from the comparison of the original ACFs profiles, the 
application of the LF-AMF determines a strong increase in the rate of dye 
release from the cubic phase. This is a clear indication the magnetic field acts 
as trigger that actuates the release of the model drug included in the aqueous 
channels of the cubic phase, boosting the spontaneous leakage and providing 
spatial (since the LF-AMF is applied in a defined region of space) and a 
temporal control.  
In a previous study on magnetoliposomes, it was verified that upon 
application of an alternating magnetic field, the local heating provoked by the 
relaxation of the nanoparticles determines the formation of temporary pores 
in the lipid membrane surrounding the aqueous pool of liposomes, thus 
determining the release of the molecules encapsulated inside the aqueous 
pool in the surrounding medium.23 
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(a) (b) 
Figure 4.10 Release of Rhodamine 110 from the aqueous channels of the bulk 
cubic phase to the aqueous environment; spontaneous release (black lines and 
markers) and release upon application of a LF-AMF (red lines and markers). Trend 
of the normalized concentration of Rhodamine 110  (reported as concentration at 
time t C divided for to the initial concentration C0), with time (a). Trend of the 
released amount of Rhodamine 110 (reported as concentration at time t Mt divided 
for the concentration at infinite time Minf) with time (black and red markers), curve 
fit of the curves according to the Ritger-Peppas model (black and red continuous 
lines) (b).
Since the cubic phase, unlike liposomes, is characterized by the presence of 
open aqueous compartments, which are connected to the external surface, it 
can be expected that small molecules are able to migrate towards the surface 
of the cubic phase, under a concentration gradient.  
 
Figure 4.11 Schematic representation of the Rhodamine 110 release from aqueous 
channels of the cubic phase into external aqueous environment in the presence and 
in the absence of the LF-AMF. 
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Thus as evident from the displayed data (Figure 4.9a and 4.10a) Rhodamine 
110 molecules are spontaneously and slowly released from the cubic phase. 
The increase in the release rate in the presence of an applied LF-AMF can be 
due to an additional contribution to the release kinetics, which is much more 
effective with respect to the spontaneous migration, due to the formation of 
pores in the lipid bilayered structure of the cubic phase, allowing the 
hydrophilic solutes present in the aqueous channels to overcome the tortuous 
pathway of the cubic phase to be rapidly released in the aqueous 
environment. In order to investigate the release kinetics, the Ritger-Peppas 
model to define the solute transport process in the presence and in the 
absence of applied LF-AMF, was employed. Figure 4.10b reports the 
concentration of the solute (Rhodamine 110) at time ? (??) normalized for 
the concentration of solute at infinite time (the theoretical concentration for 
quantitative release as ???? ?was chosen) in the absence (black markers) and 
in the presence (red markers) of the LF-AMF. The Ritger-Peppas model 
describes the general release kinetic process (as already mentioned in section 
3.3) as:32-34 
 
??
???? ? ??
? ?????? ???? ? ??? (4.4) 
 
being thus ?? ????  the solute fraction released at time ? , ?  the kinetics 
constant and n the diffusion exponent, which is related to the transport 
mechanism. From the fitting of the experimental data according to the Ritger-
Peppas model, it was found n = 0.78 concerning the spontaneous release of 
Rhodamine 110 from the cubic phase, while n increases up to 1 upon 
application of the LF-AMF. Classically, values of n comprised between 0.4 
and 0.5 are due to a purely Fickian transport mechanism (case-I), while case-
II transport occurs when n = 1 and a so-called "anomalous transport" is 
observed when the two processes are coupled. It is known9 that the release 
from a bicontinuous cubic phase is expected as purely Fickian, while in our 
case a higher value of n is obtained. This effect could be possibly due to the 
very slow release observed in our system (so we are able to investigate only 
the very early stage of the release process) and to the experimental setup, 
where the bulk cubic phase is deposited on the bottom of the measurement 
well as a semispherical paste exposed to the solvent, with a limited control on 
the actual surface exposed to the external medium and, moreover, the 
extended application of a laser beam to the system could cause a local slight 
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increase in the temperature, that could affect the release process. These 
factors could lead to an anomalous behavior of the diffusion from the cubic 
phase to the aqueous environment. However, the application of the magnetic 
field changes the transport process, which follows a case-II transport kinetics, 
which can be attributed to the destabilization of the lipid membrane and to 
the formation of pores, similarly to what previously observed on 
magnetoliposomes (paragraph 3.3).24 
4.4 Release from magnetocubosomes 
To the best of our knowledge, no studies have addressed the issue of a 
triggered release of a drug from cubosomes or magnetocubosomes. In this 
work, for the first time the release of the fluorescent tag from 
magnetocubosomes, prepared as described in the previous section, is 
reported. The retention of a hydrophilic drug inside the cubosomes' aqueous 
channels and the control of its release is much more challenging with respect 
to the cubic phase, since the small size of cubosomes determines a strong 
decrease in the tortuous pathway of the encapsulated molecules to reach the 
surface and thus facilitates a lot the spontaneous release of a hydrophilic drug 
embedded in the aqueous channels. 
 
Figure 4.12 Representative FCS curves acquired for cubosomes loaded with 
magnetic oleic acid-coated Fe3O4 NPs containing both Octadecyl Rhodamine B and 
Rhodamine 110 tags, respectively in the lipid region and in the aqueous channels, 
before (a) and ten minutes after (b) the application of a LF-AMF. Curve fit carried 
out according to a 3D one component diffusion model (for Octadecyl Rhodamine B 
diffusion, 4.3 with i=1) and to a two-components 3D diffusion model (eq. 4.3 i=2), 
being the diffusion coefficients of the two components (Rhodamine 110 inside 
cubosomes and free Rhodamine 110) kept fixed at 2.4 µm2s-1 and 430 µm2s-1, 
respectively. 
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The diffusion of magnetocubosomes containing both the Octadecyl 
Rhodamine B tag embedded in the lipid structure and the hydrophilic 
Rhodamine 110 in the aqueous channels was studied through FCS 
investigation. Figure 4.12a displays representative ACFs acquired for the 
same magnetocubosomes' sample by monitoring at the same time the 
diffusion of the Octadecyl Rhodamine B lipid tag (red markers) and of the 
Rhodamine 110 (green markers). The diffusion of Octadecyl Rhodamine B is 
attributable to the solely relaxation of the molecules present inside the 
cubosomes (see Figure 4.8 and discussion) and is thus analyzed according to 
a one diffusing component 3D diffusion model (eq. 4.3, i=1, Figure 4.12 red 
continuous lines). Conversely, the diffusion of Rhodamine 110 is due to the 
combination of the contribution of the free Rhodamine in solution (with D1 = 
430 μm2s-1) and the contribution of the Rhodamine inside cubosomes. This 
latter diffusion coefficient can be assumed equal to that of the Octadecyl 
Rhodamine B inside cubosomes, determined by the translational motion of 
the entire cubosomes (D2 = 2.4 μm2s-1). A two component 3D diffusion was 
thus employed to analyze the motion of magnetocubosomes labeled with 
Rhodamine 110 (eq. 4.3 i=2, Figure 4.12 green continuous lines), keeping 
fixed the diffusion coefficient values (D1 = 430 μm2s-1, D2 = 2.4 μm2s-1) and 
obtaining, as a result, the relative percentage of each contribution (free 
Rhodamine 110 and Rhodamine 110 embedded inside cubosomes) to the 
overall autocorrelation function. Before the application of the LF-AMF to the 
cubosomes' dispersion the two-components analysis of the Rhodamine 110 
diffusion leads to an evaluation of the retained percentage of Rhodamine 110 
inside cubosomes of 17.2%. This percentage can be considered low, 
however, it has to be considered that Rhodamine 110 is a small molecule, 
compared to possible drugs, and that cubosomes were prepared 24h before 
the measurements. The measured concentration of Rhodamine 110 found free 
outside the cubosomes (82.8%) can be considered as that spontaneously 
released in a long time. Moreover, it can be expected that the size exclusion 
column employed for the elimination of the Rhodamine110 excess is not able 
to completely purify the sample from the free Rhodamine 110, especially 
taking into account the high sensitivity of the FCS technique. After ten 
minutes application of the LF-AMF (Figure 4.12b) the percentage of 
Rhodamine 110 retained inside cubosomes decreases to 7.8%, thus a 9.4% 
release of Rhodamine 110 in solution is observed as a direct consequence of 
the application of the LF-AMF. This experimental result highlights that the 
application of a LF-AMF to magnetocubosomes can be effective as a trigger 
to the release of a model hydrophilic drug from magnetocubosomes. 
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4.5 Final remark 
The last part of my research work has been focused on a new biocompatible 
multifunctional and responsive drug delivery system where glyceryl-
monooleate (GMO) cubosomes are loaded with magnetic oleic acid-coated 
Fe3O4 nanoparticles. These magnetocubosomes are able to host both 
hydrophilic and hydrophobic therapeutics in separated compartments, and to 
release the payload in a space and time controlled manner, upon application 
of a low frequency alternating magnetic field (LF-AMF). 
The encapsulation of hydrophobic magnetite nanoparticles in the lipid bilayer 
of the GMO cubic phase was characterized, proving that small nanoparticles, 
featuring a diameter of the core comparable with the lipid bilayer thickness of 
the cubic phase, are efficiently embedded in the lipid region of the cubic 
structure, without disrupting the overall symmetry of the liquid crystalline 
phase. Moreover, a stable and monodisperse cubosomes and 
magnetocubosomes by swelling the bulk cubic phase, both in the absence and 
in the presence of nanoparticles, by means of the stabilizing agent Pluronic F-
127 were obtained. 
For the first time, Fluorescence Correlation Spectroscopy (FCS) was 
employed to investigate the diffusing behavior of model hydrophilic and 
hydrophobic drugs encapsulated inside the cubic phase, proving that they are 
efficiently retained inside the cubic phase, which can thus efficiently act as a 
vector for therapeutics with different molecular characteristics and water 
affinity. Finally, for the first time FCS was employed to investigate both the 
spontaneous and the LF-AMF actuated release of a model hydrophilic drug 
from the aqueous channels of a cubic phase and of magnetocubosomes. It 
was proved that the application of the LF-AMF dramatically increases the 
release of the hydrophilic molecules from the water channels of the Fe3O4 
nanoparticles loaded cubic phase and of magnetocubosomes, acting as a 
proper external trigger to the release.  
Both components of these multifunctional devices are biocompatible. Thus, it 
is possible to believe that this novel hybrid platform, endowed with 
responsiveness to an external mild stimulus can represent an extremely 
interesting and flexible device for the targeted delivery of multiple 
therapeutic and or/diagnostic agents. 
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5 Experimental methods  
5.1 Small Angle Scattering (SAS) 
Small Angle Scattering (SAS) is a powerful technique used to study large-
scale structure from 10 Å up to several tens of thousands of angstroms. The 
SAS collects three different techniques: small angle neutron (SANS), X-ray 
(SAXS) and light (LS) scattering. Each of these is based on the elastic 
scattering of a radiation after its interaction with structures much larger than 
the wavelength of the radiation. The angle of deflection of the scattered 
radiation is low (0.1-10°), so for this reason the name small angle. The 
scattering pattern obtained supply information about the size, shape and 
orientation of some components of the sample. Therefore, with the SAS 
method the analysis of the inner structure of disordered systems with random 
arrangement of density inhomogeneities is possible. The type of the sample 
that can be investigated depends from the nature of the radiation employed. 
All three techniques are based by the same basic relations that can be used to 
analyze data, excluding some minor adjustments dependent on the radiation 
used. In the Table 5.1 the main features of these methods are shown and it is 
possible to see that each one is sensible to different aspects of the 
investigated molecules. In fact, they study different sizes of the sample. 
Table 5.1 Small angle scattering techniques. 
Radiation X-ray Neutron Light (laser) 
Wavelength 1-50 nm 10-150 nm 100-1000 nm 
Sensible to Electron density Nuclear density Refractive index 
Technique SAXS SANS LS 
Sample thick 1-2 mm 1-2 mm 1-10 mm 
 
In a SAS experiment, a collimated beam radiation strike the sample and it is 
illuminated a volume V. A part of this radiation is absorbed, another part is 
transmitted and scattered by the sample. The detector reveals the intensity of 
the radiation scattered I(q) from uniform nanoparticles constituting the 
sample. The scattering patterns are usually presented as function of the 
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scattering vector or momentum transfer (q or Q) that is the resultant 
scattering vector between the incident and scattering (final) wavevectors (Ki 
and Kf), and it is given by: 
? ? ??? ? ??? ? ?
???
? ???? (5.1) 
 
where ? is the half of the scattering angle and ? is the solution refractive 
index. The standard unit for ???is Å-1 or nm-1.  
 
Figure 5.1 Schematic representation of the scattering vector. 
In this work Dynamic Light Scattering (DLS) and Small Angle X-ray 
Scattering (SAXS) have been employed to characterize the prepared 
nanosystems.   
5.1.1 Dynamic Light Scattering (DLS) 
5.1.1.1 Basic principles 
Dynamic Light Scattering (DLS), or also known as Photon Correlation 
Spectroscopy (PCS) or Quasi-Elastic Light Scattering (QELS), is a method 
relied on the variation of the scattered intensity with scattering angle to 
measure the size distribution of sub-micron particles suspended in a fluid. 
The DLS method is based on two common characteristics of colloids, i.e., the 
Tyndall effect (scattering) and Brownian motion. The basic principle is that a 
laser beam (monochromatic and coherent light source) hits a sample and 
scattered light is probed by a detector allocated at an angle ? respect to the 
incident beam direction. 
Most of the light passes through the particle unscattered and the scattered 
light is much weaker with its phase inverted on scattering. The intensity of 
scattered light from a colloidal suspensions depends on the scattering angle  
5 – Experimental methods 
 
 141 
(?) and the observation time (t). For this reason two type of experiments are 
possible: static light scattering (SLS) in which the time averaged scattering 
intensity at various scattering angles is measured (it can produce 
thermodynamic data like molecular weight) and the dynamic light scattering 
in which the rapid fluctuations in the scattered intensity signal in the time is 
measured. These fluctuations arise from the fact that, at ambient conditions, 
colloidal particles are not stationary in the medium, rather they move in a 
random way by the Brownian motion process, so the distance between the 
scatters in the solution is constantly changed with the time. When a laser 
beam impinges on collection of particles, each particle acts as secondary 
source for the scattering of the radiation. But, since the particles move 
randomly in the space, due to the interference of scattered waves from 
particles, the net intensity fluctuates randomly in time as the relative 
positions of the particles changes.1 
 
 
Figure 5.2 Scattering geometry and intensity fluctuation at detector. 
In DLS experiment, the characteristic time of fluctuations in the scattering 
intensity is measured and it depends on the diffusion coefficient of the 
particles undergoing Brownian motions. The speed of these is influenced by 
particle size, sample viscosity and temperature. Smaller particles have more 
fast Brownian motion than larger particles and higher temperatures lead to 
more rapid Brownian motions.  
There are several approaches to describe the scattering of the particles and to 
derive dynamic information about particles’ movements in solution by 
Brownian motions. They are the rigorous solution or Mie theory and three 
theories derived from it, which are approximations of scattering from 
particles with size smaller o larger compared to wavelength of the light.2,3 
The most important are Rayleigh theory that is applicable for small particles 
5 – Experimental methods 
 
 142
whose diameters are less than 1/10th of the laser wavelength and the Mie 
theory that is an exact description of how spherical particles of all sizes and 
optical properties scatter light. The intensity of the scattering light is 
influenced by the direction of the incident light, scattering angle and 
refractive index ratio between the molecules and the medium. According to 
the Rayleigh approximation, valid for molecules of size much smaller than 
the wavelength of the light, the scattering intensity, ??, is inversely 
proportional to the fourth power of the wavelength (?) and directly 
proportional to the sixth power of the dimensions of the particles: 
 
?? ? ?
??
?? (5.2) 
  
?? ? ?? (5.3) 
  
Instead the Mie solution is applicable for particles with sizes larger and 
almost equivalent to the wavelength. This theory can be applied in the case of 
spherical, homogeneous, isotropic and non-magnetic particles in non-
absorbing medium.4 
5.1.1.2 Instrumentation 
The DLS instrumentation consists of several components. A light source 
generates a laser beam that passes through optics devices to be transmitted 
and focused on a scattering volume of the sample. The latter is contained in a 
glass cuvette immerged in a “toluene” bath in order to avoid reflexes and 
control accurately the temperature. The scattering light from a defined 
volume is collected by collecting optics and then detected at an angle θ by a 
photomultiplier or photodiodes, that convert a variation of intensity into a 
variation of voltage, transferring the signal to a PC. The attenuator, that 
reduces the intensity of the laser and the scattering light, have the purpose to 
protect the detector from a too high photon flux. A time correlation function 
of the scattering intensity is computed through an autocorrelator to extract 
useful information from the signal. The autocorrelator is a computer provided 
of special boards in order to allow a rapid real-time calculation of the 
scattered intensity time correlation function. Substantially, the output of the 
photomultiplier is then digitized by a photon counting system and the output 
sent to an autocorrelator, in which these counts are used to produce the 
autocorrelation function.5 
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Commercial “particle sizing” systems mostly operate at only one angle (90°) 
and use red light (675 nm). 
 
 
Figure 5.3 Schematic representation of DLS instrument set-up.6 
DLS measurements were carried out on a Brookhaven Instruments apparatus, 
New York, USA (BI 9000 AT correlator and BI 200 SM goniometer). The 
signal was detected by an EMI 9863B/350 photomultiplier. The light source 
was the second harmonic of a diode Nd:YAG laser (λ= 532 nm, 20 mW) 
Coherent DPY315M-100, linearly polarized in the vertical direction. It was 
also used a JDS Uniphase He-Ne laser (λ= 635 nm, 5 mW). The laser long 
term power stability was ± 0.5 %. Self-beating detection was recorded by 
using decahydronaphtalene (thermostated by a water circulating system) as 
index matching liquid. Measurements have been performed at 25°C on 0.6 
mL or 1.5 mL samples previously transferred into cylindrical Hellma 
scattering cells. The time autocorrelation functions of the intensity of the 
scattered light were measured at the scattering angle θ= 90° and analyzed 
according to the Siegert relationship (eq. 5.5). For each sample at least three 
separate measurements were performed and generally data analysis has been 
done according to standard procedure by analyzing the field autocorrelation 
functions through a cumulant analysis stopped to second order.  
5.1.1.3 Data analysis  
The autocorrelation is a signal processing technique that provides 
quantitative information regarding the time scale of the fluctuations in the 
scattered intensity. The autocorrelation function (ACF) determines in which 
extent two dynamical properties are correlated over a period of time. The 
essence of DLS method lies in analyzing the ACF to obtain the particle size 
information. The variable in the ACF can be considered either the electric 
field or the light intensity. In the latter case the ACF is called the scattered 
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intensity time autocorrelation function and it is a second-order 
autocorrelation function indicated as G(2)(τ)? ? ? ?  is the correspondent 
normalized intensity autocorrelation function, as it is shown follow: 
 
? ? ? ? ? ? ??? ? ?????? ?  (5.4) 
 
The upper equation represents the normalized ACF of the scattered intensity 
obtained from the scattered intensity of the signal at an arbitrary time as ? ?  
and those after a delay time ? as ??? ? ??. At short time delays (when ? tends 
to 0) the signal is perfectly correlated and so the correlation function is high, 
when instead ? tends to infinity it is perfectly uncorrelated and the ACF 
decays exponentially to zero, there is no correlation between the scattered 
intensity of the initial and final states. 
The eq. 5.5 relates the two autocorrelation functions (intensity ACF and 
electric field ACF) and is rarely violated. The validity of this relation rests on 
the assumption that e.g. the scattered electric field of the particles undergoes 
Brownian motions. It is called Siegert relation: 
 
???? ? ? ? ? ? ? ? ? ? ?  (5.5) 
 
where ? is the delay time, ? is the baseline as determined by the infinite 
(calculated) delay-time point, ? is a constant less or equal to one determined 
by the specific experimental setup (like the temporal and spatial coherence 
properties of the laser beam and the detector optics) and ? ? ?  is the 
normalized first-order or scattered electric field time autocorrelation 
function. For a dilute solutions of monodisperse and spherical molecules 
undergoing Brownian diffusion, the normalized electric field ACF can be 
described by a simple exponential decay, as showed follow:  
 
???? ? ? ???? (5.6) 
 
where ? is the decay constant or relaxation rate and for dilute systems where 
the decay is entirely due to translational and diffusive motion of the center of 
mass of the scatterer, it can be shown that: 
 
? ? ???? (5.7) 
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where ?? ? is the translational self-diffusion coefficient of the particles and ? 
is the magnitude of the scattering wave vector (eq. 5.1). The diffusion 
coefficient is the variable measured by DLS instrument and it provides the 
value of the hydrodynamic radius ?? of isotropic and spherical particles in 
dilute solutions by using the Stokes-Einstein relationship: 
 
?? ? ?
???
????? (5.8) 
 
where ?? is the Boltzmann’s constant, ? is the bulk viscosity of the liquid in 
which the particle moves and ? is the absolute temperature. The dependence 
of the diffusion coefficient (??) on the concentration (?) of the particles can 
be expressed by follow equation: 
 
?? ? ?? ? ? ???  (5.9) 
 
where ??  is a virial coefficient, which regards the particles-particles 
interactions and the multiple interactions. However, for very dilute samples, 
?? tends to ?? that is given by the Stokes-Einstein relation. The ?? values 
determined by DLS measurements are larger than those obtained by using 
direct imaging methods (like SEM or TEM). The reason is that when the 
particles undergo Brownian motion a layer of medium, which is part of 
electrical double layer, moves with them resulting in a larger diameter 
determined by DLS.7 
In many real systems the nanoparticles dispersions are often polydisperse that 
is there exists a distribution of particle sizes and scattering, which leads to 
deviation from expected single exponential decay of correlation function. In 
fact, these particles have different translational self-diffusion coefficients. In 
this case for a dilute solution, ???? ?? ?  is given by a sum of the single 
exponential decays corresponding to each of the particles with a specific 
diffusion coefficient (denoted by i) and so characterized by a different decay 
constant, so that 
 
???? ?? ? ? ? ?? ??? ???
?
? ? ? ???
?
?
??? ?? (5.10) 
 
where i represents a population of particles?? ?? ?with the same characteristic 
decay constant, ??, and ? is the scattering vector.  
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There are different algorithms that are able to extract the decay constant and 
so the particle size (see eq. 5.7 and 5.8) information from the measured data 
in polydisperse samples. One of the most common methods to fit the ACF is 
the method of cumulants.8 It consists in to calculate the mean and the 
variance of the distribution, without considering the higher moments and is 
applicable only for narrow monomodal distribution. In this case in addition to 
the sum of the exponentials more information can be derived about the 
polydispersity of the system as follow: 
 
? ? ?? ? ? ??? ??? ? ? ???? ?
? ? ???? ?
? ??  (5.11) 
 
where 
??
?? ?
? is the second order polydispersity index. 
Finally, one can also obtain the full distribution by performing an inversion 
of the Laplace Integral equation. Some of the commonly used methods, under 
this category, are Non-Negatively constrained Least-Squares (NNLS), 
exponential sampling and CONTIN,6 according to the specific case. CONTIN 
analysis is the most widely applied Laplace Integral transform algorithm, 
developed by Provencher, and it is ideal for polydisperse and multimodal 
systems.  
5.1.2 Small Angle X-Ray Scattering (SAXS) 
5.1.2.1 Basic principles 
The SAXS is a X-ray technique in which the elastic scattered radiation by the 
sample is revealed at low angles (generally 0.1-10°). In this angular range 
this method provides information on the structural features of the materials 
such as shape, size, mass and intermolecular spacing, on a scale from 1 to 
100 nm. The analyzed materials can be solid or liquid and include all types of 
colloids, metals, cements, oils, polymers, proteins etc. In particular, SAXS is 
one of the most powerful techniques for the determination of the liquid 
crystal phase. This method is accurate, non destructive and requires only a 
minimum preparation of the sample. 
X-rays are scattered by the electrons, for this reason the Small Angle X-ray 
Scattering method observes the elastic (or coherent) scatterings of X-rays 
produced by samples with inhomogeneities in the electron densities. When a 
monochromatic beam of X-rays hits the sample electrons start to oscillate 
with same frequency and amplitude as the original beam and produce 
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secondary waves with the same wavelength of the X-ray beam but 180° out 
of phase. So, the electron scatters the radiation and the measured scattering at 
the angle of 2θ is proportional to (1+2cos22θ) and reaches a maximum when 
2θ is equal to zero. It decreases at large angles. Periodical electron density 
fluctuations in the sample may give rise to constructive interferences between 
the scattered X-rays intensity giving a diffraction pattern collected by a 
detector situated behind the sample perpendicular to the direction of the 
primary beam. Likewise the others SAS techniques, the relevant parameter to 
analyze the interaction is the momentum transfer or scattering vector, which 
was discussed in the section 5.1 (see eq. 5.1). The scattering pattern contains 
the information on the structure of the sample. The major problem that must 
be overcome in SAXS instrumentation is the separation of the weak scattered 
intensity from the strong main beam. The smaller the angle desired, the more 
difficult this becomes. In substance, the non-scattered beam that merely 
travels through the sample must be blocked without blocking the closely 
adjacent scattered radiation. Most available X-say sources produce divergent 
beams and this complicates the problem. For this reason in most laboratories 
small angle devices rely on collimated beams. 
The difference between the incident and the scattered waves is the phase 
difference (φ), which is given by the scattering vector multiplied by 2π. It is 
also related to the distance between the scatterers (Δ) by the relation of φ = q 
Δ.9 If the scattering object has an ordered structure, constructive interference 
of the out-coming X-rays may occur, giving rise to peaks in the scattering 
profile as described by Bragg’s Law (eq. 5. 12); the wavevector ? is related 
to the lattice spacing ? by the eq. 5.13: 
 
?? ? ?? ??? ? (5.12) 
  
? ? ???  (5.13) 
 
where ??is an integer, ? is a wavelength of the incoming X-rays and ??is the 
angle between the incoming X-rays and the scattering planes. 
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Figure 5.4 Bragg’s description diffraction. 
The limit of the resolution which is the minimum distance at which two 
objects can be detected is defined by one the properties of the X-rays: 
dmin=λ/2.10 Each point generates a secondary wave with amplitude defined by 
the term ????and the sum of amplitudes derived by N number of electrons is 
described by the Fourier distribution (eq. 5.14): 
 
???? ??
?
???
???? (5.14) 
 
where ??  is the scattering amplitude (or scattering factor). However, 
considering the huge number of electrons, it is more convenient to consider 
the electron density, which is defined as the number of electrons per unit 
volume and it is indicated by ????.11 Therefore, for a small volume ??, at a 
position r, there will be ??????? electrons. The summation can be replaced 
by the integration of the volume V irradiated by the incident beam (eq. 5.15), 
so the amplitude ?? is: 
 
?? ? ?? ? ???????? (5.15) 
In SAXS experiments, the measured intensity of the radiation, I(q), scattered 
by a collection of uniform particles is given by:12 
 
? ? ? ? ? ? ? ? ? ? ? ? ? ???? (5.16) 
 
where ??is the amplitude accounting for the instrumental factor, ? is the 
particle volume fraction, ? ?  is the particles form factor (intra-particle 
structure factor), ? ?  is the inter-particle structural factor accounting for the 
interparticle correlations and ???? is the incoherent background. 
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Table 5.2 Peak spacing ratio (Bragg peaks) and corresponding Miller indices for lamellar (Lα), 
hexagonal (H2), Gyroid cubic (Ia3d), Diamond cubic (Pn3m) and Primitive cubic (Im3m).13,14,15  
Liquid 
crystal 
phase 
Symmetry 
(dimensionality) 
Peaks 
Spacing 
ratio 
Miller 
Indices 
(h, k , l) 
Lattice parameter 
Lamellar 
Smetic 
(1D) 
?? 110 
???? ?
??
? ?
? ? 220 
? 300 
Hexagonal 2(D) 
?? 100 
???? ?
??
?
?
? ?
? ? ?? ? ??  
? 110 
? 200 
? 210 
? 300 
Cubic 
Gyroid 
Ia3d 
(3D) 
? 221 
???? ?
??
? ?
? ? ?? ? ??  
? 220 
Diamond 
Pn3m 
(3D) 
? 110 
? 111 
? 200 
? 211 
? 220 
? 221 
?? 300 
Primitive 
Im3m 
(3D) 
? 110 
? 200 
? 211 
? 220 
? 221 
 
The “contrast term” is the difference of scattering length density (SLD) 
values between the part of the sample and the surrounding medium, and in 
SAXS it arises out of the differences in electron density. The form factor, 
? ? , is a function that describes how the scattering vector, q, is modulated 
by interference effects between radiation scattered by different parts of the 
same scattering body; consequently it is very dependent on the shape of the 
scatterer. Several analytic expressions exist for most common shapes and 
expressions for more complexes topologies can usually be deduced from 
these. The inter-particles structure factor,?? ? , is a function that describes 
how q is modulated by interference effects between radiation scattered by 
different scattering bodies; consequently it depend on the degree of local 
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order in the sample and on the sample concentration. Generally, for diluted 
system, ? ?  can be discarded and considered equal to 1. 
Peaks can arise also from non crystalline structure, such as microemulsion 
and micellar systems, but in this case, broad peaks are commonly observed. 
The SAXS technique is the most recognized method to study the structural 
features of the lyotropic liquid-crystalline mesophase, both in their bulk or 
dispersed form. In the diffraction pattern, the small angle region identifies the 
symmetry and long range organization of the phase, whereas the wide angle 
region gives information on the molecular packing. The position of the peaks 
of the plot I(q) vs q, can be used to characterize the structure in terms of 
space groups and the unit cell dimensions of the single liquid crystal phases. 
The space groups are obtained by comparing the Bragg peaks and the Miller 
indices (h, k, l) for different phases. Usually, three or more peaks are 
necessary for an unequivocal identification. The relationship between the 
Bragg peaks and the Miller indices is summarized in Table 5.2. 
5.1.2.2 Instrumentation 
The basic components of the SAXS instrument are shown in Fig. 5.5. It 
consists of a source, a collimation system, the beam stop and the detector. 
The source can be an X-ray tube or tube with rotating anode, but 
synchrotrons can also be used. The advantage of synchrotrons is the 
production of highly collimated, low divergent and focused X-ray beam. The 
collimation system is required to reduce the divergence of the incoming beam 
before hitting the sample. The collimation system constitutes of a series of 
slits or pinholes, which reduce the intensity of the beam and produce a 
parasitic scattering.11 The beam stop prevents the beam to hit the detector.16 
 
Figure 5.5 Schematic representation of the components of a SAXS instrument.9 
SAXS measurements were carried out on a S3-MICRO SAXS/WAXS 
instrument (HECUS X-ray Systems GmbH, Graz, Austria) which consists of 
a GeniX microfocus X-ray sealed CuKα source (Xenocs, Grenoble, France) 
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power 50 W which provides a detector focused X-ray beam with λ = 0.1542 
nm CuKα line. The instrument is equipped with two one-dimensional (1D) 
position sensitive detectors (HECUS 1D-PSD-50 M system), each detector is 
50 mm long (spatial resolution 54 μm/channel, 1024 channels) and cover the 
SAXS Q-range (0.003 < Q < 0.6 Å−1) and the WAXS Q-range (1.2 < Q < 1.9 
Å−1). 
SAXS measurements of the liposomes, magnetoliposomes and magnetic 
nanoparticles were carried out instead with a HECUS SWAX-camera 
(Kratky) equipped with a position sensitive detector (OED 50 M) containing 
1024 channels of width 54 μm. X-ray generator (Seifert ID-3003), operating 
at a maximum power of 2 kW, provides CuKα radiation of wavelength 1.524 
Å. A 10 μm thick nickel filter was used to remove the CuKβ radiation.  
The temperature was controlled by means of a Peltier TCCS-3 Hecus. SAXS 
spectra were recorded at 25°C with an accuracy of ± 0.1°C, with an 
acquisition time of 2 hours. The volume between the sample and the detector 
was kept under vacuum (P < 1 mBar) during measurements to minimize 
scattering from air. The liquid samples (magnetic nanoparticles, liposomes’ 
and cubosomes’ dispersions) were filled into 1 mm glass capillary an then 
sealed. While, the paste (cubic phase) was loaded in a solid sample-holder 
constituted by two windows of kapton® which absorbs at 4e-1 Å (or 700 
number of channel). All scattering curves were corrected for the solvent 
contribution (ultrapure water) in the liquid-sample case. Instead, in the solid-
sample study the correction has been done for the kapton® contribution of 
the sample-holder. The liquid crystalline phases were identified by using the 
software 3D-View (Hecus, Graz). 
5.2  Zeta Potential  
Zeta Potential (usually denoted as ζ-potential) is the electric potential in the 
interfacial double layer that is located at the slipping plane relative to a point 
away from the interface in the bulk fluid. In other words, the zeta potential is 
the potential difference between the dispersion medium and the stationary 
layer of fluid attached to the dispersed particles which moves together to 
them. Thus the zeta potential is not equal to the Stern potential or electric 
surface potential in the double layer, because these are defined at different 
locations. Nevertheless, ζ-potential is often the only available path for the 
double-layer properties determination. The zeta potential value is not 
measurable directly and so several techniques exist, for measuring this 
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quantity, based on one of the three electrokinetic effects: electrophoresis, 
electroosmosis and streaming potential.17 In the electrophoresis method the 
zeta potential is determined from the experimentally-determined 
electrophoretic mobility. Substantially, an electric field is applied across the 
dispersion and the particles within the dispersion will migrate toward the 
electrode of opposite charge with a velocity proportional to the magnitude of 
their charge (their zeta potential).18 The particles mobility is measured as the 
frequency or phase shift of an incident laser beam caused by the moving 
particles . This mobility (μ) is converted to the zeta potential at which is 
related by the Smoluchowski equation (eq. 5.17): 
 
? ? ??????
?
??? ? ? ??  (5.17) 
 
where ?? and??? ?are the electrical permittivity of a vacuum and the relative 
dielectric constant respectively, ? is the solution viscosity, ??is the particle 
radius and ? is the Debye-Hükel parameter defined by the equation 5.18: 
 
? ? ????
???
???????
? ?
 (5.18) 
 
where ?? is the bulk ionic concentration, ? is the valence of the ion,?? is the 
charge of an electron, ?? is the Boltzmann constant and ? is the absolute 
temperature. Smoluchowski’s theory is powerful because it is valid for 
dispersed particles of any shape and any concentration. However it has a 
limitation: this theory is valid only for a sufficiently thin double layer. 
The instrument that measures zeta potential is based on one of the two 
different experimental techniques: microelectrophoresis and electrophoresis 
light scattering. The latter is based on dynamic light scattering method. This 
kind of measuring technique may require dilution of the sample, but 
sometimes this dilution might affect properties of the sample and change the 
zeta potential. 
Thus, this method makes it possible determine the surface charge of 
submicron structures in solution and it provides indication on the stability of 
colloidal dispersions. Usually, the absolute value of the zeta potential is 
correlated to the colloid’s stability with respect to the flocculation and 
aggregation.  
5 – Experimental methods 
 
 153 
The zeta potential magnitude in fact indicates the degree of electrostatic 
repulsion between adjacent similarly charged particles in a dispersion. For 
small particles a high value of zeta potential (negative or positive) will confer 
stability and so the dispersion will resist to aggregation and flocculation and 
it will be electrically stabilized. Instead, lower values of zeta potential 
indicate attractive forces that exceed the repulsion and the nanoparticles of 
the dispersion will tend to aggregation and precipitation. Generally a zeta 
potential value in the range between ± 30 and ± 60 is correlated to a good 
colloidal stability. 
For the inorganic nanoparticles the surface charge is a very fundamental 
parameter because a negative charge surface makes nanoparticles more 
biocompatible, while a positive charge increase the interaction between them 
and cell but is more toxic too. 
 
Zeta potential measurements were taken using a zeta potential analyzer (Zeta 
Plus system, Brookhaven Instruments Corporation, Holtsville, NY). A laser 
beam (35 mW solid state laser, λ= 635 nm) passes through the sample placed 
in a cell containing two electrodes to provide an electric field. 
Zeta potential values were obtained from the electrophoretic mobility ?, 
according to Helmholtz–Smoluchowski equation (eq. 5.19), also represented 
as: 
 
? ? ??? ? ? (5.19) 
 
with ? being the viscosity of the medium and ? the dielectric permittivity of 
the dispersing medium. The measurements were performed at 25 °C on 1.6 
mL of sample. The zeta potential values are reported as averages from 5 
measurements on each sample. 
5.3 Microscopy 
Microscopy is the technical field of using microscopes to view samples or 
objects that cannot be seen with the unaided eye (objects that are not within 
the resolution range of the normal eye). There are three well-known branches 
of microscopy: optical, electron, and scanning probe microscopy. Optical and 
electron microscopy involve the diffraction, reflection, or refraction of 
electromagnetic radiation/electron beams interacting with the subject of 
study, and the subsequent collection of this scattered radiation in order to 
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build up an image. This process may be carried out by wide-field irradiation 
of the sample (for example standard light microscopy and transmission 
electron microscopy) or by scanning of a fine beam over the sample (for 
example confocal laser scanning microscopy and scanning electron 
microscopy). 
5.3.1 Atomic Force Microscopy (AFM) 
5.3.1.1 Basic principles 
The Atomic Force Microscopy (AFM) is one of the Scanning Probe 
Microscopy (SPM) techniques. The SPMs are a class of instrumentations 
based on short range interactions from which is possible to have a surface's 
microscopy. To obtain the images are not used lenses but sensors that consist 
of sharp tips intimately interacting with the surface of the sample. The 
sequential manner to achieve the image is similar for the whole this family of 
microscopes, the main differences are the nature of the probe and the 
corresponding interaction with the sample (electromagnetic field, the 
tunneling current, van der Waals force, etc.). The resolution depends on the 
type of interaction, the shape and size of the probe and the specific structure 
of the sample, but it is free by the diffraction limits. The AFM is currently the 
most popular technique among them. 
It allows to perform non-destructive analysis of surfaces, with a resolution 
lower than a nanometer. The main AFM application is the determination of 
high-resolution images of different materials such as metals, polymers and 
biomolecules. For ultra-flat and stiff surfaces the technique is able to obtain 
images with atomic resolution. Moreover, through the existence of different 
experimental variants, several structural properties of the sample’s surface 
such as composition, friction, elasticity, electrical and magnetic features can 
be analyzed.  
The atomic force microscope consists of a flexible arm (called cantilever) to 
the end of which is located a sharp tip, generally composed of silicon oxide 
or nitride and with a radius typically between 4 and 60 nm.19,20 The tip, which 
constitutes the physical probe that scans the sample along the x and y 
directions, is placed in close proximity to the sample surface. It must be very 
sharp to allow a high lateral resolution. On the other hand, the cantilever 
must have an appropriate resonant frequency and flexibility for the selected 
operative mode. When the tip is located at interatomic distances from the 
surface, it compresses the electron clouds of the atoms of the sample 
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producing a repulsive force which varies with the profile of the surface. This 
force between the tip and the sample causes a deflection of the cantilever. 
The recordable cantilever’s deflection is in the order of fractions of the 
nanometer and it is due to forces of the order of nanonewtons. Generally, an 
optical system is used to record and amplify these displacements: a laser 
beam hits the top of the cantilever and the reflected beam reaches a 
photodiode array detector which produces an output signal depending on the 
position of the reflected beam on its surface. This makes it possible to detect 
vertical and torsion displacements of the probe. 
A feedback system (feedback circuit) based on the signal coming from the 
photodiode regulates the sample surface-tip distance according to the selected 
acquisition mode so as to avoid that the tip can collide with the surface 
damaging it. All the sample movements are realized through a piezoelectric 
guide which ensures high accuracy (typically lower than a nanometer) along 
the three axes. Furthermore, the variations of the applied voltage to this 
piezoelectric guide are also electronically translated in a topographic image 
of the surface. Generally, the sample is placed on a piezoelectric tube which 
can move it in a perpendicular direction (z direction) in order to maintain a 
specific tip-surface distance and in the plane (x and y direction) to analyze 
the surface. The resulting map represents the topography of the sample 
surface. 
Regarding the resolution, there is no currently an accepted general definition 
but it is clear that the tip plays an important role with its shape and its 
dimensions, so the analyzed surface is deformed by the pressure of the tip 
and the resolution can be consequently affected. In reality, it must be also 
evaluate that, according to the tip-surface distance, the interacting forces may 
also be attractive, therefore the overall interaction tip-surface can be 
described by the Lennard-Jones potential: 
 
? ? ???? ?
?
??
 (5.20) 
 
where A and B are the constants which depend by the constituting materials 
of the tip and sample surface while r is the distance between them. The first 
term represents the short range repulsive forces due to the interaction 
between the electrons of the tip and the surface. The second term represents 
the attractive component generated by the interaction between the dipoles of 
the tip and the sample. 
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5.3.1.2 Operating modes 
Over the years, several operating methods have been developed for the 
atomic force microscopy. The main operative modes are: contact mode, non-
contact mode and dynamic mode whose main technique is the tapping 
mode.21  
 
Contact mode 
This is the simplest operative method in AFM, in which the tip is always in 
physical contact with the sample surface. So, it is possible obtain 
topographical images of the surface through the deflection of the cantilever. 
The contact mode can be used in the scanning of hard and stable samples that 
do not suffer the friction forces due to the constant contact between tip and 
surface. The applied forces are usually in the order of nN. The repulsive 
forces of Van der Waals are responsible of the deflection of the lever. It is 
required a small elastic constant of the lever in order to avoid an excessive 
pressure on the sample. In general, besides to the topographic image, the 
processor generates an image related to the tip-surface friction, through the 
deflection of the cantilever, dependent on topography and composition. The 
image of friction allows to distinguish chemically different regions on the 
same surface. Moreover, this method allows another kind of determination. 
In fact, the direct contact tip-surface leads to lateral torsions of the cantilever 
in the xy plane. These torsions depend once again from the properties of 
friction of the surface and may be monitored by the photodiode. The variant 
of the contact mode in which these torsions are determined is called Lateral 
Force Mode (LFM). If the tip is chemically modified with a hydrophobic or 
hydrophilic functional group, this approach allows to determine hydrophobic 
and hydrophilic areas of the surface. It is not always necessary to change the 
tip to obtain information on the composition of the surface.  
 
Non-contact mode 
The effects of lateral forces and the strong interactions that cause damage to 
soft samples can be reduced by keeping the tip distant few nanometers from 
the sample surface. The tip vibrates close to its natural resonance frequency 
and it is preferable a high elastic constant. In these conditions, the attractive 
forces of Van der Waals are involved and as they are weakly dependent on 
the distance, do not allow a high lateral resolution (10 nm). The variations in 
the oscillation frequency are used to reconstruct the image. 
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Tapping mode 
This method allows an improvement of the resolution because a sweeter 
interaction between tip and sample surface is involved. The lever oscillates at 
its resonance frequency or close, so that the tip has only a transient contact 
with the surface. Thus, no lateral forces of friction which may damage the 
sample, alter the data, or to slow down the tip are exercised on the sample. 
The force applied by the tip can be absorbed by the majority of the samples 
without damage. However, a high elastic constant is required, so that the 
lever has the necessary potential energy to retract itself from the sample after 
touching the surface. When the tip touches the surface, it loses energy and the 
oscillation amplitude decreases: a piezoelectric guide then moves the sample 
along the z axis maintaining a constant oscillation amplitude of the 
cantilever. The "phase imaging" is an extension of the "tapping" which 
provides information on the nanoscaled surface’s structure. By tracing the 
map of the oscillation phase of the lever during the scan, besides the surface 
topography also other characteristics such as viscosity, elasticity and changes 
in chemical composition can be revealed. The "phase imaging" can be carried 
out simultaneously with the "tapping mode". It has been highlighted that in 
the sample surface-tip interaction a large number of forces are involved 
simultaneously. But the capillarity and atomic repulsive forces are dominant 
for the operating mode in the air, both in contact and tapping mode. In fact, 
there is always a thin layer of water on the surface of the sample, which 
generates an attractive capillary force of a few hundred of nN. A humidity 
control can reduce this force to 10 nN. In contact mode the capillary force 
fixes the tip to the surface perturbing the net interaction tip-surface. Instead, 
in tapping mode this undesired contribution determines the lower limit to the 
required oscillation amplitude to prevent blocking of the tip.22 
 
The AFM provides a broad spectrum of values for the resolution and 
different operative modes to obtain the image. For low resolution (on large 
areas) it can be used as a supplementary technique to the optical microscopy 
with the advantages of a better vertical resolution and a more simple 
preparation of the samples. The mechanical parameters of a lever (elastic 
constant, resonance frequency and its physical dimensions) play an important 
role in determining the sensitivity and resolution of the technique. The 
optimal value of elastic constant depends on the operative mode (contact or 
non-contact) and the physical characteristics of the tested sample.23 
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5.3.1.3 Instrumentation 
AFM images were collected using a Park XE-100 microscope (Park Systems) 
operating in non-contact mode. The probes used were Park NCHR probes, 
nominal resonant frequency 300 kHz, radius of curvature about 5 nm.  
 
Figure 5.6 Schematic representation of the AFM instrumentation. 
The instrumentation is placed on an anti-vibration table in order to avoid that 
even slight vibrations may affect the acquisition. When the tip is suspended 
in air, the laser will hit the center of the quadrant photodetector. If the tip 
encounters a feature on the surface, the tip deflects and the laser will move on 
the quadrant photodetector. This is relayed to a motor controlling the tip 
which adjusts the tip’s vertical position until the laser is aimed in the center 
of the quadrant photodetector once again. Effectively, this keeps the tip at a 
constant distance from the sample surface. By recording the position of the 
motor height, it possible to know the topography of the sample surface. In 
this set-up the tip works according to the “non contact” mode and so rather 
than relying on physical contact with the surface, the cantilever/tip is 
oscillated at a given frequency above the sample surface, and interactive 
forces from the surface lead to changes in the amplitude/phase of this 
oscillation.  
5.3.2 Scanning Electron Microscopy (SEM) 
5.3.2.1 Basic principles 
Scanning Electron Microscopy (SEM) is a method for high resolution 
imaging of surfaces. The SEM focuses an electron beam over a surface to 
create an image, much as a light microscope uses visible light. The electrons 
in the beam interact with the sample, producing various signals that can be 
used to obtain information about the surface topography and composition. 
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The advantages of SEM over light microscopy include much higher 
magnification (>100,000 X) and greater depth of field up to 100 times that of 
light microscopy. The resolving power of the microscope is not only limited 
by the number and quality of the lenses but also by the wavelength of the 
light used for illumination. The electron microscope was developed when the 
wavelength became the limiting factor in light microscope. In fact, electrons 
have much shorter wavelengths, enabling better resolution.  
The SEM produces magnified images by scanning the sample with a high-
energy beam of electrons. When the electron beam hits the surface of the 
sample, it penetrates the sample to the depth of a few microns, depending on 
the accelerating voltage and the density of the sample. The interaction of the 
electron beam with the surface or bulk of a sample produces a wide variety of 
signals: secondary electrons (SE), backscattered electrons (BE), characteristic 
X-rays and Auger electrons (AE), which can provide a signature of the 
sample, specially information on its structure and chemical composition. In 
particular, secondary electrons provide information on the surface 
topography producing a high-resolution imaging of the surface. They are 
emitted lower-energy electrons, from the near sample’s surface, resulting 
from the inelastic electron scattering caused by the interaction between the 
sample’s electrons and the incident electrons. The topography of surface 
features influences the number of electrons that reach the secondary electron 
detector from any point on the scanned surface. This local variation in 
electron intensity creates the image contrast that reveals the surface 
morphology. The energy of SEs is typically 50eV or less. The backscattered 
electrons are high-energy electrons that are produced by the elastic collision 
of incident electron typically with a sample atom’s nucleus. The energy of 
BE will be comparable to that of the incident electrons. These high-energy 
electrons can escape from much deeper than secondary electrons, so surface 
topography is not as accurately resolved as for secondary electron imaging. 
The backscattering electron yield depends on the average atomic number (Z) 
of the atoms present in the sample, which results in image contrast as a 
function of composition, i.e., higher atomic number appears brighter than low 
atomic number material in a backscattered electron image.  
Regarding X-rays, they are produced by the interaction of the incident 
primary electrons with the inner-shell electrons of the atoms present in the 
sample. Characteristic X-rays are emitted by the de-energization of the 
specimen atom after a secondary electron is produced. The incident electrons 
eject electrons from one of the inner shell (usually K-shell) during the 
secondary electron process and create a vacancy. Electrons from higher 
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energy shells drop into the lower energy shell, filling the vacancy and 
emitting energy, usually X-rays. The energy of the X-rays is unique and 
characteristic of the element with which the primary electron is interacting; 
this allows elemental identification. Emitted X-rays can be used to obtain 
both qualitative and quantitative chemical information about the atoms 
present in the sample. Finally, Auger electrons are produced also by the de-
energization of the specimen atom after a secondary electron is produced. 
The vacancy in the inner shell (usually K-shell), generated by the incident 
electrons, is once again filled by an electron from the outer higher shell. The 
energy difference is transferred to a third outer electron, which is an Auger 
electron. These electrons are emitted from an atom with a characteristic 
energy, which is unique to each element, and which provides chemical 
compositional information about the sample. 
The electron-sample interaction volume is a function of the electron-beam 
energy and the atomic number of the sample (Z). Most of the primary 
incident electrons penetrate deeply into a low-Z specimen and are absorbed. 
For high-Z materials, a significant scattering occurs near the surface and, 
hence, a large fraction of incident primary electrons is backscattered. 
Moreover, elemental analysis (qualitative and quantitative) can be performed 
on any feature observed with an integrated Energy Dispersive X-ray 
Spectroscopy (EDS or EDX) detector. EDS is a technique based on the 
collection and energy dispersion of X-rays created when high-energy 
electrons bombard a sample. The X-rays have energies that are characteristic 
of the elements in the sample. The instrument’s electronics process the 
signals to give histograms of energy vs signal strength, the latter being 
related to relative concentration. EDS analysis can also provide elemental 
maps of the sample that can be compared to the electron micrographs and it is 
able to detect all elements except for H, He, Li, and Be in areas as small as 
one micrometer in diameter.24,25 
With a SEM it is possible to obtain microscopic feature measurements, 
fracture characterization, microstructure studies, thin coating evaluation and 
surface contamination examination and other possible applications. 
Backscattered electron imaging can be performed on conductive or 
nonconductive samples. For secondary electron imaging, samples must be 
electrically conductive. Non-conductive materials can be coated by 
depositing through evaporation a thin film of carbon, gold or other 
conductive material to obtain conductivity without significantly affecting 
observed surface morphology.  
5 – Experimental methods 
 
 161 
5.3.2.2 Instrumentation 
The SEM generates a beam of incident electrons in a top of an electron 
column above the sample chamber. The electrons can be produced in three 
commonly types of electron sources: tungsten filament source that consists of 
an inverted V-shaped wire of tungsten, about 100 mm long, which is heated 
resistively to produce electrons. This is the most basic type of electron 
source. Lanthanum hexaboride (LaB6) or Cerium hexaboride (CeB6) are 
instead thermionic emission gun. It is the most common high-brightness 
source. This solid state crystal source offers about 5-10 times the brightness 
and a much longer lifetime than tungsten. Field emission gun (FEG) is 
another type of electron source that consists in a wire of tungsten with a very 
sharp tip, less than 100 nm. It uses field electron emission to produce the 
electron beam. The small tip radius improves emission and focusing ability. 
The energy of the incident electrons can be as low as 100 eV or as high as 30 
keV depending on the evaluation objectives. The beam then follows a vertical 
path in the column where the electromagnetic lenses steer the beam to a fine 
focused spot onto the sample's surface, which is located on a movable stage. 
Scanning coils near the end of the column are used to deflect the beam in the 
x and y axes so that it scans in a raster fashion over the surface of the sample. 
The beam can also be focused at a single point or scanned along a line for X-
ray analysis and it can be focused to a final probe diameter as small as about 
10 Å. So, the emitted electrons are detected for each position in the scanned 
area by an electron detector. The intensity of the emitted electron signal is 
displayed as brightness on a cathode ray tube (CRT). By synchronizing the 
CRT scan to that of the scan of the incident electron beam, the CRT display 
represents the morphology of the sample surface area scanned by the beam. 
Magnification of the CRT image is the ratio of the image display size to the 
sample area scanned by the electron beam. Two electron detector types are 
predominantly used for SEM imaging. Scintillator type detectors (Everhart-
Thornley) are used for secondary electron imaging. This detector is charged 
with a positive voltage to attract electrons to the detector for improved signal 
to noise ratio. Detectors for backscattered electrons can be scintillator types 
or a solid-state detector. 
The SEM column and sample chamber are at a moderate vacuum to allow the 
electrons to travel freely from the electron beam source to the sample and 
then to the detectors. Samples must be compatible with at least a moderate 
vacuum. For high-resolution secondary electron imaging, the sample 
environment is at a pressure of 1?10-5 to 10-7 Torr. Imaging of nonconductive, 
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volatile, and vacuum-sensitive samples can be performed at higher pressures 
(2 Torr). 
 
SEM experiments were carried out with a Field Emission Gun (FEG)-SEM, 
mod. ΣIGMA by Carl Zeiss, working at different acceleration potentials 
(generally, values are reported in the images). Images were acquired by 
collecting Secondary Electrons (SE) with a conventional SE detector (when 
working at high accelerating potentials) or with an In-Lens detector (when 
working at lower potentials). X-ray fluorescence profiles were acquired 
through an Oxford EDX system. 
5.3.3 Transmission Electron Microscopy (TEM) 
5.3.3.1 Basic principles 
Transmission Electron Microscopy (TEM) provides highly magnified images 
and with a high resolution, like SEM. Both are techniques that refer to 
electron microscopy and so also TEM uses electron beams to illuminate the 
specimen and thus creates an image. However, SEM and TEM also share 
some differences. The method used in SEM is based on scattered electrons 
while TEM is based on transmitted electrons. The scattered electrons in SEM 
are classified as backscattered or secondary electrons. Nevertheless, there is 
no other classification of electrons in TEM. In TEM, electrons are directly 
pointed toward the sample. The electrons that pass through the sample are the 
parts that are illuminated in the image. The focus of analysis is also different. 
SEM focuses on the sample’s surface and its composition. On the other hand, 
TEM seeks to see what is inside or beyond the surface. SEM also shows the 
sample bit by bit while TEM shows the sample as a whole. SEM also 
provides a three-dimensional image while TEM delivers a two-dimensional 
picture. In terms of magnification and resolution, TEM has an advantage 
compared to SEM. TEM has up to 50 million magnification level while SEM 
only offers 2 million as a maximum level of magnification. The resolution is 
0.5 Å while SEM has 4 Å nm. However, SEM images have a better depth of 
field compared to TEM produced images. Another point of differences is the 
sample thickness, “staining” and preparation. In SEM, the sample is prepared 
on specialized aluminum stubs and placed on the bottom of the chamber of 
the instrument. The image of the sample, then is projected onto the CRT. On 
the other hand, TEM requires the sample to be prepared in a TEM grid and 
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placed in the middle of the specialized chamber of the microscope. 
Moreover, the image is produced by the microscope via fluorescent screens. 
TEMs provide topographical, morphological, compositional and crystalline 
information, allowing to view samples on a molecular level, making it 
possible to analyze structure and texture. 
A source at the top of the microscope emits the electrons that travel through 
vacuum in the column of the microscope. Electromagnetic lenses focus the 
electrons into a very thin beam. The electron beam then travels through the 
sample. Depending on the density of the material present, some of the 
electrons are scattered and disappear from the beam. At the bottom of the 
microscope the unscattered electrons hit a fluorescent screen, which gives 
rise to a "shadow image" of the specimen with its different parts displayed in 
varied darkness according to their density. The image can be studied directly 
by the operator or photographed with a camera.26,27 
5.3.3.2 Instrumentation 
The main components of a TEM are: an electron source, electromagnetic 
lenses, sample stage and an imaging system. The electron source is an 
electron gun which consists of a tungsten filament. This filament emits 
electrons when it is heated. Electrons are emitted from a metal by two 
possible methods. Thermionic emission in which the electrons are emitted 
from the metals by heating them or field emission where instead the electrons 
are emitted from metals under strong electric fields. The latter gives much 
higher source brightness than thermionic guns, but requires a very good 
vacuum. Once emitted by the source, the electron beam passes through 
multiple electromagnetic lenses. These solenoids are tubes with coil wrapped 
around them. Air needs to be pumped out of the vacuum chamber, creating a 
space where electrons are able to move. In this way, the electrons are focused 
on the sample. The beam of electron that has been partially transmitted 
through the very thin specimen carries information about the structure of the 
sample. 
The spatial variation in this information (the "image") is then magnified by a 
series of magnetic lenses until it is recorded by hitting a fluorescent screen, 
photographic plate, or light sensitive sensor like CCD (charge-coupled 
device) camera. The image detected by the CCD may be displayed in real 
time on a monitor or computer. The image can be manipulated by adjusting 
the voltage of the gun to accelerate or decrease the speed of electrons as well 
as chancing the electromagnetic wavelength via the solenoids. The lighter 
areas of the image represent the places where a greater number of electrons 
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were able to pass through the sample and the darker areas reflect the dense 
areas of the object. These differences provide information on the structure, 
texture, shape and size of the sample. To obtain a TEM analysis, samples 
need to have certain properties. They need to be sliced thin enough for 
electrons to pass through, a property known as electron transparency. 
Samples need to be able to withstand the vacuum chamber and often require 
special preparation before viewing.  
 
In this work TEM images were acquired with a STEM CM12 Philips electron 
microscope. The nanoparticle samples dispersed in hexane solution were cast 
onto a carbon-coated copper grid sample holder, followed by evaporation at 
room temperature. 
5.4 Fluorescence Spectroscopy 
5.4.1 Basic principles 
Fluorescence spectroscopy is a spectrochemical method of analysis where the 
molecules of the analyte are excited by irradiation at a certain wavelength 
and emit radiation of a different wavelength. The usual option is an 
ultraviolet light that is used to excite electrons in the molecules. This leads to 
production of a light emitting phenomenon of lower energy, which can be 
within the visible and non-visible light spectra. The emission spectrum 
provides information for both qualitative and quantitative analysis. 
It has a wide area of applications such as in pharmaceutical sciences, 
chemistry, molecular biology, biotechnology etc. Fluorescence spectroscopy 
involves the electronic and vibrational states of the sample molecules. 
Fluorimetry and spectrofluorimetry are other names for fluorescence 
spectroscopy. The device used for the fluorescence analysis is known as 
spectrofluorimeter and it work by measuring the amount of light that has 
been emitted from the material from longer wavelengths of light. 
When light of an appropriate wavelength is absorbed by a molecule (i.e., 
excitation), the electronic state of the molecule changes from the ground state 
to one of many vibrational levels in one of the excited electronic states. The 
excited electronic state is usually the first excited singlet state, S1. Once the 
molecule is in this excited state, relaxation can occur via several processes. 
Fluorescence is one of these processes and results in the emission of light. It 
corresponds to the relaxation of the molecule from the singlet excited state to 
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the singlet ground state with emission of light. Fluorescence has short 
lifetime (~10-8 sec) so that in many molecules it can compete favorably with 
collisional deactivation, intersystem crossing and phosphorescence. The 
wavelength (and thus the energy) of the light emitted is dependent on the 
energy gap between the ground state and the singlet excited state. An overall 
energy balance for the fluorescence process could be written as:  
 
?????? ? ???? ? ???? ? ???????????? (5.21) 
 
where ?????? is the energy of the emitted light, ????  is the energy of the light 
absorbed by the molecule during excitation, and ???? is the energy lost by the 
molecule from vibrational relaxation. The ???????????? term arises from the 
need for the solvent cage of the molecule to reorient itself in the excited state 
and then again when the molecule relaxes to the ground state. As can be seen 
from equation (5.21), fluorescence energy is always less than the absorption 
energy for a given molecule. Thus the emitted light is observed at longer 
wavelengths than the excitation. Moreover, fluorescence intensity may also 
be reduced or eliminated if the luminescent molecule forms ground or excited 
state complexes (quenching). 
The quantum yield or quantum efficiency for fluorescence is the fraction of 
the number of molecules that give luminescence respect to the total number 
of excited molecules. According to the previous discussion, the quantum 
yield (?) for a compound is determined by the following relation: 
 
? ? ???? ? ?? ? ??? ? ??? ? ??? ? ?? (5.22) 
 
and it depends from the relative rate constants (??) for the processes which 
deactivate the lowest excited singlet states, namely, fluorescence (??? , 
intersystem crossing (???, external conversion (????, internal conversion 
(???), pre-dissociation (???) and dissociation (???. 
Fluorescence spectroscopy can yield low detection limits, high sensitivity and 
high specificity. The high specificity is largely due to the fact that 
fluorophores exhibit specific excitation (absorption) and emission 
(fluorescence) wavelengths. These wavelengths can be determined via the 
collection of two spectra, an excitation spectrum and an emission spectrum. 
Although the approximate excitation and emission wavelengths for many 
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molecules are known, these wavelengths should generally be optimized for 
the specific conditions employed.28,29 
5.4.2 Instrumentation 
Spectrofluorimeter uses a light source that is excited and passed through 
either the filter or the monochromator and lands on the sample. The sample 
absorbs a portion of the incident light and the fluorescent molecules in the 
sample emit the light. A detector is attached at a viewing angle (usually 
around 90 degrees), which prevents that the incident light can affect the 
detected fluorescent light. The sample can be excited through different light 
sources to measure the produced fluorescence. The most common types of 
light sources are: lasers, photodiodes, lamps, Xenon Arcs and Mercury vapor. 
Different light sources are used simply because they offer different levels of 
irradiation due to the wavelength of light that is causing the excitation. Filters 
and monochromators can be used in a spectrofluorimeter device. 
Monochromators allow wavelength adjustment, which makes it possible to 
get the right amount of stimuli into the materials to provide the fluorescence 
and data necessary when testing samples. The primary filters that excite the 
sample provide the appropriate wavelength necessary, while the secondary 
filters monochromate the emitted light when sent to the detector. Another 
reason for using a filter or monchromator is to remove “pollution” or stray 
light from the wavelength that is used to excite the sample. This improves the 
reading and data’s accuracy that the sample provides. For this reason, 
detectors in the setup are often positioned at a 90 degree angle in order to 
receive less stray light from the reading by only allowing scattered light that 
comes from the sample as stray light to have a lowered signal to noise ratio, 
which is better for detecting the intended emitted wavelengths rather than the 
stray light. The 90 degree detector also makes it possible to measure samples 
from the front when they are opaque or turbid by measuring the emitted light. 
Fluorescence spectroscopy detectors may have a single channel or multiple 
channels. Single channeled detectors only detect a single wavelength from a 
sample at a time. Multiple channeled detectors are much more suited for 
getting multiple wavelength intensity readings at the same time. When using 
a multiple channel detector, it is possible to reduce the need to use a 
monochromator or filter in the excitation/emission of the samples. 
In this research work fluorescence spectroscopy has been used to investigate 
the release behavior of a fluorescent molecule Carboxyfluorescein (CF) 
through its de-quenching process when it is released from the aqueous pool 
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of magnetoliposomes. Steady-state fluorescence was measured with a LS50B 
Spectrofluorimeter (Perkin Elmer, Italy). The emission fluorescence spectra 
of CF were recorded between 500 and 610 nm in the corrected spectrum 
mode with excitation wavelength set at 492 nm and 2.5 nm slit. At least 5 
scans were averaged for each spectrum. The release behavior was checked in 
time-drive modality by measuring the fluorescence intensity every 10 
minutes during 16 hours, and checking the fluorescence intensity value after 
18, 24 and 40 h after the LF-AMF exposure. The samples were diluted 1:67 
with PBS and bovine serum (10% and 55%). The data were analyzed by 
calculating the release percentage and by using the Ritger-Peppas equation 
for the kinetic release analysis (see paragraph 3.3). 
5.5 Fluorescence Correlation Spectroscopy (FCS) 
Fluorescence Correlation Spectroscopy (FCS) is an experimental 
technique (introduced by Magde et al in 1972) based on the analysis of the 
time fluctuations of the fluorescent intensity of a selected fluorescent probe, 
due to concentration temporal fluctuations inside a small defined detection 
volume. It allows the measurement of diffusion coefficients and 
concentrations for fluorescent systems providing information about the size 
and weight of the moving particle. FCS is usually performed on a confocal 
microscope and may be applied to any fluorescently labeled molecules in 
solution (generally water or buffer solution), on membranes and even inside 
living cells.29 
5.5.1 Confocal Microscopy 
In FCS the small focal volume is achieved by using a confocal microscope 
and it is on the order of 1 fl = 10-15 l = 1 μm3. The experimental optical setup 
can be described as represented in Fig. 5.7.30 A high numerical aperture 
microscope objective (typically water or oil immersion) is used to focus the 
laser beam (an incident excitation blue light) to a diffraction limited spot into 
the sample. The emitted fluorescent light is collected by the same objective. 
After passing through a dichroic mirror and an emission filter, it is imaged 
onto a confocal pinhole, which blocks the fluorescent light not originating 
from the focal region. In this way a very small observation volume V of less 
than 1 μm3 is created. The detection is performed by a fast and sensitive 
detector, typically a single photon counting avalanche photodiode (ADP). 
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Figure 5.7 Schematic representation of a typical confocal FCS setup and its 
principle of operation. Reprinted from reference.30 
By plugging a laser-scanner that deflects the laser beam in two directions 
directly in front of the objective lens, it is possible to convert the confocal 
microscope into a laser-scanning confocal microscope (LSCM), which may 
also be used to do fluorescence imaging of the sample. With such a LSCM it 
is also possible to freely select the location for the FCS measurement inside 
the sample. 
5.5.2 Autocorrelation analysis 
In a FCS experiment the samples are maintained at thermal equilibrium so 
that all of the processes under analysis are in fact statistical fluctuations 
around equilibrium. Like the name Fluorescence Correlation Spectroscopy 
states, the data that at the end of each FCS measure we obtain is the 
autocorrelation function ? ?  of the particles fluctuating in the confocal 
volume. The temporal fluctuations in the detected fluorescence intensity, 
caused by the diffusion of the fluorescent species inside and outside the 
observation volume, are recorded and analyzed through their autocorrelation 
function (equation 5.23) that it is calculated as a function of the fluctuations 
of the signal from the averaged value: 
 
? ? ? ????? ? ???? ? ?????? ?  (5.23) 
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where the intensity temporal fluctuations are evaluated by comparison of the 
signal obtained at the time ?  with the signal at the time ? ? ? ; the 
fluctuations of the signal from the averaged value are expressed as:  
 
?? ? ? ? ? ? ????  (5.24) 
 
with the averaged signal defined as:31 
 
???? ? ? ? ? ? ? ??
?
?
 (5.25) 
  
The models employed for the analysis of the ACFs take into account the 
shape and the exact size of the detection volume, that generally it is 
approximated as 3D-ellipsoidal Gaussian shape with axial (z0) and lateral (w0 
or r0), defining parameters. These parameters can be determined through 
calibration, by employing a reference fluorescent dye with well known 
diffusion coefficient. Several artifacts and physical processes, not specifically 
correlated to the phenomena under investigation have to be considered, 
which could critically contribute to the ACFs profiles and bias the data. 
Optical aberration, due to incorrect coverslip thickness, refractive index 
mismatch, disactivation of the fluorescent probe due to the decay to a triplet 
fluorescently silent state, photobleaching i.e. the irreversible photoinduced 
destruction of the fluorophore, especially critical for slow diffusing 
molecules and high laser powers,31 are the main limitations. They have to be 
known in advance and possibly prevented by e.g. low laser excitation power, 
careful choice of the fluorescent probe and of the experimental set up, as well 
as the previously mentioned accurate calibration procedure. This latter step 
can be avoided if more advanced calibration-free techniques are employed.31 
The diffusion coefficient D (units μm2s-1) describes the diffusive motion of 
the particles in a specific volume. The higher the diffusion coefficient is, the 
faster the particle moves. The trajectory may be characterized by its so called 
mean square displacement (MSD) ?? , which describes the area that the 
particle covers in a certain time, it is linear in time and the proportionality is 
given by the diffusion coefficient. The general scaling law, which expresses 
the MSD of the molecule as a function of the time is so given by the eq. 5.26: 
 
?? ? ????? (5.26) 
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where ? is the diffusion coefficient of the molecule, ??is the dimensionality 
of the diffusing medium and α the anomalous (α ≠ 1) or normal (α = 1) 
diffusion parameter. For purely diffusive fluctuations, this relationship is 
used to mode the ACF that describes the fluctuation of fluorescence 
intensity.32 The case of a 3D (z = 3) normal diffusion (α = 1) with a 3D 
Gaussian volume shape, is described by the ACF expression as (eq. 5.27): 
 
? ? ? ?? ? ?
?
??
??
? ? ?????
???
 (5.27) 
 
where ? is the aspect ratio of the detection volume and is connected to the 
experimental setup and ? and ?? contain the information on the sample. ? is 
the average number of particles in the effective detection volume and the 
diffusion time ?? is given by: 
 
?? ?
???
?? (5.28) 
 
with ??  as lateral parameter of the confocal volume and ?  diffusion 
coefficient of the probe. The potentially accurate evaluation of these 
parameters with nM concentration range of the fluorescent probe, makes FCS 
an almost single-molecule technique with spatially resolved 
diffusion/concentration measurements.33,34 Moreover, physical or chemical 
processes producing fluorescence fluctuations inside the observation volume 
due to changes in fluorescence quantum efficiency can be investigated 
through FCS to obtain information on the kinetics of these processes and the 
corresponding rate constants.35-37 Finally, FCS allows the specific 
investigation of selected phenomena within complex environments, thus 
making it interesting for the study of a host of processes related to 
biologically relevant systems.38 A specifically growing field of interest relies 
in the investigation of diffusion in confined environments, in particular lipid 
membranes, where the motion of a fluorescent unit covalently attached to a 
lipid molecule is defined by the 2D dimensionality of membrane leaflet. 
Many efforts have been devoted to the technical implementation of 2D 
diffusion within lipid membranes measurement.39 A few studies have 
considered the effect of confinement and crowding in the free diffusion of 
fluorescent probes, and have addressed the issue of environment 
dimensionality on the probe diffusion.40-43 
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In our study, we use FCS by employing the fluorescent molecules Octadecyl 
Rhodamine B and Rhodamine 110, in order to investigate their diffusion in a 
lipid region and in aqueous domain respectively, of the bulk cubic phase, 
cubosomes and magnetocubosomes, thus obtaining structural and 
dimensional information, already investigated through SAXS study. FCS 
experiments were also performed to study the release kinetics of the 
Rhodamine 110 from the aqueous channels of both bulk cubic phase and 
magnetocubosomes in the external aqueous environment, thus demonstrating 
the possibility to employ them as drug delivery systems of hydrophilic drugs. 
FCS experiments were carried out with a laser scanning confocal microscope 
Leica TCS SP2 (Leica Microsystems GmbH, Wetzlar, Germany) equipped 
with a 63x water immersion objective instrument by using the 561 nm and 
488 nm laser lines, respectively for Octadecyl Rhodamine B and Rhodamine 
110. The fluorescence emission was acquired with a ISS module (ISS, 
Inc.1602 Newton Drive Champaign, IL, USA) equipped with two APD with 
500-530 nm (where the fluorescence emission of Rhodamine 110 was 
acquired) and 607-683 nm (where the fluorescence emission of Octadecyl 
Rhodamine B was acquired) band pass, respectively. 
5.6 Magnetic Field 
A sinusoidal magnetic field was generated in the gap of a broken toroidal 
magnet (ferrite) carrying a solenoid through which an alternating electric 
current (AC) from a tone generator was led. The samples to be treated with 
low-frequency alternating magnetic field (LF-AMF) were placed in the 
middle of the gap, within 1 cm cylindrical quartz cells (Fig. 5.8). Due to the 
design of the experimental apparatus, the magnetic field inside the cell is not 
isotropic.44 
 
 
Figure 5.8 Broken toroidal magnet used to apply the LF-AMF. The position of the 
sample during the LF-AMF treatment is indicated by the red arrow. 
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The operating conditions and magnetic field values at different positions of 
the broken toroidal magnet used to apply the LF-AMF, as measured by 
means of a GM-07 Gaussmeter (HIRST Magnetic Instruments Ltd, UK), are 
reported in Fig. 5.9. Since the measured magnetic fields are different 
depending on the sample positioning, the sample undergoes magnetic field 
gradients that cannot be avoided. During the release experiments, the field 
frequency was set at 5.7 kHz. 
 
Figure 5.9 Operating conditions and magnetic field values at different positions of 
the broken toroidal magnet used to apply the LF-AMF. 
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6 Conclusions 
Biocompatible multifunctional nanostructures have focused increasing 
interest in the biomedical area as drug delivery systems, due to their ability to 
improve the biocompatibility, bioavailability and targeting of therapeutic 
molecules, in order to enhance their therapeutic efficacy and to reduce, at the 
same time, drug doses and side effects on other tissues. Many efforts have 
been done in this direction over the past years by employing several kinds of 
nanocarriers, belonging to soft and hard matter, able to load and carry drug 
molecules protecting them against degradation and inactivation thus 
extending also their circulation time. In literature different studies report the 
effect of this drug delivery systems on the pharmacokinetics, 
pharmacodynamics and active intracellular uptake of several therapeutic 
drugs, such as peptide, proteins or nucleic acids. Among various 
nanostructured drug vectors studied large interest was focused on 
nanosystems endowed of high efficacy of confinement and selectivity of 
transport characterized also by low toxicity and relatively easy synthesis 
processes. These features combined with a high control of the therapeutic 
principle release make nanostructured functional matrices highly valuable for 
drug delivery systems.  
The aim of this work was focused on the design, synthesis and 
characterization of nanostructured materials for drug delivery of therapeutic 
molecules and nucleic acids. In particular inorganic and magnetic 
nanoparticles were studied during the first part of work and subsequently 
they were employed to create highly biocompatible hybrid platform 
constituted by lipid moiety combined with magnetic nanoparticles in order to 
obtain responsive systems for spatially and temporally controlled release 
upon low frequency-alternating magnetic field exposure (LF-AMF).  
The first part of this thesis was dedicated to a study on physical-chemical 
characteristics of inorganic Calcium Phosphate nanoparticles Ca3(PO4)2 (CaP 
NPs). The main advantage related to CaP NPs is their high biocompatibility 
and biodegradability, but on the other hand they require the presence of a 
stabilizing agent to ensure the colloidal stability of the system. We have 
report an easy and low-cost strategy to obtain aqueous CaP NPs dispersion 
stabilized by a short oligonucleotide interacting with NPs’ surface. Therefore, 
the oligonucleotide is the colloidal stabilizing agent and also the therapeutic 
molecule allowing to use the designed inorganic CaP NPs like nanocarriers 
6 – Concusions 
 
 180
for e.g. Gene Therapy. With Dynamic Light Scattering (DLS) and Zeta 
Potential investigation we have shown CaP NPs of diameter around 170 nm 
stable in the time. Atomic Force Microscopy (AFM) was used instead to 
perform a morphologic study highlighting lower dimensions of the 
nanoparticles with a disk-like shape rather than spheric.  
Other kind of inorganic nanoparticles featuring magnetic responsiveness 
were prepared and characterized through DLS, Zeta Potential and Small 
Angle X-ray Scattering (SAXS). Hydrophobic Fe3O4 NPs stabilized by oleic 
acid and oleylamine and hydrophilic Fe3O4 NPs stabilized with citrate were 
synthesized in order to employ them both alone like simple magnetic drug 
carriers and like actuators of a magnetically triggered drug release from more 
complex hybrid architectures. Concerning the first goal the same magnetic 
nanoparticles were prepared with a gold covering in order to achieve a more 
biocompatible core-shell system endowed of a magnetic core combined with 
a high versatility in terms of functionalization of the gold shell. Regarding 
the second aim the physical-chemical characterization of the magnetic 
nanoparticles has revealed suitable NPs’ size for encapsulating them both in a 
hydrophilic core of liposomes and in lipid bilayer with thickness around 4 
nm. 
In the second part, our work was focused on nanocomposite mixed 
SPIONs/lipid drug delivery systems to investigate the triggered release by an 
external magnetic stimulus both in aqueous buffer and in biological fluids 
(such as bovine serum). Magnetoliposomes with hydrophilic Fe3O4 NPs in 
the aqueous pool and magnetoliposomes with hydrophobic γ-Fe2O3 NPs in 
the lipid bilayer were separately prepared and characterized by DLS and 
SAXS. The enhancement of the liposome permeability upon magnetic field 
exposure was monitored by measuring the de-quenching of 
carboxyfluorescein (CF) released from the aqueous pool of the 
magnetoliposomes, in function of the time exposure to the LF-AMF. The 
results have displayed a higher CF’s leakage from magnetoliposomes with γ-
Fe2O3 NPs entrapped in the lipid bilayer upon LF-AMF exposure than the 
magnetoliposomes with MNPs in the aqueous pool, due to the lipid bilayer 
destabilization caused by the friction between MNPs and the viscous lipid 
when exposed to the magnetic field. Moreover, the release study performed 
in bovine serum (10% and 55% in protein concentration) have showed that 
the serum proteins adsorbed on the magnetoliposomes’ surfaces hinder the 
CF’s release and give rise to protein-vesicle complexes formation. In this last 
case the magnetic external contribution to the CF release was found rather 
negligible.1 
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In the last part, a novel hybrid platform endowed of two different 
environments able to host simultaneously both hydrophilic and hydrophobic 
molecules was studied and for the first time on bulk cubic phase and 
cubosomes were performed release study through Fluorescence Correlation 
Spectroscopy (FCS). First step was to encapsulate oleic acid-coated Fe3O4 
NPs in the lipid bilayer of both bulk cubic phase and cubosomes, obtaining 
so-called magnetocubosomes and so exploiting the responsiveness of these 
nanoparticles to make versatile drug delivery systems with the possibility to 
remotely control their accumulation in the body and their responsivity to an 
alternating magnetic field. Bulk cubic phase with SPIONs and 
magnetocubosomes were characterized by SAXS, DLS and Zeta Potential. 
FCS was employed to investigate the diffusion behavior of a hydrophilic 
model drug (Rhodamine 110) inside the aqueous channels and of a 
hydrophobic model drug (Octadecyl Rhodamine B) in the lipid domains of 
both bulk cubic phase and magnetocubosomes, demonstrating that the model 
drugs are efficiently retained inside the aqueous or lipid domain where they 
can diffuse. By this experiment we can state that cubic phase and 
magnetocubosomes can act as a vector for therapeutics with different 
chemical affinities, which can be confined in the inner cubic structure. With 
the same technique the release of a hydrophilic model drug (Rhodamine 110) 
from the aqueous channels of the bulk cubic phase and magnetoliposomes 
was investigated. It was possible to monitor both the spontaneous release and 
the release triggered by the alternating magnetic field exposure of 5.7 kHz. 
The FCS investigation have highlighted that the LF-AMF application 
increase dramatically the amount of hydrophilic drug released in the external 
aqueous environment from both DDS containing Fe3O4 NPs, demonstrating 
that the external magnetic field acts as a proper external trigger to the release. 
The results achieved make it possible to state that this novel hybrid 
nanostructured architectures endowed with magnetic responsiveness provide 
a new multifunctional and flexible scaffold for the encapsulation and targeted 
delivery of different therapeutic and/or diagnostic molecules.2 
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Diastereoselective self-assembly of
clofarabine lipids
Peter Sandin,†ab Francesca Baldelli Bombelli,†acd Benedetta Castroflorio,a
Christoph Mu¨ller,e Ju¨rgen Obermeier,e Go¨ran Karlsson,f Katarina Edwards,f
Piero Baglionia and Debora Berti*a
Clofarabine is a nucleosidic chemotherapeutic approved for the treatment of acute lymphoblastic leukemia,
currently undergoing clinical trials for the treatment of solid tumors. Like for many others, lipidic derivatization
of this drug improves pharmacokinetics and relieves the heavy side effects. Since the self-assembly pattern
can modulate the bioactivity profile, a precise knowledge of the aggregation behavior of these nucleolipids
and of the microstructure of the aggregates is central to design formulations that efficiently provide sufficient
bioavailability. In this contribution we investigate the self-assembly behavior of two Clofarabine dioxy-ether
derivatives, the diastereomers (1-2S and 1-2R). These clofarabine lipid derivatives showed an unexpected
diastereoselective self-assembly effect, which we have monitored by observing the time evolution of self-
assemblies and their microstructural response to thermal treatment. Dynamic Light Scattering and Circular
Dichroism provide an ensemble of results which correlate with the occurrence of a hierarchical association of
wormlike aggregates, imaged using Electron Microcopy. A strikingly different behavior for the two
diastereomers was observed. This behavior can be crucial for the different bioavailability observed in vivo.
Introduction
Clofarabine is a cytotoxic deoxyadenosine analogue that received
accelerated approval in 2004 from FDA1 and recently from EMEA2
for the treatment of pediatric acute lymphoblastic leukemia,
currently under clinical trials for some adult solid tumors.3
A dose-dependent severe myelosuppression represents its most
serious side-effect.4 Like for many other nucleosidic chemothera-
peutics, a pro-nucleotide approach,5 with a specific lipid carrier
linked to the nucleoside via a covalent phosphodiester bond, can
reduce these effects, improve pharmacokinetic behavior and over-
come or decrease the development of resistance against the drug.
Recently we have synthesized a specific conjugate of clofarabine
with a synthetic dialkyl lipid phosphate, (1, Fig. 1), which showed
improved pharmacokinetic, pharmacodynamic and toxicologic
properties compared to free clofarabine.6
In vivo 1 is activated by membrane associated specific
hydrolases, releasing the free clofarabine into the respective
cells. Since 1 is a 1 : 1 mixture of two diastereomers (1-2S and
1-2R, Fig. 1), the question arose whether the two diastereomers
would differ with regard to biological activity, with the 1-2R,
sterically similar to natural phospholipids, expected to be the
most active. For this reason we synthesized 1-2S and 1-2R.
Remarkably, 1-2S, with the ‘‘unnatural’’ S configuration at
carbon SN2 in the lipid part, showed higher bioavailability
and anti-tumor activity in vivo.6 The stereochemical difference
involves a portion of the molecule, which is cleaved away from
the active clofarabine part, and should in principle have little
effect on biological properties. The reasons for the observed
difference in bioactivity must therefore lay elsewhere. The
amphiphilic properties of 1-2R and 1-2S suggest the possibility
of aggregation and formation of ordered supramolecular structures
in solution. Amphiphilic self-assemblies display a rich phase
behavior, characterized by a large structural diversity, in terms
of size, shape and flexibility of the aggregates. The typical
independent parameters of the amphiphilic phase diagram
are surfactant volume fraction, temperature and ionic strength:
subtle variations of local microstructure can lead to cascade
effects with dramatic morphological transitions on the mesoscale.7
This effect is particularly important for biologically-inspired
functional surfactants, such as peptide-amphiphiles and
oligonucleotide-amphiphiles,8–11 where a biological recognition
unit is incorporated in the amphiphile molecular architecture.
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This work investigates the self-assembly behavior displayed
by clofarabine lipid diastereomers reported in Fig. 1, which
could influence their biological activity.
A diastereoselective assembly is by no means obvious for
ionic amphiphiles, because predictions on the morphology of
the aggregate are based on the balance of molecular packing
parameters and excluded volume or electrostatic repulsive
interactions between the polar heads. Therefore, a different
stereochemistry at the C2 should in principle play little or no
role in the structural properties of the aggregates.
On the other side, lipophilic nucleosides are known to give
rise to interesting and extremely rich phase behavior in aqueous
solutions. Clofarabine is a derivative of adenosine and we have
previously studied the aggregation behavior of phosphatidyl-
nucleosides, where a natural RNA nucleotide is conjugated to a
double-chain glycerol lipid skeleton. These derivatives self-organize
in aqueous solution as assemblies of various size, shape and
interfacial curvature, according to the length of the two hydropho-
bic portions.12,13 The nucleic motif imparts molecular recognition
capability to self-assemblies. A coarse-grained mapping of the phase
behavior in aqueous solutions can be predicted by comparison with
the corresponding phosphatidylcholine precursors:14 as the hydro-
phobic double chain is lengthened, the dimensionless surfactant
packing parameter p = v/a0lc, with v the volume of the alkyl chain, a0
the cross section of the polar head and lc the fully extended length
of the hydrophobic portion, increases until it reaches an
asymptotic value. In this progression, we observed the usual
phase evolution, from positively curved surfactant films
(globular micelles) to flat assemblies (bilayers). However, since
the geometry of spontaneous self-assembly and interfacial film
properties are the result of a delicate balance between hydrophobic
forces and polar head interactions, the properties of nucleolipid
self-assemblies is further modulated by base–base interactions
that are triggered by aggregation.15 Their self-assemblies show a
strong dependence on subtle changes of molecular details of the
monomer, such as the syn or anti conformation of the nucleo-
side. Some reports on amphiphiles with functional polar heads
have shown that, when a complex interaction pattern at the intra-
and inter-aggregate level can occur at the interface, variations in the
stereochemistry of the polar head, of the counterions, or slight
changes in the experimental conditions, can promote drastic altera-
tions of the aggregate morphology.16–19 An illuminating example is
provided by dilauroyl-phosphatidyl-N (DLPN), with N either adeno-
sine or uridine, whose aggregation properties have been studied in
detail, to better highlight the contribution of the functional polar
head to local and mesoscopic properties of the aggregates. Freshly
prepared dilauroyl-phosphatidyl-adenosine solutions are mostly
composed of threadlike flexible micelles whose cross-section size is
about 5 nm. The observed time evolution of the aggregate morphol-
ogy results in twisted superstructures, which account for the appear-
ance of an ultraslow relaxation in quasielastic light scattering.
Conversely DLPU forms wormlike flexible micelles, whose structure
is stable with time and which do not associate into superstructures.
DLPA superstructures arise from the hierarchical aggregation of
wormlike structures identical to dilauroyl-phosphatidyl-uridine
micelles. The higher stacking constant of the former nucleotide is
responsible for the different self-assembly behavior, which is also
strictly dependent on the thermal history of the samples, which
alters the syn–anti distribution of conformers of the adenosine
headgroups. The syn–anti redistribution is then retained when the
sample is brought back to room temperature, due to the intermo-
lecular constraints present in the self-assembled structure.20
In this contribution we focus on an even subtler aspect, i.e.
the stereochemistry of the polar head at the SN2 carbon. If
base–base associative interactions at the polar head level are
operative, then despite the same charge of the headgroups, the
stereochemical details may have a deep influence on the self-
assembly and on the hierarchical assembly of associated units.
To address this issue, we compare the microstructure of the
aggregates formed by 1-2R and 1-2S.
We expect the local structure to be similar to the DLPN case, i.e.
that the amphiphiles will assemble into locally cylindrical micelles.
Any difference of the flexibility of the aggregates, and the association
of simpler associated units into hierarchical super-twisted super
structures, should be ascribed to the specificity of the polar head and
to the effect that the stereochemistry of the SN2 Carbon has on the
interaction pattern.
Materials and methods
Synthesis and characterization of the diastereomers
The preparation of [2-chloro-9-(2 0-deoxy-20-fluoro-b-D-arabino-
furanosyl)adenine]-50-phosphoric acid-(2R-decyloxy-3-dodecyloxy)-
propyl ester (1-2R) is shown in Scheme 1.
Fig. 1 Chemical structures of 1 and its diastereomers 1-2R and 1-2S.
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All the reagents, chemicals and solvents have been purchased
from Sigma Aldrich and used without further purification.
4.41 g (9.17 mmol) of enantiomerically pure phosphoric
acid-(2R-decyloxy-3-dodecyoxo-)propyl ester, synthesised from
(S)-(+)-1,2-isopropylideneglycerol as previously described,21 are
treated twice with 50 ml of anhydrous pyridine and concen-
trated by evaporation. The residue is dissolved in 180 ml of
anhydrous pyridine at room temperature, treated with 5.56 g
(18.35 mmol) of 2,4,6-triisopropylbenzenesulfonyl chloride
under nitrogen and stirred at 20–25 1C for 1 hour. Then
4.18 g (13.76 mmol = 1.5 eq.) of 2-chloro-9-(20-deoxy-20-fluoro
arabinofuranosyl)adenine (clofarabine) are added at once, and
the mixture is stirred under nitrogen for 20 hours. Hydrolysis is
performed by adding 100 ml of saturated sodium hydrogen
carbonate solution; the mixture is stirred for another 0.5 hour
at room temperature until evolution of carbon dioxide stops
and it is freed from the solvent under vacuum at 40 1C. Acetone
(150 ml) is added to the solid residue vigorously stirred for an
additional hour. The resulting suspension is filtrated with
suction and the residual salt is washed with 50 ml acetone.
The combined acetone filtrate and washings are concentrated
and the residue is purified by HPLC on Lichrospher 60 RPselect
B with methanol/aqueous 40 mM sodium acetate 85 : 15 as the
eluent. The product containing fractions is evaporated. The
residue is distributed between 200 ml of tert-butylmethylether
and 60 ml of 2 N hydrochloric acid. The organic layer is
evaporated, the residue is dissolved in a mixture of 20 ml of
methanol and the pH is adjusted to pH 7 by addition of sodium
methanolate (30% in methanol). The solvent is stripped off and
the residual sodium salt dissolved in 25 ml acetone and
dropped at 0 1C to 50 ml acetonitrile. The resulting suspension
is stirred for 1 h at 0 1C, the precipitate is filtered off with
suction and washed with 50 ml ice cold acetonitrile and dried
in vacuum: 5.50 g (76%) sodium salt of 1-2R as a white
amorphous powder.
1H NMR (300 MHz, DMSO-d6): 8.2 (s, 1H, H8), 8.0, (s (br), 1H,
NH2), 6.6, (s, 1H, 30-OH), 6.3 (dd, 1H, H10), 5.2 (dt, 1H, H20), 4.5,
(dt, 1H, H30), 3.9–4.0, (m, 3H, H40, POCH2), 3.6, (m, 1H, –H5a0),
3.6 (m, 1H, H5b0), 3.2–3.5 (m, 7H, 4CHOCH2–, –CH2OCH2),
1.1–1.4 (m, 32H, –(CH2)9–, –(CH2)7–), 0.8 (m, 6H, CH2–CH3);
3J10-H,20-H E
3J20-H,30-H E
3J30-H,40-H E 4.6 Hz,
3J10-H,F = 13.2 Hz,
2J20-H,F = 52.7 Hz,
3J30-H,F = 19.4 Hz.
13C NMR (75.0 MHz, DMSO-d6): 156.6, 153.1, 150.0 (C-2, C-4,
C-6), 139.7 (C-8), 117.2 (C-5), 95.8 + 93.9 (C-20), 82.0 (C-40), 81.2
(C-10), 77.7 (O-CHo), 73.1 (C-30), 70.7, 70.4 (CH2–CH2O–CH2–),
69.1 (CH2–CH2O–CHo), 63.6 (C-50), 63.3 (50-O-P(O)2OCH2),
21.8–31.1 (–(CH2)9–, –(CH2)7–), 13.6 (2  CH3).
31P NMR (121.5 MHz, DMSO-d6): 0.23 ppm (singlet).
19F NMR (282 MHz, DMSO-d6): 199.5 ppm (singlet – 1H-
decoupled).
Mass spec. (FAB–): m/z = 764.39 [M-Na+]
The preparation of [2-chloro-9-(20-deoxy-20-fluoro-b-D-arabino-
furanosyl)adenine]-50-phosphoric acid-(2S-decyloxy-3-dodecyloxy)-
propyl ester (1-2S) is similar to that reported for 1-2R, except for
the use of enantiomerically pure phosphoric acid-(2S-decyloxy-3-
dodecyloxoy)propyl ester (synthesised from (R)-()-1,2-isopro-
pylideneglycerol as in WO 96/06620). 1-2S is obtained as a
sodium salt in 28% yield.
19F NMR (282 MHz, DMSO-d6): 198.5 ppm (singlet –
1H-decoupled).
Dynamic Light Scattering (DLS)
DLS experiments were carried out on a Brookhaven Instrument
apparatus, New York, USA (BI 9000AT correlator card and BI
200 SM goniometer). The signal was detected using an EMI
9863B/350 photomultiplier. The light source was the doubled
frequency of a Coherent Innova diode pumped Nd-YAG laser
(l = 532 nm, 20 mW). The laser long term power stability was
0.5%. Self-beating detection was recorded using decahydro-
naphthalene (thermostated by a water circulating system) as
the index matching liquid. A temperature probe was inserted in
the sample to monitor T while simultaneously recording auto-
correlation functions. Measurements have been performed at
20 1C on 0.5 ml samples previously transferred into cylindrical
Hellma scattering cells. For each sample at least three separate
measurements were performed at different angles (i.e. 701, 901,
1201) corresponding to three different scattering vectors; n is
the refractive index of the medium equal to 1.33. In Dynamic
Light Scattering experiments, the normalized time autocorrela-
tion function g2(q,t) of the scattered intensity is measured
according to:
g2ðq; tÞ ¼ I
ðq; 0ÞIðq; tÞh i
Iðq; 0Þ2
D E (1)
For ergodic systems, this function can be expressed in terms of the
field autocorrelation function g1(q,t) through the Siegert relation:
g2(q,t) = A[1 + b
2g1(q,t)
2] (2)
where A is the baseline and b2 is the coherence factor dependent
on the scattering geometry and details of the detection system.
Data analysis has been performed by fitting the field auto-
correlation functions through a double exponential decay,
yielding two distinct decay rates, labeled as ‘‘fast’’ and ‘‘slow’’
decay modes. The analytical expression used to fit the field
autocorrelation functions was:
g1ðq; tÞ ¼ A PeG1t þ ð1 PÞeG2t
 þ B (3)
where A is the total amplitude of the correlation function, P is
the contribution of the first mode to the total amplitude, B isScheme 1 Synthetic pathway to the diastereomer 1-2R.
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the baseline. The extracted decay modes have a typical diffusive
scaling: it is commonly agreed that a linear dependence of the
decay rate on the square scattering vector, q2, indicates a
diffusive origin (Fig. 2). The line slope is the translational
diffusion coefficient Dt of that population. The diffusion coefficients
provide access to the hydrodynamic correlation lengths RH for
isotropic particles through the Stokes–Einstein relationship
Dt ¼ kBT
6pZsRH
(4)
where Zs is the solvent viscosity and kB the Boltzmann constant.
Although such hydrodynamic sizes cannot be related to any
structural parameter of anisotropic particles, as they refer to the
radius of the equivalent diffusing spheres, they can qualitatively
indicate the order of magnitude of the size of the diffusing self-
assemblies.
Circular Dichroism Spectroscopy (CD)
Circular Dichroism spectra were collected on a J-715 Jasco
spectro-polarimeter. Hellma quartz cylindrical cells with vari-
able path-length, selected not to exceed 0.8 optical density,
were used. The observed Circular Dichroism was converted into
Molar Ellipticity, normalizing for pathlength and dichroic
chromophore concentration.
Cryo-transmission electron microscopy (Cryo-TEM)
The preparation of the samples for Cryo-TEM was performed as
follows: a small droplet of the solution was placed under
controlled conditions on a pretreated 20 mm thick Cu grid,
coated with a perforated cellulose acetate butyrate film. The
excess material was removed by gently wiping off with a filter
paper. The specimen was vitrified by a rapid transfer into liquid
ethane close to its freezing temperature. The examination of
the sample was then performed using a Zeiss 902A electron
microscope operating at 80 kV and 100 K. The temperature of
the specimen was kept below 165 1C both during the transfer
to the microscope and the examination. Images were recorded
at under focus settings of about 2–3 mm to enhance the image
contrast.
Results and discussions
We studied the microstructure of 0.5 mM clofarabine lipids
dissolved in 50 mM PBS, as a function of time and of the thermal
history of the sample, by DLS, CD and Cryo-TEM investigations.
The samples were prepared by dissolving the dry powder in the
buffer, through mild vortex-mixing. After having obtained a
transparent solution, no further stirring was applied.
Time evolution of the lipidic self-assembly
Fig. 3 shows the time evolution of the Dynamic Light Scattering
(DLS) and Circular Dichroism (CD) data for the two diastereomers
freshly dissolved in PBS. The autocorrelation functions (Fig. 3A and
B) can be fitted with a double exponential decay. Both modes are
diffusive, as the linear trend of the decay rates vs. the squared
Fig. 2 Decay modes, extracted from the field autocorrelation functions
through eqn (3), are reported as a function of the squared scattering vector
q. G1 and G2 are the fast and slow decay mode, respectively. The linear
dependence of the decay rate on the squared scattering vector, q2,
indicates a diffusive nature of both decays. The values of the diffusion
coefficients are shown in Table 1.
Fig. 3 Time evolution of DLS field autocorrelation functions and CD for
1-2S and 1-2R micellar solution. DLS field autocorrelation functions for
(A) 1-2S and (B) 1-2R fresh micellar solutions (&), sample aged at 25 1C for
one day (J) and four days (,). Solid curves are the best double-
exponential fittings (eqn 3) from which we extracted the characteristic
decay modes (see text and Table 1). While the autocorrelation functions of
the two fresh samples are very similar, 1-2S show a dramatic change
already after one day whereas for 1-2R the change is less pronounced.
(C) and (D) The time evolution of the CD spectra of 1-2S and 1-2R,
respectively, fresh micellar solution (dashed curve), sample aged one (&)
and four (K) days at 25 1C. 1-2S shows a gradual change from fresh to four
days while 1-2R shows no change over the same time interval. All
measurements were carried out at 0.5 mM in 50 mM PBS buffer at
25 1C, the DLS measurements were made at y = 90.
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scattering vector, reported in Fig. 2, reveals. These contributions are
due to centre-of-mass motion of the aggregates.
The fast decay mode corresponds to a diffusion coefficient,
which is identical for the two derivatives within experimental
uncertainty (D E 1.2  107 cm2 s1, RH E 178 Å). The slow
decay mode, due to larger aggregates, is different for the two
diastereomers even in the freshly prepared samples (DE 4.5 
108 cm2 s1, RH E 476 Å and D E 2.6  108 cm2 s1, RH E
824 Å for 1-2S and 1-2R, respectively).
The hydrodynamic sizes inferred from the diffusion coefficients
indicate that, even for the faster decay, the aggregates cannot be
accounted for by spherical micellar aggregates, (considering a
monomer size of B20 Å), but rather suggest the presence of
elongated structures.
Surprisingly, 1-2S aggregates show a noticeable evolution
toward larger aggregates already after 24 hours and are then
stable, while 1-2R has a much slower evolution, involving only
the long-time decay, as reported in Fig. 3 and Table 1.
CD offers insight into the base–base interaction pattern as
the CD signal is sensitive to mutual interactions of the nucleobase
analogs. The CD spectra of 1-2S (Fig. 3C) reveal a significant change
over time, which suggests that the structural evolution observed in
DLS is accompanied by a change in the base–base interaction
pattern. Conversely, 1-2R does not show any significant change in
the CD spectra over the time course of the experiment.
Thermal effects on the self-assembly
The effects of thermal cycles on the self-assembling properties
of these derivatives were also investigated. In previous studies
on the nucleolipid dilauroyl-phosphatidyl-adenosine (DLPA) we
have shown that the thermal history of the sample has a dramatic
effect on the resulting superstructures,17 since the temperature can
promote the formation of long-lived non-equilibrium states.
Incubation at 45 1C for 48 hours drastically alters the structural
features of 1-2S assemblies, as revealed both by DLS and CD (Fig. 4),
Table 1 Results obtained from the fitting of the field autocorrelation functions
using eqn (3) for fresh and aged samples of the two diastereoisomers at 25 1C
Sample D1 (cm
2 s1) A1 (%) D2 (cm
2 s1) Rh1
a (Å) Rh2
a (Å)
1-2S-fresh 1.2  107 87 4.5  108 178.3 475.5
1-2R-fresh 1.2  107 77 2.6  108 178.3 823.7
1-2S-2days 7.6  108 33 9.0  109 281.6 2377.8
1-2R-2days 1.0  107 70 2.4  108 214.0 891.7
1-2S-4days 7.6  108 33 9.0  109 178.3 2377.8
1-2R-4days 1.1  107 72 1.54  108 195.8 1389.2
a Hydrodynamic radii are only indicative since they were calculated
using the Stokes–Einstein relationship (eqn (4)), which gives the
hydrodynamic radius of the equivalent diffusing sphere. Recall the
complex structures of these self-assemblies, it is not possible to relate
them to structural parameters.
Fig. 4 Time evolution of DLS field autocorrelation functions and CD for
1-2S and 1-2R micellar solution after four days of aging at 25 1C and two
days of incubation at 45 1C. DLS field autocorrelation functions for (A) 1-2S
and (B) 1-2R after four days at 25 1C (dashed lines), directly after incubation
at 25 1C for two days (J), after one day at 25 1C after incubation (n), after
two days at 25 1C after incubation (&) and seven days at after 25 1C after
incubation (+). CD spectra of (C) 1-2S and (D) 1-2R after four days at 25 1C
(dashed lines), directly after incubation at 25 1C for two days (J), after one
day at 25 1C after incubation (+), after two days at 25 1C after incubation
(n). The incubation at 45 1C has a strong affect on 1-2S as seen in the
significant changes in both DLS and CD. Although the DLS and the CD
changes also for 1-2R after incubation the effect is significantly less
pronounced. All measurements were carried out at 0.5 mM in 50 mM
PBS buffer at 25 1C, the DLS measurements were made at y = 90.
Fig. 5 Representative Cryo-TEM micrographs of 1-2S, 0.5 mM in 50 mM
PBS, before (A) and after (B) incubation (48 h incubation at 45 1C). In both
cases there are elongated threads, characterized by certain stiffness,
occasionally aggregated through side-by-side interactions. In the aged
samples before incubation smaller wormlike micelles are observed, while
the incubated sample shows a higher supraorganization of these fibers to
form stacked superstructures through side–side interactions. The length
of the scale bar is 100 nm.
NJC Paper
Pu
bl
is
he
d 
on
 0
1 
Se
pt
em
be
r 
20
14
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f 
W
in
ds
or
 o
n 
30
/1
0/
20
14
 1
7:
59
:3
4.
 
View Article Online
5252 | New J. Chem., 2014, 38, 5247--5253 This journal is©The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2014
i.e. of those aggregates which, under ambient conditions, show a
stronger structural evolution. CD and DLS also change for
1-2R, but in a much less dramatic way when compared to 1-2S.
To summarize, DLS highlights a complex self-assembly pattern,
different time evolution of the structures and different thermal
history behaviour.
Cryo-TEM investigation
Information on the morphology, flexibility and super-organization
can be obtained by direct imaging of the aqueous aggregates by
Cryo-TEM. Representative Cryo-TEM micrographs of 1-2S and
1-2R, both aged and incubated samples, are shown in Fig. 5 and
6, respectively. 1-2S (Fig. 5A and B) shows extremely elongated
threads, characterized by a notable stiffness, often associated
through side-by-side interactions. The characteristic size of the
thinner fibers is consistent with the monomer size, thus
indicating that the primary aggregates are formed by cylindrical
micelles. There are also small wormlike micelles visible in
the background. Incubation increases the side-association
in superaggregates, while it does not appear to reduce the
stiffness. These results support the size variation observed in
DLS as well as the change in the base–base interaction pattern
when the ‘‘primary’’ flexible wormlike micelles hierarchically
organize into superaggregated structure. This structural tran-
sition is accompanied by a change in base–base interactions,
as the variation of CD patterns indicates for this derivative.
Fig. 6 shows a completely different behavior for 1-2R.
The structures are characterized by a much higher degree of
flexibility of the aggregates (Fig. 6A and B), which can even-
tually wind around each other to form helicoidal superstruc-
tures with locally cylindrical curvature. Incubated samples
display, in addition to twisted structures, elongated and
apparently stiff, bilayer bands (Fig. 6C). The large degree of
diversity in this sample makes both DLS and CD much more
difficult to be interpreted.
Conclusions
The two nucleolipid diastereomers of 1 give rise to complex
superstructures with different aggregation morphologies and
sometimes resulting in distinct interfacial curvatures. It is clear
that, on the molecular scale, a different bending rigidity of the
amphiphilic film is responsible of the meso-scale behaviour.
The different stereochemistry of the polar head results in a
different flexibility of the aggregates, which in turn causes a
completely different structural behaviour on a much higher
length scale. These findings can be correlated with the differ-
ence in bioavailability and anti-tumor activity for the two
diastereomers, administered at similar concentrations and
conditions as those investigated in this study. In particular,
the complex twisted aggregates formed by the 1-2R derivative
(Fig. 6A and B) give rise to a lesser oral bioavailability and anti-
tumor activity with respect to the more rigid structures formed
by the 1-2S derivative. We hypothesize that the different
morphologies, resulting from diastereoselective self-assembly
can definitely play a role and practically account for the
different bioavailability. It is clear that a deeper investigation
is needed to completely understand the chemical and biological
mechanisms behind this effect.
This study highlights that a successful application of
lipid pro-drugs as a means of drug delivery demands special
attention to the self-aggregation behavior since very subtle
structural features of the monomer can play a crucial role at
the mesoscopic scale which may seriously affect the therapeutic
efficiency.
Fig. 6 Representative Cryo-TEM micrographs of 1-2R, 0.5 mM in 50 mM
PBS buffer, before (A, B) and after (C) incubation (48 h incubation at 45 1C).
1-2R shows a very different self-assembling behaviour with respect to 1-2S:
the cylindrical curvature is maintained but the fibers are much more flexible
and tend to wound each other to form helicoidally superstructures which
coexist with the starting structures. The increase in temperature induces
significant changes in the self-assembling behaviour with the coexistence of
different superstructures such as twisted structures, fibers and elongated
and apparently stiff bilayer bands. The length of the scale bar is 100 nm.
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a b s t r a c t
The design of nanostructured drug delivery systems (DDS) that improve the efficacy of therapeutic prin-
ciples by enhancing their biocompatibility, bioavailability and targeting, has been the focus of extensive
research over the past years. Of particular relevance in this field is the development of multifunctional
architectures that can deliver different therapeutics or diagnostic agents and release them in a controlled
way. In this study we report on the design, preparation and characterization of a DDS where hydrophobic
Fe3O4 magnetic nanoparticles (NPs) are included in the bilayer of bicontinuous cubic lipid nanoparticles
of Glyceryl Monooleate (GMO). The ‘‘magnetocubosomes’’ are characterized and investigated in terms of
their ability to encapsulate and release both hydrophilic and hydrophobic model drugs. For the first time
Fluorescence Correlation Spectroscopy (FCS) is used to study the diffusion of encapsulated molecules
inside the bicontinuous cubic phase and to monitor their release from the matrix towards the aqueous
phase. In addition, we show with the same technique that magnetocubosomes are responsive to a low
frequency alternating magnetic field (LF-AMF), which acts as an external trigger to boost the release of
model drugs confined in the cubic phase. Magnetocubosomes, reported for the first time in this paper,
represent a novel biocompatible, multifunctional and responsive DDS.
 2014 Elsevier Inc. All rights reserved.
1. Introduction
Responsive biocompatible drug delivery systems (DDS) are of
great interest for the development of smart, efficient and non-toxic
vectors for therapeutics. The design and development of therapeu-
tic vectors for drugs and/or diagnostic imaging agents, character-
ized by a controlled size in the submicron range, able to interact
and be internalized by cells without toxic side effects, are among
the main goals of research in this field [1,2]. These carriers should
promote therapeutic efficacy, by enhancing the circulation time of
active principles inside the organism, by protecting them from
degradation, and by targeting them to the designed biological
objective. In addition, it is of utmost importance that, once the tar-
get is reached, the payloads are released with spatial and temporal
control.
A main issue in the design of such biomedical devices is bio-
compatibility. For instance inorganic nanostructured systems are
intrinsically characterized by a high surface energy: therefore they
show robust interactions with biological fluids and interfaces, pos-
sibly causing toxic effects on cells and organisms [3,4]. In this
regard, lipid nanostructured assemblies are completely safe and
non-toxic, and can be easily employed as scaffolds for the develop-
ment of multifunctional devices. Lipid self-assembly in aqueous
media gives rise to a multitude of architectures, characterized by
the coexistence of separate hydrophobic and hydrophilic regions
within the same nanosized structure, that can spontaneously host
both hydrophilic and hydrophobic drugs. This feature provides a
multifunctional integrated platform, where drugs or imaging
agents with different water affinity can be stored and delivered
to the same target and eventually released simultaneously in a
controlled way.
Liposomes are the most popular and widely employed lipid
carriers for therapeutics [5], while there are comparatively less
studies on dispersions of cubic lipid nanoparticles. Cubosomes
are dispersed lipid nanoparticles characterized by a cubic liquid
crystalline internal structure, where a lipid bilayer folds in a tridi-
mensional architecture forming a bicontinuous phase of lipid
bilayered regions and aqueous channels [6–10]. The main advanta-
ges of cubosomes with respect to liposomes as DDS, lie in this inner
cubic structure, which determines a high interfacial surface, able to
encapsulate and protect a higher amount of both hydrophilic and
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hydrophobic drugs, with respect to liposomes [11,12]. Moreover,
the structure of the assemblies improves the ability of the DDS
to interact with the lipid bilayer of the cell membrane, and there-
fore reach the designed biological targets inside the cells [13].
As already mentioned, one of the main goals in the develop-
ment of DDS is to control the temporal (i.e., at a given time after
administration) and spatial (i.e., in proximity of a selected tissue
or cell) drug release profile from the vector, with the aim to
improve the efficacy and the selectivity of the drug, and to limit
its side effects on healthy tissues. To this purpose, many examples
of responsive systems have been proposed, employing specific
responsive features of the lipids with respect to the environment
of the biological target, i.e. variations in temperature [14], pH
[15] or molecular composition of the media [16], as triggers for
drug release.
A different approach to address this point is to make use of an
external trigger, such as an alternating magnetic field, by exploit-
ing the magnetic properties of super-paramagnetic iron oxide
nanoparticles (SPIONs) embedded in the delivery device.
Aqueous ferrofluids composed of iron oxide nanoparticles have
obtained clinical approval as contrast agents for magnetic reso-
nance imaging (MRI), as iron substitute products for intravenous
therapy [17,18]. Several examples concerning magnetoliposomes,
i.e. lipid vesicles containing SPIONs in their aqueous pool or in
the bilayer, have been reported in the recent past [19].
This work extends the potential of hybrid SPION/lipid systems
to cubosomes. We report on the design, preparation and character-
ization of magnetocubosomes as lipid DDS endowed with mag-
netic responsiveness. We show that magnetocubosomes are able
to release a model hydrophilic drug upon application of a low fre-
quency alternating magnetic field (LF-AMF).
To the best of our knowledge, only one recent study reports on
the preparation of hybrid cubosomes/SPION from iron oxide NPs
[20], which where designed for MRI purposes. In this work we have
a different goal, that is, to include hydrophobic NPs within the
bilayer and to use them as an internal trigger to actuate the release
of both hydrophobic and hydrophilic active principles.
A bulk cubic phase of fully hydrated GMO was prepared and
characterized in the absence and in the presence of hydrophobic
magnetite nanoparticles (NPs) through Small Angle X-ray Scatter-
ing (SAXS). With Fluorescence Correlation Spectroscopy (FCS) we
investigated the encapsulation both of model hydrophilic and
hydrophobic molecules within the cubic phase, and their diffusion
behavior was monitored within the liquid crystalline structure,
respectively inside the aqueous channels and in the lipid bilayer.
Then, we prepared cubosomes and magnetocubosomes by dispers-
ing the bulk cubic phase with Pluronic F-127, in the presence and
in the absence of NPs. Cubosomes and magnetocubosomes were
fully characterized through SAXS, Dynamic Light Scattering (DLS)
and zeta potential to assess the physicochemical features of the
designed DDS and their stability in time. Finally, we monitored
through FCS the ability of both the bulk cubic phase and of cubo-
somes loaded with NPs, to release a model drug in aqueous envi-
ronment upon application of a LF-AMF.
2. Materials and methods
2.1. Chemicals
Fe(III)acetylacetonate, 1,2-hexadecanediol, oleylamine, oleic
acid, diphenylether, ethanol and hexane employed for the synthe-
sis of the NPs, were purchased from Sigma Aldrich (St. Louis MO),
the same for the Glyceryl Monooleate (GMO) and Pluronic F-127.
GMO is a polar lipid included in the FDA Inactive Ingredients
Guide, used as a food additive and classified as ‘‘generally
recognized as safe, (GRAS) [21]. Rhodamine 110 Chloride and Octa-
decyl Rhodamine B Chloride employed for the Fluorescence Corre-
lation Spectroscopy experiments were purchased respectively
from Sigma Aldrich (St. Louis MO) and from Invitrogen (Heidel-
berg, Germany). The same for Alexa 568 employed for FCS
calibration.
2.2. Synthesis of magnetite nanoparticles
Iron oxide nanoparticles were synthesized according to the pro-
tocol reported by Wang et al. [22]. Briefly, 0.71 g Fe(acac)3
(2 mmol) were dissolved in 20 mL of phenyl ether with 2 mL of
oleic acid (6 mmol) and 2 mL of oleylamine (4 mmol) under
argon atmosphere and vigorous stirring. 1,2-hexadecanediol
(2.58 g, 10 mmol) was added into the solution. The solution was
heated to 210 C, refluxed for 2 h and then cooled to room temper-
ature. Ethanol was added to the solution and the precipitate col-
lected, washed with ethanol and redispersed in 20 mL of hexane
in the presence of75 mM each of oleic acid and oleylamine. A sta-
ble dispersion of the magnetic NPs with a hydrophobic coating of
oleic acid and oleylamine in hexane was thus obtained.
2.3. Preparation of cubic phases
30 mg of GMO were weighted in a glass vial and a small volume
of hexane was added to completely dissolve the powder. The sol-
vent was then evaporated under a stream of nitrogen and kept
under vacuum overnight. Subsequently, the proper amount of
H2O (50% w/w or more) was added to obtain a fully hydrated paste.
The samples were homogenized with ten cycles centrifugation
(1000 rpm, 50 each, alternating one cycle with the glass vial
upward and the following the other way round). For the prepara-
tion of the cubic phases loaded with nanoparticles, first the proper
amount of NPs’ dispersion in hexane was weighted in a glass vial,
in order to have 6 mg of NPs, the solvent was then evaporated
under a stream of nitrogen obtaining a dry film of NPs on the walls
of the vials. Then, 30 mg of GMO were added and the previously
described protocol adopted. For the preparation of the cubic phases
for the FCS experiments a similar procedure was followed. For the
addition of the lipophilic fluorescent tag, octadecyl Rhodamine B, a
proper amount of the solution of the probe was added to the GMO
solution in hexane, in order to obtain a 0.01% mol:mol amount of
the probe with respect to the total lipid quantity. For the addition
of the hydrophilic drug, a 1 lM (for the study on the diffusion of
Rhodamine 110 inside the cubic phase channels) or 10 lM (for
the study on the release of Rhodamine 110 from the cubic phase
channels) aqueous solution of Rhodamine 110 was employed to
hydrate the GMO or GMO-NPs films, instead of H2O.
2.4. Preparation of cubosomes
For the preparation of cubosomes, first a GMO or GMO-NPs dry
film was obtained, as previously described. 8 mg of Pluronic F-127
were added to the dry films and the mixture was put in a water
bath at 70 C for 50 to melt the Pluronic F-127 and then vortexed
for 50. Five cycles of heating-vortexing were carried out and then
500 lL of preheated H2O at 70 C were added. The dispersion
was then sonicated in a bath-sonicator for 6 h, to homogenize
the system. For the preparation of fluorescently-labeled cubo-
somes and magnetocubosomes the same preparation protocol
was employed. The proper amount of Octadecyl Rhodamine B
(0.01% with respect to total GMO amount) was added to the
GMO solution, as previously described for the preparation of the
cubic phase. 500 lL of preheated Rhodamine 110 solution was
employed instead of pure water to hydrate the GMO-(NPs)-Pluron-
ic F-127 hot paste, in order to insert the fluorescent probe
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Rhodamine 110 inside the cubosomes. The excess of Rhodamine
was eliminated by purification through a size exclusion column.
2.5. Small-angle X-ray scattering
SAXS measurements were carried out on a S3-MICRO SAXS/
WAXS instrument (HECUS GmbH, Graz, Austria) which consists
of a GeniX microfocus X-ray sealed Cu Ka source (Xenocs, Greno-
ble, France) power 50 W which provides a detector focused X-ray
beam with k = 0.1542 nm Cu Ka line. The instrument is equipped
with two one-dimensional (1D) position sensitive detectors,
(HECUS 1D-PSD-50 M system) each detector is 50 mm long
(spatial resolution 54 lm/channel, 1024 channels) and cover
the SAXS Q-range (0.003 < Q < 0.6 Å1) and the WAXS Q-range
(1.2 < Q < 1.9 Å1). The temperature was controlled by means of a
Peltier TCCS-3 Hecus. SAXS spectra were recorded at 25 C. SAXS
spectra were recorded in a glass capillary for cubosomes’ disper-
sions and NPs dispersions and in a solid sample-holder for the
cubic phases.
2.6. Dynamic light scattering
DLS measurements were carried out on a Brookhaven Instru-
ments apparatus (BI 9000AT correlator and BI 200 SM goniometer).
The signal was detected by an EMI 9863B/350 photomultiplier. The
light source was the second harmonic of a diode Nd:YAG laser,
k = 532 nm Coherent DPY315M-100, linearly polarized in the verti-
cal direction. The normalized electrical field time autocorrelation
functions of the normalized intensity time autocorrelation of the
scattered light were measured at 90 and analyzed according to
the Siegert relationship (Eq. (1)), which connects the first order
or field normalized autocorrelation function g1(q, s) to the mea-
sured normalized time autocorrelation function g2(q, s):
g2ðq; sÞ ¼ 1þ bjg1ðq; sÞj2 ð1Þ
with b being the spatial coherence factor which depends on the
geometry of the detection system. The functions (b|g1(q, s)|2)1/2)
were also normalized to vary between 0 and 1 for display purposes.
The field autocorrelation functions were analyzed through a cumu-
lant analysis stopped to the second order.
2.7. Zeta potential
Zeta potential measurements were taken using a zeta potential
analyzer (Zeta Plus, Brookhaven Instruments Corporation, Holts-
ville, NY). Zeta potentials were obtained from the electrophoretic
mobility u, according to Helmholtz–Smoluchowski equation
(Eq. (2)):
f ¼ g=e u ð2Þ
with g being the viscosity of the medium and e the dielectric per-
mittivity of the dispersing medium. The zeta potential values are
reported as averages from 5 measurements on each sample.
2.8. Transmission electron microscopy
Transmission Electron Microscopy (TEM) images were acquired
with a STEM CM12 Philips electron microscope. The nanoparticle
samples dispersed in hexane solution were cast onto a carbon-
coated copper grid sample holder, followed by evaporation at room
temperature.
2.9. Fluorescence Correlation Spectroscopy
FCS experiments were carried out with a laser scanning confo-
cal microscope Leica TCS SP2 (Leica Microsystems GmbH, Wetzlar,
Germany) equipped with a 63 water immersion objective instru-
ment by using the 561 nm and 488 nm laser lines, respectively for
Octadecyl Rhodamine B and Rhodamine 110. The fluorescence
emission was acquired with a ISS module (ISS, Inc. 1602 Newton
Drive Champaign, IL, USA) equipped with two APD with 500–
530 nm (where the fluorescence emission of Rhodamine 110 was
acquired) and 607–683 nm (where the fluorescence emission of
Octadecyl Rhodamine B was acquired) band pass, respectively.
The autocorrelation function of the fluorescence intensity, G(s), is
evaluated as a function of the fluctuations of the signal from the
average value, as:
GðsÞ ¼ dIðtÞdIðt þ sÞ
hIðtÞi2
ð3Þ
The models employed for the analysis of the autocorrelation
functions (ACFs) take into account the shape and the exact size
of the detection volume, which is approximated as 3D-ellipsoidal
Gaussian shape with axial (z0) and lateral (w0) defining parameters,
determined through a calibration performed with a reference fluo-
rescent dye with known diffusion coefficient (50 nM standard
solutions of Rhodamine 110 and Alexa 568, with respectively
D = 430 lm2 s1 and D = 332 lm2 s1 in water at 25 C). For a
three-dimensional Brownian diffusion mode in a 3D Gaussian vol-
ume shape, the ACFs profiles can be analyzed according to the
equation [23,24]:
GðsÞ ¼ 1
< c > p3=2w0z0
1þ 4Ds
w20
 1
1þ 4Ds
z20
 1=2
ð4Þ
With hci the averaged fluorophore concentration, D the diffusion
coefficient of the probe (lm2 s1).
The general expression for the analysis of the autocorrelation
function of the fluorescence intensity due to the 3D diffusion con-
tribution of different i diffusing entities, is:
GðsÞ ¼ 1
< c > p3=2w0z0
X
i
f i 1þ
4Dis
w20
 1
1þ 4Dis
z20
 1=2
ð5Þ
Being hci the average fluorophore concentration and fi the weight
factor of each i diffusing component characterized by diffusion coef-
ficient Di.
2.10. Magnetic field
A sinusoidal magnetic field was generated in the gap of a broken
toroidal magnet carrying a solenoid through which an alternating
electric current (AC) from a tone generator was led, as described
in a previous publication. The samples to be treated with LF-AMF
were placed in the middle of the gap. Due to the design of the
experimental apparatus, the magnetic field inside the cell is not
isotropic [25]. During the release experiments, the field frequency
was set at 6 kHz.
3. Results and discussion
3.1. Bulk cubic phase
Fig. 1a reports the SAXS spectra of the bulk cubic phase pre-
pared as described in the experimental section, in the absence of
NPs. As expected, the Bragg reflections of a Pn3m cubic phase
can be detected. The cubic lattice parameter a can be obtained
through the linear fit of the plot of qhkl vs (h2 + k2 + l2)1/2 (1a, inset),
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according to the crystallographic relation a = 2p/qhkl(h2 + k2 + l2)1/2,
being qhkl the measured position of each peak defined by hklMiller
indices. The resulting value a = 95.4 ± 0.9 Å is in agreement with
the data reported in the literature for the same system [26–28].
The structure of the Pn3m cubic phase, sketched in the inset of
Fig. 1a, is characterized by a continuous curved lipid bilayer region,
which forms a complex three-dimensional cubic structure separat-
ing two continuous non-intersecting water channels [29]. The
radius of the inner water channels rw can be calculated according
to the relation rw = [(r/2pv)1/2a]  l with l the lipid length
(17 Å) and r and v topological constants, characteristic of a given
cubic phase, equal to 1.919 and 2 for the Pn3m structure, respec-
tively [26]. The obtained value is 20.3 Å, which is consistent with
the literature data [26]. The structure of the cubic phase is able
to host at the same time, embedded in separated compartments,
hydrophobic and hydrophilic drugs. However, the open structure
of the cubic phase, with the channels connected to the surface
and the aqueous medium, determines a non-permanent encapsu-
lation of the hydrophilic drugs, which can diffuse spontaneously
inside the channels and reach the surface.
Several studies have addressed this issue both in terms of diffu-
sion of model drugs inside the structure of the cubic phase (e.g.
through NMR Self-Diffusion experiments and theoretical studies
[30–32]), and in terms of release rate of a model drug from the
cubic phase inside an aqueous environment [33]. However, this
point still stirs debate. In this regard, Fluorescence Correlation
Spectroscopy (FCS) provides spatially resolved information on the
diffusion both of hydrophilic and hydrophobic molecules inside
the cubic phase.
This technique monitors fluctuations of fluorescence emission
in the confocal volume; the time autocorrelation of these fluctua-
tions provides information on the diffusion coefficient of the fluo-
rescent species. FCS provides spatial selectivity with the resolution
provided by a confocal geometry and chemical selectivity, since
only the fluorescent species are detected and their behavior in a
complex matrix can be singled out.
In order to characterize the encapsulation of model drugs and
their dynamics when confined in the DDS, an amphiphilic (Octa-
decyl Rhodamine B, carrying an extended highly hydrophobic lipid
chain) and a hydrophilic (Rhodamine 110) fluorescent tag, as drugs
models, were inserted in the cubic phase and their diffusion mon-
itored through FCS. Very few studies [34–36] have been performed
on the diffusion of fluorescent probes inside mesophases. These
investigations demonstrated that the diffusion mode of the probes
(in terms of dimensionality of diffusion environment), as well as
the normal or anomalous time dependence of the mean square dis-
placement of a species, provide information on the viscosity, size
and structure of the medium. Fig. 1b reports representative FCS
curves acquired for the lipophilic Octadecyl Rhodamine B (red
markers). The curves can be analyzed according to a 3D normal dif-
fusion mode (Eq. (5), i = 1, the fitting curve is reported as a contin-
uous red line), which provides a value of 4.7 ± 0.5 lm2 s1 for the
3D diffusion coefficient of the probe within the lipid structure.
The analysis of the motion of an amphiphilic probe diffusing
along the tridimensional bilayered structure of a cubic phase is
not straightforward. Generally, the diffusion of a fluorescently-
labeled lipid in a lipid bilayer (i.e. a Supported Lipid Bilayer or a
Giant Unilamellar Vesicle (GUV) or a lamellar liquid crystalline
phase) [37,38] is analyzed according to 2D diffusion, since the cur-
vature of the lipid membrane is significantly lower with respect to
the single molecule size and to the FCS detection volume. The
motion can be then described as confined in the bilayer plane. Con-
versely, the cubic phase is characterized by a bilayered structure
with a high local curvature, since the radius of the aqueous chan-
nels is generally around 2 nm, three orders of magnitude lower
than the radius of a typical GUV, in the range of several microns.
A 3D diffusion mode can be consistent with the structure of the dif-
fusing environment experienced by the fluorescent probe. How-
ever, we are aware that the FCS investigation of the motion of a
hydrophobic molecule embedded in a complex liquid crystalline
structure is a complex issue, that will require further modeling.
Fig. 1c compares the FCS curves of the hydrophilic probe Rhoda-
mine 110 freely diffusing in water (black markers) and inside the
aqueous channels of the GMO cubic phase (green markers). Also
Fig. 1. SAXS profile of the bulk cubic phase of GMO (a); confocal microscopy image
of the GMO bulk cubic phase, prepared in the presence of the fluorescently-labeled
lipid Octadecyl Rhodamine B (red), representative FCS curve acquired for Octadecyl
Rhodamine B inside the cubic phase (red markers) and curve fit of the experimental
data according to a 3D normal diffusion model (continuous line) (Eq. (5), i = 1) (b);
confocal microscopy image of the GMO bulk cubic phase, prepared in the presence
of the water soluble fluorescent probe Rhodamine 110 (green), representative FCS
curve acquired for Rhodamine 110 in pure water (black markers) inside the cubic
phase (green markers) and curve fit of the experimental data according to a 3D
normal diffusion model (continuous lines) (Eq. (5), i = 1) (c). (For interpretation of
the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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in this case the curves were analyzed according to a 3D normal dif-
fusion mode, with the diffusion coefficient of the free diffusing
Rhodamine 110 at 25 C equal to 430 lm2 s1 [39]. Interestingly,
the diffusion of the Rhodamine 110 inside the cubic phase can still
be analyzed as a 3D diffusion inside the aqueous channels, but its
diffusion rate is slowed down of more than one order of magnitude
(11 ± 1 lm2 s1). This effect could be related to the restricted
mobility of water confined into the water channels [40,41] of the
cubic phase and/or to the possible interaction of the probe mole-
cules onto the internal surface of the aqueous channels. The hydro-
dynamic size of Rhodamine 110, evaluated through the Stokes–
Einstein equation, considering the diffusion coefficient of the mol-
ecule in pure water, yields a value of 1 nm. Therefore, the molecu-
lar hydrodynamic size, comparable with the size of the channels
(around 4.6 nm), might suggest a hampered 3D diffusion of the
molecule, due to confinement cage effects [33,42,43].
As already stated, the overall structure of the cubic phase is
characterized by the communication of the aqueous channels with
the external aqueous environment, thus, hydrophilic guest mole-
cules are spontaneously released from the cubic phase. From FCS
data we see that the spontaneous diffusion towards the surface
is more than one order of magnitude slower with respect to the
normal diffusion in the bulk phase. Therefore the hydrophilic fluo-
rescent molecules are efficiently retained inside the cubic phase,
possibly due to confinement effects. Concerning the hydrophobic
molecules embedded within the lipid structure of the cubic phase,
FCS data show that they exhibit a relatively free mobility inside the
lipid bilayered structure. It can then be expected that they are
released only upon interaction with a lipid bilayer [44] through
fusion of the cubic phase with the lipid membrane of the target
cells, while an external trigger can be used to boost the release
of the hydrophilic drug, accelerating its diffusion from the aqueous
internal channels to the external aqueous environment.
The control over release of a model hydrophilic drug can be pro-
vided by incorporation of magnetic nanoparticles inside the lipid
structure of the cubic phase. Very few examples have been pre-
sented concerning the incorporation of superparamagnetic iron
oxide nanoparticles (SPIONs) inside a cubic phase. In particular, it
has been reported that ferrite NPs can be synthesized in situ inside
the water channels of the cubic phase [45]; in addition, presynthe-
sized NPs were incorporated in the cubic phase, to build-up a new
class of MRI contrast agents [20].
In this paper we report for the first time on the inclusion of
hydrophobic magnetic NPs in the bilayer of the bicontinuous struc-
ture as a responsive system for drug release. It has been proved
that magnetic NPs encapsulated inside liposomes lead, upon appli-
cation of a LF-AMF, a structural destabilization of the bilayer with
the formation of pores, which can allow the escape of drugs from
the aqueous pool of liposomes, thus acting as a release trigger
[46–48]. Moreover, previous studies, performed on magnetic NPs
clusters connected through pairing of complementary DNA
strands, have demonstrated that the effect of local heating, gener-
ated by the application of a LF-AMF, can be employed to reach the
melting temperature of the ds-DNA and release a single-stranded
DNA in the aqueous environment [25]. In this study we employ
the SPIONs as an internal responsive component to actuate, thanks
to the application of a LF-AMF, the release of a hydrophilic mole-
cule confined within the aqueous channel of the cubic phase.
The hydrophobic Fe3O4 NPs were synthesized according to the
procedure described in the experimental section, yielding a stable
hexane dispersion of SPIONs passivated by oleic acid and oleyl-
amine. The NPs were characterized in terms of size and size-distri-
bution through TEM and SAXS measurements. Fig. 2a shows a
representative TEM image acquired for the NPs, which yields a size
of 6 ± 1 nm diameter and provides evidence of the presence of
monodisperse and non aggregated particles. The SAXS data
acquired on the same sample are displayed in Fig. 2b (black mark-
ers). A model-free analysis in the low-q range according to the Gui-
nier asymptotic law provides a value for the diameter of gyration
equal to 6.9 nm. Alternatively, the data were interpreted with a
spherical form factor and a Schultz polydispersity model (Fig. 2b,
red continuous line). From the fitting of the experimental curves,
we obtained a value of 5.4 nm for the diameter of the spheres
and 0.17 as polydispersity index, which are in agreement with
the TEM data. Taking into account that the bilayer has a thickness
of around 3.5–4 nm, the hydrophobic nanoparticles have a suitable
size to be inserted inside the lipid bilayer, causing only a local
destabilization of the lipid structure.
The fully hydrated GMO cubic phases were prepared with incor-
porated hydrophobic nanoparticles, to monitor the effect of the
NPs on the structure of the cubic phase. We performed SAXS exper-
iments on the cubic phase loaded with the NPs, as shown in Fig. 2c.
The presence of a low-q small angle contribution (highlighted by a
red ellipse), can be ascribed to the structure factor deriving from
the spatial correlation of the NPs inside the cubic structure. The
effect of the presence of NPs on the structure of the cubic phase
is modest, i.e., all the six Bragg reflections observed for the cubic
phase in the absence of NPs (Fig. 1a) are still detectable, highlight-
ing that the order on the mesoscale is not disrupted by the inclu-
sion of the NPs. From the linear fit of qhkl vs (h2 + k2 + l2)1/2
(Fig. 2c, inset) we obtain a lattice parameter a = 86.4 ± 0.8 Å.
Apparently, the incorporation of the nanoparticles in the cubic
phase results in the shrinkage of the structure, with a decrease of
the lattice parameter of about 1 nm.
Taking into account the tortuosity of the cubic phase, which
determines an interfacial area of about 400 m2/g, we can estimate
the number of NPs per surface unit. Considering the cross section
of each nanoparticle (calculated as pr2, with r the radius of the
NPs’core, obtained from TEM and SAXS measurements) and the
density of bulk magnetite, it is possible to estimate the number
of particles included in the cubic phase and hence the total inter-
acting surface of the nanoparticles. By comparing this value with
the inner surface of the cubic phase, one obtains that the nanopar-
ticles are covering around 2.5% of the inner surface of the cubic
phase structure, with an average nanoparticles’ distance of
12.5 nm, which nicely matches the structure factor position in
the scattering vector space. This amount determines a clearly
detectable effect on the lattice parameters of the cubic phase (i.e.
the shrinkage of the lattice parameter), without disrupting the
overall symmetry.
3.2. Cubosomes and magnetocubosomes
The main limitations in the employment of the cubic phases as
drug delivery systems are their rheological properties (they are
highly viscous systems, which are not suitable e.g. for injection)
and their irritating effect on the tissues. Discrete cubic nanoparti-
cles (cubosomes), obtained by dispersion of the bulk phase, have
been developed, in order to overcome these drawbacks [11].
We prepared cubosomes with a well-established top-down
approach, by hydrating the cubic phase in the presence of a stabi-
lizing agent (the block copolymer PEO/PPO/PEO Pluronic F-127)
and then providing an energy input by heating, vortexing and son-
icating in order to obtain a stable dispersion, stabilized by a surface
cushion of the triblock copolymer (see the experimental section for
details).
Fig. 3a reports the SAXS spectra obtained for the cubosomes as
prepared (black line) and loaded with NPs (red line). Clearly, the
Bragg peaks of the inner cubic phase are superimposed to a form
factor due to the dispersed nature of the lipid nanoparticles,
and only four peaks can be recognized (q = 6.66  102 Å1;
q = 8.14  102 Å1; q = 9.39  102 Å1; q = 1.15  101 Å1). By
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indexing the peaks according to a Pn3m cubic structure, the lattice
parameter results 133 Å, which is considerably higher than that of
the bulk cubic phase. It is known that the presence of solutes can
affect the internal structure of cubosomes, both concerning the lat-
tice parameter and in terms of cubic phase nature. For instance, it
has been proved [49] that high percentages of Pluronic with
respect to the GMO amount, leads to an increase of the Pn3m
lattice parameter and even to a structural variation, where the
penetration of Pluronic inside the water channels shifts the
equilibrium towards a cubic structure of Im3m geometry. Interest-
ingly, the Im3m phase is also compatible with the SAXS pattern we
observe for cubosomes. However, the quality of the data does
not allow discriminating between the two cubic phases, since
the fingerprint for the Pn3m geometry, the second peak at
q = 8.14  102 Å1, is barely distinguishable from the background
noise. In the presence of the NPs, the form factor of nanoparticles
covers almost completely the cubosomes’ internal structure factor;
however, the fourth peak of the Pn3m (or the third peak of the
Fig. 2. TEM micrography of the Fe3O4-oleate NPs (a); SAXS spectrum measured for the Fe3O4-oleate NPs (black markers) in hexane and curve fit of the experimental data
according to the Schultz-spheres fitting model (b); SAXS profile of the bulk cubic phase of GMO loaded with magnetite NPs (c).
Fig. 3. SAXS profile of the cubosomes in the absence (black line) and in the presence (red line) of Fe3O4-oleate NPs (a); representative normalized DLS curves obtained for the
cubosomes as prepared (black line) and loaded with Fe3O4-oleate NPs (red line) (b); representative FCS curve measured for cubosomes loaded with NPs containing a
Octadecyl Rhodamine B tag within the lipid region (c). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
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Im3m) is still very visible, confirming that the nanoparticles are
indeed incorporated in the cubosomes without affecting their
liquid–crystalline structure.
Fig. 3b shows some representative DLS curves of the cubosomes
(black line and markers) and of magnetocubosomes (red line and
markers). We notice a slight increase of the decay time of the
ACF in the presence of nanoparticles; however, this effect is limited
and no destabilization or occurrence of multiple size populations is
detected. Table 1 summarizes the DLS and zeta potential data
acquired on the cubosomes, whose hydrodynamic size is about
200 nm both in the absence and in the presence of nanoparticles
and is stable in time (24 h). The slightly negative charge of the
cubosomes (see zeta potential data, Table 1) can provide an addi-
tional contribution to their stability against aggregation, which
sums up to the steric stabilization due to Pluronic F-127.
Fig. 3c reports a representative FCS curve obtained for magneto-
cubosomes containing the fluorescent tag Octadecyl Rhodamine B
in the lipid bilayer (black markers). The curve was analyzed
according to a simple 3D diffusion model, obtaining for the diffu-
sion coefficient a value of 2.4 ± 0.4 lm2 s1, consistent, according
to the Stokes–Einstein equation, with a hydrodynamic diameter
of 180 nm. Considering that the FCS analysis does not take into
account any polydispersity for the particles and the size distribu-
tion range of the z-averaged values for the hydrodynamic diame-
ters (see Table 1) we can consider the agreement between the
sizes obtained for the batches as satisfying.
3.3. Release from bulk cubic phases
Finally, the release of a model hydrophilic drug from the aque-
ous channels of the hybrid lipid/SPION DDS cubic phase was inves-
tigated upon application of a LF-AMF, as external trigger with
space and time control. We studied both the release from the bulk
cubic phase and from the magnetocubosomes through FCS.
Fluorescence Correlation Spectroscopy offers a unique opportu-
nity to study spatially resolved phenomena in situ. In this work
samples were monitored during the application of the LF-AMF.
As described in the experimental section, a solution of the
hydrophilic fluorescent probe Rhodamine 110 was employed to
hydrate the dried GMO-NPs mixture.
The fluorescent probe is confined inside the aqueous channels
of the cubic phase and its diffusion is slowed down with respect
to the free diffusion in water. However, it can be expected
that upon addition of an excess of water to the bulk cubic phase,
the fluorescent molecules partition, due to the concentration
gradient, to the surface of the cubic phase in the aqueous
environment.
The leakage of the dye can be investigated in situ through FCS,
which provides, through the intercept of the correlation func-
tion, a quantitative measurement of the average concentration
of the fluorescent molecule in the observation volume (see
Eqs. (4) and (5)).
Therefore, thanks to the spatial resolution of the technique, if
this volume is selected in the excess water solution which hydrates
the cubic phase, it is possible to directly determine the dye concen-
tration, the dimensionality of its diffusion motion, and the diffu-
sion coefficient. These two latter pieces of information are
important to rule out any presence of mixed lipid/Rhodamine
assemblies.
Fig. 4a displays some representative FCS curves acquired in the
excess aqueous phase of the measurement well containing the
cubic phase, just after the addition of the excess water (t = 00)
and every 10 min for thirty minutes. The same experiment was
performed by applying to the measurement chamber a LF-AMF
(Fig. 4b).
The main parameters characterizing a FCS curve are the decay
time, which corresponds to the s value of the inflection point
and is connected to the diffusion coefficient of the fluorescent
Table 1
Hydrodynamic diameter (Dh) and polydispersity index (PDI) of cubosomes’ disper-
sions, in the absence (cubosomes) and in the presence (magnetocubosomes) of Fe3O4-
oleateNPs, obtained from the analysis of DLS measurements carried out just after and
after 24 h from samples preparation; zeta potential values (f-potential) measured for
cubosomes in the absence and in the presence of NPs.
Cubosomes Magnetocubosomes
f-potential 16 ± 4 mV 14 ± 3 mV
Dh (t = 0) 210 ± 30 nm 230 ± 50 nm
PDI (t = 0) 0.08 ± 0.05 0.09 ± 0.05
Dh (t = 24 h) 250 ± 40 nm 240 ± 50 nm
PDI (t = 24 h) 0.12 ± 0.05 0.13 ± 0.05
Fig. 4. FCS curves acquired for Rhodamine 110 released from GMO cubic phase to
the surrounding aqueous medium spontaneously (a) and upon application of an
AMF (b). Curves measured at t = 0; 100; 200; 300 after the addition of water to the
measurement chamber containing the cubic phase (markers); curve fitting of the
experimental data (continuous lines). (For interpretation of the references to colour
in this figure legend, the reader is referred to the web version of this article.)
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species, and the intercept value G(0), which is inversely propor-
tional to the concentration of the fluorescent molecule.
The diffusion coefficient of Rhodamine 110 in water at 25 C is,
as already stated, known (430 lm2 s1). Conversely, the concentra-
tion of the probe inside the aqueous phase of the well is the
unknown quantity and should increase with time due to the diffu-
sion of Rhodamine 110 from the cubic bulk phase to the excess
water. This effect is clear from the progression of the profiles of
the FCS curves acquired for increasing elapsed times, which exhibit
a steady decrease of the ACF intercept value, i.e. an increase of the
probe concentration in solution.
In the presence of the applied magnetic field this effect is how-
ever much more pronounced, (Fig. 4b) with respect to the ‘‘sponta-
neous’’, i.e. driven by thermal equilibrium, process (Fig. 4a).
All the curves were analyzed according to a 3D diffusion of the
dye (Eq. (5), i = 1), with the diffusion coefficient of Rhodamine 110
kept constant, to obtain a more robust estimate of the dye
concentration.
Fig. 5a displays the time progression (monitored for 60 min) of
Rhodamine 110 concentration in the excess solution, obtained
from the analysis of the FCS curves in the absence (black circles)
and in the presence (red triangles) of the magnetic field. The con-
centration values are normalized with respect to the concentration
measured at t = 0 min (C/C0) and a linear fit of the experimental
points is included as a guide for the eye. As already visible from
the comparison of the original ACFs profiles, the application of
the LF-AMF determines a strong increase in the rate of dye release
from the cubic phase.
This is a clear indication the magnetic field acts as trigger that
actuates the release of the model drug included in the aqueous
channels of the cubic phase, boosting the spontaneous leakage
and providing spatial (since the LF-AMF is applied in a defined
region of space) and a temporal control.
In a previous study on magnetoliposomes, we verified that upon
application of an alternating magnetic field, the local heating pro-
voked by the relaxation of the nanoparticles determines the forma-
tion of temporary pores in the lipid membrane surrounding the
aqueous pool of liposomes, thus determining the release of the
molecules encapsulated inside the aqueous pool in the surround-
ing medium [50]. Since the cubic phase, unlike liposomes, is char-
acterized by the presence of open aqueous compartments, which
are connected to the external surface, it can be expected that small
molecules are able to migrate towards the surface of the cubic
phase, under a concentration gradient. Thus as evident from the
displayed data (Figs. 4a and 5a) Rhodamine 110 molecules are
spontaneously and slowly released from the cubic phase. The
increase in the release rate in the presence of an applied AMF
can be due to an additional contribution to the release kinetics,
which is much more effective with respect to the spontaneous
migration, due to the formation of pores in the lipid bilayered
structure of the cubic phase, allowing the hydrophilic solutes pres-
ent in the aqueous channels to overcome the tortuous pathway of
the cubic phase to be rapidly released in the aqueous environment.
In order to investigate the release kinetics, we employed the Rit-
ger–Peppas model to define the solute transport process in the
presence and in the absence of applied AMF. Fig. 5b reports the
concentration of the solute (Rhodamine 110) at time t (Mt) normal-
ized for the concentration of solute at infinite time (we chose the
theoretical concentration for quantitative release as Minf) in
the absence (black markers) and in the presence (red markers) of
the LF-AMF. The Ritger–Peppas model describes the general release
kinetic process as [51–53]:
Mt
Minf
¼ ktn ð6Þ
for Mt/Minf < 0.6, being thus Mt/Minf the solute fraction released at
time t, k the kinetics constant and n the diffusion exponent, which
is related to the transport mechanism. From the fitting of the exper-
imental data according to the Ritger–Peppas model, we find n = 0.78
concerning the spontaneous release of Rhodamine 110 from the
cubic phase, while n increases up to 1 upon application of the
AMF. Classically, values of n comprised between 0.4 and 0.5 are
due to a purely Fickian transport mechanism (case-I), while case-
II transport occurs when n = 1 and a so-called ‘‘anomalous trans-
port’’ is observed when the two processes are coupled. It is known
[33] that the release from a bicontinuous cubic phase is expected as
purely Fickian, while in our case a higher value of n is obtained. This
effect could be possibly due to the very slow release observed in our
system (so we are able to investigate only the very early stage of the
release process) and to the experimental setup, where the bulk
cubic phase is deposited on the bottom of the measurement well
as a semispherical paste exposed to the solvent, with a limited con-
trol on the actual surface exposed to the external medium and,
moreover, the extended application of a laser beam to the system
Fig. 5. Release of Rhodamine 110 from the aqueous channels of the cubic phase to the aqueous environment; spontaneous release (black lines and circles) and release upon
application of an AMF (red lines and triangles). Trend of the normalized concentration of Rhodamine 110 (reported as concentration at time t C divided for to the initial
concentration C0), with time (a). Trend of the released amount of Rhodamine 110 (reported as concentration at time t Mt divided for the concentration at infinite time Minf)
with time (black and red markers), curve fit of the curves according to the Ritger–Peppas model (black and red continuous lines) (b). (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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could cause a local slight increase in the temperature, that could
affect the release process. These factors could lead to an anomalous
behavior of the diffusion from the cubic phase to the aqueous envi-
ronment. However, the application of the magnetic field changes
the transport process, which follows a case-II transport kinetics,
which can be attributed to the destabilization of the lipid mem-
brane and to the formation of pores, similarly to what previously
observed on magnetoliposomes [47].
3.4. Release from magnetocubosomes
To the best of our knowledge, no studies have addressed the
issue of a triggered release of a drug from cubosomes or magneto-
cubosomes. We report here for the first time the release of the fluo-
rescent tag from magnetocubosomes, prepared as described in the
experimental section. The retention of a hydrophilic drug inside
the cubosomes’ aqueous channels and the control of its release is
much more challenging with respect to the cubic phase, since
the small size of cubosomes determines a strong decrease in the
tortuous pathway of the encapsulated molecules to reach the sur-
face and thus facilitates a lot the spontaneous release of a hydro-
philic drug embedded in the aqueous channels. We studied with
FCS the diffusion of magnetocubosomes containing both the Octa-
decyl Rhodamine B tag embedded in the lipid structure and the
hydrophilic Rhodamine 110 in the aqueous channels. Fig. 6a dis-
plays representative ACFs acquired for the same magnetocubo-
somes’ sample by monitoring at the same time the diffusion of
the Octadecyl Rhodamine B lipid tag (red triangles) and of the Rho-
damine 110 (green circles). The diffusion of Octadecyl Rhodamine
B is attributable to the solely relaxation of the molecules present
inside the cubosomes (see Fig. 3c and discussion) and is thus ana-
lyzed according to a one diffusing component 3D diffusion model
(Eq. (5), i = 1, Fig. 6 red continuous lines). Conversely, the diffusion
of Rhodamine 110 is due to the combination of the contribution of
the free Rhodamine in solution (with D1 = 430 lm2 s1) and the
contribution of the Rhodamine inside cubosomes. This latter diffu-
sion coefficient can be assumed equal to that of the Octadecyl Rho-
damine B inside cubosomes, determined by the translational
motion of the entire cubosomes (D2 = 2.4 lm2 s1). A two compo-
nent 3D diffusion was thus employed to analyze the motion of
magnetocubosomes labeled with Rhodamine 110 (Eq. (5) i = 2,
Fig. 6 green continuous lines), keeping fixed the diffusion coeffi-
cient values (D1 = 430 lm2 s1, D2 = 2.4 lm2 s1) and obtaining,
as a result, the relative percentage of each contribution (free Rho-
damine 110 and Rhodamine 110 embedded inside cubosomes) to
the overall autocorrelation function. Before the application of the
AMF to the cubosomes’ dispersion the two-components analysis
of the Rhodamine 110 diffusion leads to an evaluation of the
retained percentage of Rhodamine 110 inside cubosomes of
17.2%. This percentage can be considered low, however, it has to
be considered that Rhodamine 110 is a small molecule, compared
to possible drugs, and that cubosomes were prepared 24 h before
the measurements. The measured concentration of Rhodamine
110 found free outside the cubosomes (82.8%) can be considered
as that spontaneously released in a long time. Moreover, it can
be expected that the size exclusion column employed for the elim-
ination of the Rhodamine 110 excess is not able to completely pur-
ify the sample from the free Rhodamine 110, especially taking into
account the high sensitivity of the FCS technique. After ten minutes
application of the AMF (Fig. 6b) the percentage of Rhodamine 110
retained inside cubosomes decreases to 7.8%, thus a 9.4% release of
Rhodamine 110 in solution is observed as a direct consequence of
the application of the AMF. This experimental result highlights that
the application of a LF-AMF to magnetocubosomes can be effective
as a trigger to the release of a model hydrophilic drug from
magnetocubosomes.
4. Conclusions
In this work we present a new biocompatible multifunctional
and responsive drug delivery system where glyceryl-monooleate
(GMO) cubosomes are loaded with magnetic Fe3O4 nanoparticles.
These magnetocubosomes are able to host both hydrophilic and
hydrophobic therapeutics in separated compartments, and to
release the payload in a space and time controlled manner, upon
application of a low frequency alternating magnetic field (LF-AMF).
We characterized the encapsulation of hydrophobic magnetite
nanoparticles in the lipid bilayer of the GMO cubic phase, proving
that small nanoparticles, characterized by a diameter of the core
comparable with the lipid bilayer thickness of the cubic phase,
are efficiently embedded in the lipid region of the cubic structure,
without disrupting the overall symmetry of the liquid crystalline
phase. Moreover, we obtained stable and monodisperse cubosomes
Fig. 6. Representative FCS curves acquired for cubosomes loaded with magnetic
NPs containing both Octadecyl Rhodamine B and Rhodamine 110 tags, respectively
in the lipid region and in the aqueous channels, before (a) and ten minutes after (b)
the application of an AMF. Curve fit carried out according to a 3D one component
diffusion model (for Octadecyl Rhodamine B diffusion, Eq. (5) i = 1) and to a two-
components diffusion model (Eq. (5) i = 2), being the diffusion coefficients of the
two components (Rhodamine 110 inside cubosomes and free Rhodamine 110) kept
fixed at 2.4 lm2 s1 and 430 lm2 s1, respectively. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of
this article.)
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and magnetocubosomes by swelling the bulk cubic phase, both in
the absence and in the presence of nanoparticles, by means of the
stabilizing agent Pluronic F-127.
For the first time, Fluorescence Correlation Spectroscopy (FCS)
was employed to investigate the diffusing behavior of model
hydrophilic and hydrophobic drugs encapsulated inside the cubic
phase, proving that they are efficiently retained inside the cubic
phase, which can thus efficiently act as a vector for therapeutics
with different molecular characteristics and water affinity. Finally,
for the first time FCS was employed to investigate both the sponta-
neous and the LF-AMF actuated release of a model hydrophilic
drug from the aqueous channels of a cubic phase and of magneto-
cubosomes. We prove that the application of the LF-AMF dramati-
cally increases the release of the hydrophilic molecules from the
water channels of the Fe3O4 nanoparticles loaded cubic phase
and of magnetocubosomes, acting as a proper external trigger to
the release.
Both components of this multifunctional devices are biocom-
patible. We believe that this novel hybrid platform, endowed with
responsiveness to an external mild stimulus can represent an
extremely interesting and flexible device for the targeted delivery
of multiple therapeutic and or/diagnostic agents.
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